Search
Patexia Research
Case number 1:19-cv-05859

Evolve BioSystems, Inc. et al v. Abbott Laboratories > Documents

Date Field Doc. No.Description (Pages)
Sep 19, 2023 325 MINUTE entry before the Honorable Heather K. McShain: The Court has reviewed the parties' joint status report 324 which reports expert discovery is progressing. Parties propose an extended expert discovery schedule 319 because defendant's motion for leave to amend final invalidity and noninfringement contentions 292 remains pending. The Court adopts the parties' proposed expert discovery schedule as follows. Initial expert disclosures due 10/20/2023. Rebuttal reports due 12/01/2023. Defendant's reply expert report due 12/22/2023. Expert discovery to close 01/19/2024. Parties are placed on notice that the Court has updated its standing order on discovery motion requirements. This update makes changes to the parties' meet-and-confer requirements. In advance of the filing of any discovery motion, parties are directed to review Magistrate Judge McShain's updated requirements for discovery motions (available on the Court's website at www.ilnd.uscourts.gov by selecting the link for Magistrate Judge McShain and then the link for " Discovery Motion Requirements "). Moving forward, any motion that does not comply with the Court's standing order will be considered unripe for the Court's consideration. A joint status report is due 11/17/2023 to update the Court on the progress of expert discovery and any other matters the parties wish to raise with the Court. The parties may contact chambers at any time (by email to Chambers_McShain@ilnd.uscourts.gov) if they would like the Court's assistance with settlement. Mailed notice (ags) (Entered: 09/19/2023) (1)
Sep 18, 2023 324 STATUS Report (Joint) by Evolve BioSystems, Inc., Regents of the University of California Presented before Magistrate Judge (Chivvis, Matthew) (Entered: 09/18/2023) (3)
Sep 11, 2023 323 MINUTE entry before the Honorable Jorge L. Alonso: The parties' Joint motion for a trial date 321 is granted. Final Pretrial Order shall be emailed to Judge Alonso's proposed order email address by 8/16/24. Motions in limine with supporting memoranda shall be filed by 8/16/24; responses shall be filed by 8/30/24. Final Pretrial Conference set for 9/12/24 at 1:00 p.m. Jury trial set for 9/23/24 at 9:00 a.m. Motion hearing date of 9/12/23 is stricken. Notice mailed by Judge's staff (lf, ) (Entered: 09/11/2023) (1)
Sep 6, 2023 321 MOTION by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California for a Trial Date (Joint) Presented before District Judge (Chivvis, Matthew) (Entered: 09/06/2023) (2)
Sep 6, 2023 322 NOTICE of Motion by Matthew Alan Chivvis for presentment of motion for miscellaneous relief 321 before Honorable Jorge L. Alonso on 9/12/2023 at 09:30 AM. (Chivvis, Matthew) (Entered: 09/06/2023) (2)
Sep 5, 2023 319 MINUTE entry before the Honorable Heather K. McShain: Parties' joint stipulation 318 , which requests defendant be permitted to submit a reply expert report within thirty-five days after the deadline for rebuttal reports 302 , is granted. Initial expert disclosures due the earlier of: (a) three weeks from the District Judge's ruling on defendant's pending motion for Leave to Amend Final Invalidity and Noninfringement Contentions 292 or; (b) 10/06/2023. Rebuttal reports will be due 35 days later. Defendant's reply expert report will be due 35 days later. Expert discovery to close 35 days after the deadline for defendant's reply expert report. Enter order. Mailed notice. (pk, ) (Entered: 09/05/2023) (1)
Sep 5, 2023 320 JOINT STIPULATION AND ORDER ON ADDRESSING SECONDARY CONSIDERATIONS OF NON-OBVIOUSNESS IN EXPERT REPORTS. Signed by the Honorable Heather K. McShain on 9/5/2023. Mailed notice. (pk, ) (Entered: 09/05/2023) (1)
Sep 1, 2023 317 MINUTE entry before the Honorable Jorge L. Alonso: The Court has reviewed the parties' joint stipulation and proposed order 316 . The parties have included this Judge's name in the signature block of the "proposed order" filed on the docket, but this Judge has not found any corresponding proposed order in his proposed order email inbox, and the issue seems to be within the scope of the referral to Judge McShain. In the future, if the parties request any action from this Court, they shall file a motion and notice the motion for presentment before this Court. Notice mailed by Judge's staff (lf, ) (Entered: 09/01/2023) (1)
Sep 1, 2023 318 STIPULATION and Proposed Order on Addressing Secondary Considerations of Non-Obviousness in Expert Reports (Joint) (Wickramasekera, Nimalka) (Entered: 09/01/2023) (2)
Aug 30, 2023 316 STIPULATION and Proposed Order on Addressing Secondary Considerations of Non-Obviousness in Expert Reports (Joint) (Wickramasekera, Nimalka) (Entered: 08/30/2023) (2)
Aug 7, 2023 315 RESPONSE by Defendant Abbott Laboratories to objections, 314 (Wickramasekera, Nimalka) (Entered: 08/07/2023) (4)
Aug 4, 2023 314 OBJECTIONS by Evolve BioSystems, Inc., Regents of the University of California to reply, 312 , response in support of motion,, 311 to Defendant's Reply in Support of Its Motion to Amend Final Invalidity and Noninfringement Contentions (Attachments: # 1 Declaration of M. Chivvis, # 2 Exhibit A to M. Chivvis Declaration)(Chivvis, Matthew) (Entered: 08/04/2023) (0)
Jul 27, 2023 311 RESPONSE by Abbott Laboratoriesin Support of MOTION by Defendant Abbott Laboratories for Leave to Amend Final Invalidity and Noninfringement Contentions Presented before Presiding Judge 292 (Attachments: # 1 Declaration of Nimalka Wickramasekera in Support of Reply, # 2 Exhibit 16, # 3 Exhibit 17, # 4 Exhibit 18, # 5 Exhibit 19, # 6 Exhibit 20, # 7 Exhibit 21, # 8 Exhibit 22, # 9 Exhibit 23, # 10 Exhibit 24, # 11 Exhibit 25, # 12 Exhibit 26, # 13 Exhibit 27, # 14 Exhibit 28, # 15 Exhibit 29, # 16 Exhibit 30)(Wickramasekera, Nimalka) (Entered: 07/27/2023) (0)
Jul 27, 2023 312 SEALED REPLY by Abbott Laboratories to MOTION by Defendant Abbott Laboratories for Leave to Amend Final Invalidity and Noninfringement Contentions Presented before Presiding Judge 292 (Attachments: # 1 Exhibit 18, # 2 Exhibit 19, # 3 Exhibit 23, # 4 Exhibit 24, # 5 Exhibit 26, # 6 Exhibit 28, # 7 Exhibit 30)(Wickramasekera, Nimalka) (Entered: 07/27/2023) (0)
Jul 27, 2023 313 MOTION by Defendant Abbott Laboratories to seal document reply, 312 and Exhibits 18, 19, 23, 24, 26, 28, and 30 to Wickramasekera Declaration in Support thereof (Unopposed) Presented before Presiding Judge (Wickramasekera, Nimalka) (Entered: 07/27/2023) (4)
Jul 24, 2023 310 MINUTE entry before the Honorable Heather K. McShain: The Court has reviewed the parties' joint status report 308 which reports on expert discovery that parties are discussing a stipulation that would allow plaintiffs to address secondary considerations of non-obviousness in a rebuttal expert report and defendant to submit a reply expert report in response. A joint status report is due 09/18/2023 to update the Court on the progress of expert discovery and any other matters the parties wish to raise with the Court. The parties may contact chambers at any time (by email to Chambers_McShain@ilnd.uscourts.gov) if they would like the Court's assistance with settlement. Mailed notice. (pk, ) (Entered: 07/24/2023) (1)
Jul 21, 2023 309 TRANSCRIPT OF PROCEEDINGS held on June 8, 2023 before the Honorable Jorge L. Alonso. Order Number: 46309. Court Reporter Contact Information: Annette Montalvo, annette.montalvo@gmail.com. IMPORTANT: The transcript may be viewed at the court's public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through the Court Reporter/Transcriber or PACER. For further information on the redaction process, see the Court's web site at www.ilnd.uscourts.gov under Quick Links select Policy Regarding the Availability of Transcripts of Court Proceedings. Redaction Request due 8/11/2023. Redacted Transcript Deadline set for 8/21/2023. Release of Transcript Restriction set for 10/19/2023. (Montalvo, Annette) (Entered: 07/21/2023) (0)
Jul 18, 2023 308 STATUS Report (JOINT) by Evolve BioSystems, Inc., Regents of the University of California Presented before Magistrate Judge (Chivvis, Matthew) (Entered: 07/18/2023) (4)
Jul 13, 2023 307 MINUTE entry before the Honorable Jorge L. Alonso: The motion hearing noticed for 7/18/23 is stricken. Because it will serve interests of judicial economy to decide the motion to seal following briefing of the underlying motion to amend 296 , the Court takes the motion to seal 305 under advisement.Notice mailed by Judge's staff (lf, ) (Entered: 07/13/2023) (1)
Jul 10, 2023 303 RESPONSE by Evolve BioSystems, Inc., Regents of the University of Californiain Opposition to MOTION by Defendant Abbott Laboratories for Leave to Amend Final Invalidity and Noninfringement Contentions Presented before Presiding Judge 292 (Public/Redacted Versions) (Attachments: # 1 Declaration of James R. Hancock, # 2 Exhibit 1 to Hancock Decl, # 3 Exhibit 2 to Hancock Decl, # 4 Exhibit 3 to Hancock Decl, # 5 Exhibit 4 to Hancock Decl, # 6 Exhibit 5 to Hancock Decl, # 7 Exhibit 6 to Hancock Decl, # 8 Exhibit 7 to Hancock Decl, # 9 Exhibit 8 to Hancock Decl, # 10 Exhibit 9 to Hancock Decl, # 11 Exhibit 10 to Hancock Decl, # 12 Exhibit 11 to Hancock Decl, # 13 Exhibit 12 to Hancock Decl, # 14 Exhibit 13 to Hancock Decl, # 15 Exhibit 14 to Hancock Decl, # 16 Exhibit 15 to Hancock Decl, # 17 Exhibit 16 to Hancock Decl, # 18 Exhibit 17 to Hancock Decl, # 19 Exhibit 18 to Hancock Decl, # 20 Exhibit 19 to Hancock Decl, # 21 Exhibit 20 to Hancock Decl, # 22 Exhibit 21 to Hancock Decl, # 23 Exhibit 22 to Hancock Decl, # 24 Exhibit 23 to Hancock Decl, # 25 Exhibit 24 to Hancock Decl)(Chivvis, Matthew) (Entered: 07/10/2023) (0)
Jul 10, 2023 304 SEALED RESPONSE by Evolve BioSystems, Inc., Regents of the University of California to MOTION by Defendant Abbott Laboratories for Leave to Amend Final Invalidity and Noninfringement Contentions Presented before Presiding Judge 292 (Sealed/Unredacted Versions) (Attachments: # 1 Exhibit 2 to Hancock Decl (unredacted), # 2 Exhibit 8 to Hancock Decl (unredacted), # 3 Exhibit 15 to Hancock Decl (unredacted), # 4 Exhibit 16 to Hancock Decl (unredacted), # 5 Exhibit 21 to Hancock Decl (unredacted))(Chivvis, Matthew) (Entered: 07/10/2023) (0)
Jul 10, 2023 305 MOTION by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California to seal document sealed response,, 304 Unopposed Motion for Leave to File Under Seal Plaintiffs' Opposition to Defendant's Motion for Leave to Amend Final Invalidity and Noninfringement Contentions and Supporting Exhibits to the Declaration of James R. Hancock Presented before Presiding Judge (Chivvis, Matthew) (Entered: 07/10/2023) (4)
Jul 10, 2023 306 UNOPPOSED NOTICE of Motion by Matthew Alan Chivvis for presentment of motion to seal document, 305 before Honorable Jorge L. Alonso on 7/18/2023 at 09:30 AM. (Chivvis, Matthew) (Entered: 07/10/2023) (2)
Jun 8, 2023 301 MINUTE entry before the Honorable Jorge L. Alonso: Telephonic motion hearing held. Plaintiffs' response to Defendant's motion for leave to amend final invalidity and noninfringement contentions 292 shall be filed by 7/10/23; Defendant's reply shall be filed by 7/27/23. Defendant's Unopposed motion for leave to file under seal portions of Defendant's motion for leave to amend final invalidity and noninfringement contentions 296 is taken under advisement and will be ruled on with the Motion seeking leave to amend. Plaintiffs' motions for leave to appear pro hac vice 285 and 286 are granted. Notice mailed by Judge's staff (lf, ) (Entered: 06/08/2023) (1)
Jun 8, 2023 302 MINUTE entry before the Honorable Heather K. McShain: Counsel for Evolve reached out to the Magistrate Judge's Chambers via email received on 06/08/2023 informing the Court that parties have come to an agreement on an expert discovery schedule and no longer require a status hearing before the Court. Accordingly, the status hearing set for 06/08/2023 299 is stricken. The Court adopts the parties' proposed expert discovery schedule as follows. Initial expert disclosures due the earlier of: (a) three weeks from the District Judge's ruling on defendant's pending motion for Leave to Amend Final Invalidity and Noninfringement Contentions 292 or; (b) 10/06/2023. Rebuttal reports will be due 35 days later. Expert discovery to close 35 days after the deadline for rebuttal reports. A joint status report is due 07/18/2023 to update the Court on the progress of fact discovery and any other matters the parties wish to raise with the Court. The parties may contact chambers at any time (by email to Chambers_McShain@ilnd.uscourts.gov) if they would like the Court's assistance with settlement. Mailed notice. (pk, ) (Entered: 06/09/2023) (1)
Jun 7, 2023 300 MINUTE entry before the Honorable Jorge L. Alonso: Telephonic motion hearing set for 6/8/23 at 9:30 a.m. Members of the public and media will be able to call in to listen to this hearing. The call-in number is 888-808-6929 and the access code is 4911854. Counsel of record will receive an email 30 minutes prior to the start of the telephonic hearing with instructions to join the call. Persons granted remote access to proceedings are reminded of the general prohibition against photographing, recording, and rebroadcasting of court proceedings. Violation of these prohibitions may result in sanctions, including removal of court issued media credentials, restricted entry to future hearings, denial of entry to future hearings, or any other sanctions deemed necessary by the Court. Notice mailed by Judge's staff (lf, ) (Entered: 06/07/2023) (1)
Jun 6, 2023 298 ATTORNEY Appearance for Plaintiffs Evolve BioSystems, Inc., Regents of the University of California by David Alan Deschepper, Jr (Deschepper, David) (Entered: 06/06/2023) (1)
Jun 6, 2023 299 MINUTE entry before the Honorable Heather K. McShain: Due to technological difficulties, telephonic status hearing set for 06/06/2023 is reset to 06/08/2023 at 11:00 a.m. To participate in the telephonic status hearing, the dial-in number is 888-684-8852, followed by access code 8623687#. Persons granted remote access to proceedings are reminded of the general prohibition against photographing, recording, and rebroadcasting of court proceedings. Violation of these prohibitions may result in sanctions, including removal of court issued media credentials, restricted entry to future hearings, denial of entry to future hearings, or any other sanctions deemed necessary by the Court. Mailed notice. (pk, ) (Entered: 06/06/2023) (1)
Jun 5, 2023 297 STATUS Report - Joint by Evolve BioSystems, Inc., Regents of the University of California Presented before Magistrate Judge (Chivvis, Matthew) (Entered: 06/05/2023) (11)
Jun 2, 2023 292 MOTION by Defendant Abbott Laboratories for Leave to Amend Final Invalidity and Noninfringement Contentions Presented before Presiding Judge (Klein, Charles) (Entered: 06/02/2023) (3)
Jun 2, 2023 293 MEMORANDUM by Abbott Laboratories in support of motion for miscellaneous relief 292 for leave to Amend Final Invalidity and Noninfringement Contentions (Redacted) (Attachments: # 1 Declaration of Kevin Boyle, # 2 Exhibit 1 (Redacted), # 3 Exhibit 2 (Redacted), # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9 (Redacted), # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13 (Redacted), # 15 Exhibit 14 (Redacted), # 16 Exhibit 15 (Redacted))(Klein, Charles) (Entered: 06/02/2023) (0)
Jun 2, 2023 294 NOTICE of Motion by Charles Bennett Klein for presentment of motion for miscellaneous relief 292 before Honorable Jorge L. Alonso on 6/8/2023 at 09:30 AM. (Klein, Charles) (Entered: 06/02/2023) (3)
Jun 2, 2023 295 SEALED DOCUMENT by Defendant Abbott Laboratories / Memorandum in Support of Defendant's Motion for Leave to Amend Final Invalidity and Noninfringement Contentions; and Exhibits 1, 2, 9, 13, 14, and 15 to Declaration of Kevin Boyle in Support Thereof (Attachments: # 1 Exhibit 1 to Boyle Decl., # 2 Exhibit 2 to Boyle Decl., # 3 Exhibit 9 to Boyle Decl., # 4 Exhibit 13 to Boyle Decl., # 5 Exhibit 14 to Boyle Decl., # 6 Exhibit 15 to Boyle Decl.)(Klein, Charles) (Entered: 06/02/2023) (0)
Jun 2, 2023 296 MOTION by Defendant Abbott Laboratories to seal document sealed document, 295 Memorandum in Support of Defendant's Motion for Leave to Amend Final Invalidity and Noninfringement Contentions; and Exhibits 1, 2, 9, 13, 15, and 15 to Declaration of Kevin Boyle in Support Thereof Presented before Presiding Judge (Klein, Charles) (Entered: 06/02/2023) (4)
May 31, 2023 290 STIPULATION and [Proposed] Order to Extend Time (JOINT) (Klein, Charles) (Entered: 05/31/2023) (2)
May 31, 2023 291 MINUTE entry before the Honorable Heather K. McShain: The Court has reviewed the parties' joint status report 287 . A telephonic status hearing is set for 06/06/2023 at 10:15 a.m., to discuss the matters raised in the joint status report. To participate in the telephonic status hearing, the dial-in number is 888-684-8852, followed by access code 8623687#. Persons granted remote access to proceedings are reminded of the general prohibition against photographing, recording, and rebroadcasting of court proceedings. Violation of these prohibitions may result in sanctions, including removal of court issued media credentials, restricted entry to future hearings, denial of entry to future hearings, or any other sanctions deemed necessary by the Court. Mailed notice. (pk, ) (Entered: 05/31/2023) (1)
May 3, 2023 289 ATTORNEY Appearance for Defendant Abbott Laboratories by Stephen Victor D'Amore (Corrected) (D'Amore, Stephen) (Entered: 05/03/2023) (1)
May 2, 2023 288 ATTORNEY Appearance for Defendant Abbott Laboratories by Stephen Victor D'Amore (D'Amore, Stephen) (Entered: 05/02/2023) (1)
Apr 24, 2023 287 STATUS Report Joint Status Report by Evolve BioSystems, Inc., Regents of the University of California (Chivvis, Matthew) (Entered: 04/24/2023) (8)
Apr 14, 2023 285 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number AILNDC-20542343. (Anderson, Tait) (Entered: 04/14/2023) (2)
Apr 14, 2023 286 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number AILNDC-20543904. (Vu, Chan) (Entered: 04/14/2023) (2)
Mar 22, 2023 284 MINUTE entry before the Honorable Heather K. McShain: The Court has reviewed the parties' joint status report 283 which reports the discovery stay 278 282 ended on 03/17/2023 and parties are proceeding with fact discovery. A joint status report is due 04/24/2023 to update the Court on the progress of fact discovery and any other matters the parties wish to raise with the Court. The parties may contact chambers at any time (by email to Chambers_McShain@ilnd.uscourts.gov) if they would like the Court's assistance with settlement. Mailed notice. (pk, ) (Entered: 03/22/2023) (1)
Mar 21, 2023 283 STATUS Report - Joint by Evolve BioSystems, Inc., Regents of the University of California (Chivvis, Matthew) (Entered: 03/21/2023) (3)
Feb 1, 2023 282 JOINT STIPULATION and Order to Extend Stay. Signed by the Honorable Jorge L. Alonso on 2/1/2023. Notice mailed by Judge's staff (lf, ) (Entered: 02/01/2023) (3)
Jan 26, 2023 281 STIPULATION (JOINT) and [Proposed] Order to Extend Stay (Chivvis, Matthew) (Entered: 01/26/2023) (3)
Jan 13, 2023 280 NOTIFICATION of Affiliates pursuant to Local Rule 3.2 by Abbott Laboratories (Wickramasekera, Nimalka) (Entered: 01/13/2023) (2)
Dec 29, 2022 279 ANNUAL REMINDER: Pursuant to Local Rule 3.2 (Notification of Affiliates), any nongovernmental party, other than an individual or sole proprietorship, must file a statement identifying all its affiliates known to the party after diligent review or, if the party has identified no affiliates, then a statement reflecting that fact must be filed. An affiliate is defined as follows: any entity or individual owning, directly or indirectly (through ownership of one or more other entities), 5% or more of a party. The statement is to be electronically filed as a PDF in conjunction with entering the affiliates in CM/ECF as prompted. As a reminder to counsel, parties must supplement their statements of affiliates within thirty (30) days of any change in the information previously reported. This minute order is being issued to all counsel of record to remind counsel of their obligation to provide updated information as to additional affiliates if such updating is necessary. If counsel has any questions regarding this process, this LINK will provide additional information. Signed by the Executive Committee on 12/29/2022: Mailed notice. (tg, ) (Entered: 12/30/2022) (1)
Nov 28, 2022 278 MINUTE entry before the Honorable Jorge L. Alonso: Pursuant to the parties' stipulation 276 , this case is stayed till February 17, 2023, while the parties pursue a private mediation. The parties shall file a joint status report by February 18, 2023. Notice mailed by Judge's staff (lf, ) (Entered: 11/28/2022) (1)
Nov 21, 2022 277 STATUS Report (Joint) by Abbott Laboratories (Klein, Charles) (Entered: 11/21/2022) (3)
Nov 18, 2022 276 STIPULATION (JOINT) and [Proposed] Order to Stay (Chivvis, Matthew) (Entered: 11/18/2022) (3)
Nov 8, 2022 274 order on motion for protective order (1)
Docket Text: MINUTE entry before the Honorable Heather K. McShain: For the reasons stated in the Order, Abbott's motion for a protective order [248] is denied. Enter Order. The joint status report deadline of 11/21/2022 [273] stands. Mailed notice. (pk, )
Nov 8, 2022 275 order (5)
Docket Text: ORDER. Signed by the Honorable Heather K. McShain on 11/8/2022. Mailed notice. (pk, )
Oct 27, 2022 273 set deadlines (1)
Docket Text: MINUTE entry before the Honorable Heather K. McShain: The Court has reviewed the parties' joint status report [272]. Both sides express dissatisfaction with the other side's production on supplemental discovery requests and deposition plans. However, the report notes that the parties are currently reviewing each other's most recent document productions from 10/20/2022 and 10/21/2022, made by Abbott and Evolve, respectively. The report also states Evolve is searching for and collecting documents to produce that are responsive to Abbott's 9/30/2022 requests for the production of documents. Further, the report shows that the parties are meeting and conferring to resolve ongoing discovery issues. Thus, the issues are not ripe for Court resolution, and the Court directs the parties to fully exhaust their meet and confer obligations regarding their disputes over document productions and deposition plans and, only after those discussions have been exhausted, file an appropriate motion. By 11/21/2022, the parties are to file a joint status report to update the Court on the same items as the instant status. The Court is in receipt of Abbott's reply [267] to its motion for protective order [248] and, now fully briefed, the motion is under advisement. Mailed notice. (pk, )
Oct 24, 2022 270 order on motion to seal document (1)
Docket Text: MINUTE entry before the Honorable Heather K. McShain: Defendant Abbott Laboratories unopposed motion to seal document [268] is granted, and the Court notes that sealed and redacted versions of the reply and exhibits have already been filed on 10/21/2022 [[26]6, [267]]. Mailed notice. (pk, )
Oct 24, 2022 271 order on motion for miscellaneous relief (1)
Docket Text: MINUTE entry before the Honorable Heather K. McShain: The Court is in receipt of the parties' joint status report, which requests an extension of the deadline but does not include a date [269]. The Court takes from the filing that the parties seek a revised deadline of 10/24/2022. The joint extension request is granted, and the parties' joint status report [262] is to be filed on 10/24/2022. Mailed notice. (pk, )
Oct 24, 2022 272 status report (13)
Docket Text: STATUS Report (JOINT) by Evolve BioSystems, Inc., Regents of the University of California (Chivvis, Matthew)
Oct 21, 2022 265 certificate (2)
Docket Text: CERTIFICATE Amended Disclosure to Advise Court of Name Change (Ellis, John)
Oct 21, 2022 266 reply (Main Document) (18)
Docket Text: REPLY by Defendant Abbott Laboratories to motion for protective order[248], response in opposition to motion,,,,,, [252] Reply Memorandum in Support of Defendant's Motion for Protective Order (Redacted) (Attachments: # (1) Declaration of Kevin J. Boyle, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D, # (6) Exhibit E (Redacted), # (7) Exhibit F (Redacted), # (8) Exhibit G (Redacted))(Wickramasekera, Nimalka)
Oct 21, 2022 266 reply (Declaration of Kevin J. Boyle) (2)
Docket Text: REPLY by Defendant Abbott Laboratories to motion for protective order[248], response in opposition to motion,,,,,, [252] Reply Memorandum in Support of Defendant's Motion for Protective Order (Redacted) (Attachments: # (1) Declaration of Kevin J. Boyle, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D, # (6) Exhibit E (Redacted), # (7) Exhibit F (Redacted), # (8) Exhibit G (Redacted))(Wickramasekera, Nimalka)
Oct 21, 2022 266 reply (Exhibit A) (5)
Docket Text: REPLY by Defendant Abbott Laboratories to motion for protective order[248], response in opposition to motion,,,,,, [252] Reply Memorandum in Support of Defendant's Motion for Protective Order (Redacted) (Attachments: # (1) Declaration of Kevin J. Boyle, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D, # (6) Exhibit E (Redacted), # (7) Exhibit F (Redacted), # (8) Exhibit G (Redacted))(Wickramasekera, Nimalka)
Oct 21, 2022 266 reply (Exhibit B) (5)
Docket Text: REPLY by Defendant Abbott Laboratories to motion for protective order[248], response in opposition to motion,,,,,, [252] Reply Memorandum in Support of Defendant's Motion for Protective Order (Redacted) (Attachments: # (1) Declaration of Kevin J. Boyle, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D, # (6) Exhibit E (Redacted), # (7) Exhibit F (Redacted), # (8) Exhibit G (Redacted))(Wickramasekera, Nimalka)
Oct 21, 2022 266 reply (Exhibit C) (24)
Docket Text: REPLY by Defendant Abbott Laboratories to motion for protective order[248], response in opposition to motion,,,,,, [252] Reply Memorandum in Support of Defendant's Motion for Protective Order (Redacted) (Attachments: # (1) Declaration of Kevin J. Boyle, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D, # (6) Exhibit E (Redacted), # (7) Exhibit F (Redacted), # (8) Exhibit G (Redacted))(Wickramasekera, Nimalka)
Oct 21, 2022 266 reply (Exhibit D) (3)
Docket Text: REPLY by Defendant Abbott Laboratories to motion for protective order[248], response in opposition to motion,,,,,, [252] Reply Memorandum in Support of Defendant's Motion for Protective Order (Redacted) (Attachments: # (1) Declaration of Kevin J. Boyle, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D, # (6) Exhibit E (Redacted), # (7) Exhibit F (Redacted), # (8) Exhibit G (Redacted))(Wickramasekera, Nimalka)
Oct 21, 2022 266 reply (Exhibit E (Redacted)) (1)
Docket Text: REPLY by Defendant Abbott Laboratories to motion for protective order[248], response in opposition to motion,,,,,, [252] Reply Memorandum in Support of Defendant's Motion for Protective Order (Redacted) (Attachments: # (1) Declaration of Kevin J. Boyle, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D, # (6) Exhibit E (Redacted), # (7) Exhibit F (Redacted), # (8) Exhibit G (Redacted))(Wickramasekera, Nimalka)
Oct 21, 2022 266 reply (Exhibit F (Redacted)) (1)
Docket Text: REPLY by Defendant Abbott Laboratories to motion for protective order[248], response in opposition to motion,,,,,, [252] Reply Memorandum in Support of Defendant's Motion for Protective Order (Redacted) (Attachments: # (1) Declaration of Kevin J. Boyle, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D, # (6) Exhibit E (Redacted), # (7) Exhibit F (Redacted), # (8) Exhibit G (Redacted))(Wickramasekera, Nimalka)
Oct 21, 2022 266 reply (Exhibit G (Redacted)) (1)
Docket Text: REPLY by Defendant Abbott Laboratories to motion for protective order[248], response in opposition to motion,,,,,, [252] Reply Memorandum in Support of Defendant's Motion for Protective Order (Redacted) (Attachments: # (1) Declaration of Kevin J. Boyle, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D, # (6) Exhibit E (Redacted), # (7) Exhibit F (Redacted), # (8) Exhibit G (Redacted))(Wickramasekera, Nimalka)
Oct 21, 2022 268 motion to seal document (4)
Docket Text: MOTION by Defendant Abbott Laboratories to seal document reply, [267] Reply Memorandum in Support of Defendant's Motion for Protective Order and Exhibits E, F and G to Boyle Declaration (Wickramasekera, Nimalka)
Oct 21, 2022 269 motion for miscellaneous relief (3)
Docket Text: STATUS Report (Joint) by Abbott Laboratories (Klein, Charles) Modified on 10/24/2022 (pk, ).
Oct 17, 2022 264 order on motion for miscellaneous relief (1)
Docket Text: MINUTE entry before the Honorable Heather K. McShain: The Court has reviewed the parties' joint status report [263]. By 10/21/2022, Abbott is to file its reply to its motion for protective order [248]. The joint status report details ongoing issues with respect to the parties' document productions and deposition plans, as well as Abbott's opposed request to extend the fact discovery deadline from 11/11/2022 to 12/16/2022. Notwithstanding Evolve's objection to the extension request and well-founded frustration with the timing of Abbott's production on supplement discovery requests that have been pending since as early as May 2021 and were reiterated on 08/01/2022 [263] 4, given the pending discovery motion and the parties' deposition plans, the Court sees the likelihood of both oral and written discovery completing by the current deadline of 11/11/2022 to be slim. Accordingly, the Court grants Abbott's extension request and fact discovery is to close by 12/16/2022. The Court will endeavor to issue a ruling in short order on the motion for protective order upon receipt of Abbott's reply and the parties are to continue to work cooperatively and diligently to move discovery forward in light of this new deadline, which will not be further extended unless the moving party can demonstrate unforeseen and extraordinary circumstances. Mailed notice. (pk, ) Modified on 10/17/2022 (pk, ).
Oct 14, 2022 263 motion for miscellaneous relief (10)
Docket Text: STATUS Report Joint Status Report by Evolve BioSystems, Inc., Regents of the University of California (Chivvis, Matthew) Modified on 10/17/2022 (pk, ).
Oct 4, 2022 262 set deadlines (1)
Docket Text: MINUTE entry before the Honorable Heather K. McShain: The Court has reviewed the parties' joint status report [256]. The report includes lengthy dueling statements for each side about pending discovery disputes, with each side alleging that the other is either improperly withholding documents or has failed to sufficiently search for and produce responsive documents in their respective supplemental productions. It appears from the report, however, that the discussions are ongoing and at least one of the parties is still in the process of searching for and collecting documents for review and potential protection. Thus the issues are not ripe for Court resolution, and the Court directs the parties to fully exhaust their meet and confer obligations regarding their ongoing disputes over document productions and, only after those discussions have been exhausted, file an appropriate motion. The Court further notes that it is amenable to an extension of the fact discovery deadline should the parties require additional time for supplemental discovery, in order to exhaust their ongoing discussions and in light of the pending motion for a protective order [248]. Further joint status report due 10/21/2022 to update the Court on the same items as the instant status. The Court encourages the parties to continue cooperating and attempting to move discovery forward before seeking relief from the Court. Mailed notice. (pk, )
Oct 3, 2022 260 order on motion to withdraw as attorney (1)
Docket Text: MINUTE entry before the Honorable Jorge L. Alonso: Plaintiffs' Motion to withdraw as attorney [258] is granted. Attorney Todd H. Flaming is given leave to withdraw as counsel for Plaintiffs. Attorney John C. Ellis is given leave to file an appearance on behalf of Plaintiffs. Motion hearing date of 10/4/22 is stricken. Notice mailed by Judge's staff (lf, )
Oct 3, 2022 261 attorney appearance (1)
Docket Text: ATTORNEY Appearance for Counter Claimants Evolve BioSystems, Inc., Regents of the University of California, Counter Defendants Evolve BioSystems, Inc., Regents of the University of California, Plaintiffs Evolve BioSystems, Inc., Regents of the University of California by John C. Ellis (Ellis, John)
Sep 28, 2022 258 motion to withdraw as attorney (2)
Docket Text: MOTION by Attorney Todd H. Flaming to withdraw as attorney for Evolve BioSystems, Inc., Regents of the University of California. No party information provided (Chivvis, Matthew)
Sep 28, 2022 259 notice of motion (2)
Docket Text: (UNOPPOSED MOTION) NOTICE of Motion by Matthew Alan Chivvis for presentment of motion to withdraw as attorney[258] before Honorable Jorge L. Alonso on 10/4/2022 at 09:30 AM. (Chivvis, Matthew)
Sep 16, 2022 255 order on motion to seal document (1)
Docket Text: MINUTE entry before the Honorable Heather K. McShain: The Court is in receipt of Plaintiffs' unopposed motion for leave to file under seal their opposition to Defendant's motion for protective order [254]. Given that the motion for leave to file under seal is unopposed, and that Plaintiffs' response in opposition to the motion for a protective order includes confidential information, the Court finds good cause to grant Plaintiffs' request to file portions of its response under seal. Plaintiffs' motion for leave to file under seal [254] is therefore granted, and the Court notes that sealed and redacted versions of the response and exhibits have already been filed on 09/11/2022 [252], [253]. Mailed notice. (pk, )
Sep 16, 2022 256 status report (10)
Docket Text: STATUS Report JOINT STATUS REPORT by Evolve BioSystems, Inc., Regents of the University of California (Chivvis, Matthew)
Sep 15, 2022 252 response in opposition to motion (Main Document) (15)
Docket Text: RESPONSE by Evolve BioSystems, Inc., Regents of the University of Californiain Opposition to MOTION by Defendant Abbott Laboratories for protective order [248] (Public/Redacted Versions) (Attachments: # (1) Declaration of M. Chivvis, # (2) Exhibit 1 to Chivvis Decl, # (3) Exhibit 2 to Chivvis Decl, # (4) Exhibit 3 to Chivvis Decl, # (5) Exhibit 4 to Chivvis Decl, # (6) Exhibit 5 to Chivvis Decl, # (7) Exhibit 6 to Chivvis Decl, # (8) Exhibit 7 to Chivvis Decl, # (9) Exhibit 8 to Chivvis Decl, # (10) Exhibit 9 to Chivvis Decl, # (11) Exhibit 10 to Chivvis Decl, # (12) Exhibit 11 to Chivvis Decl, # (13) Exhibit 12 to Chivvis Decl, # (14) Exhibit 13 to Chivvis Decl, # (15) Exhibit 14 to Chivvis Decl, # (16) Exhibit 15 to Chivvis Decl, # (17) Exhibit 16 to Chivvis Decl, # (18) Exhibit 17 to Chivvis Decl, # (19) Exhibit 18 to Chivvis Decl, # (20) Exhibit 19 to Chivvis Decl, # (21) Exhibit 20 to Chivvis Decl, # (22) Exhibit 21 to Chivvis Decl, # (23) Exhibit 22 to Chivvis Decl, # (24) Exhibit 23 to Chivvis Decl, # (25) Exhibit 24 to Chivvis Decl, # (26) Exhibit 25 to Chivvis Decl, # (27) Exhibit 26 to Chivvis Decl, # (28) Exhibit 27 to Chivvis Decl, # (29) Exhibit 28 to Chivvis Decl, # (30) Exhibit 29 to Chivvis Decl, # (31) Exhibit 30 to Chivvis Decl, # (32) Exhibit 31 to Chivvis Decl, # (33) Exhibit 32 to Chivvis Decl, # (34) Exhibit 33 to Chivvis Decl, # (35) Exhibit 34 to Chivvis Decl, # (36) Exhibit 35 to Chivvis Decl, # (37) Exhibit 36 to Chivvis Decl)(Chivvis, Matthew)
Sep 15, 2022 252 response in opposition to motion (Declaration of M. Chivvis) (6)
Docket Text: RESPONSE by Evolve BioSystems, Inc., Regents of the University of Californiain Opposition to MOTION by Defendant Abbott Laboratories for protective order [248] (Public/Redacted Versions) (Attachments: # (1) Declaration of M. Chivvis, # (2) Exhibit 1 to Chivvis Decl, # (3) Exhibit 2 to Chivvis Decl, # (4) Exhibit 3 to Chivvis Decl, # (5) Exhibit 4 to Chivvis Decl, # (6) Exhibit 5 to Chivvis Decl, # (7) Exhibit 6 to Chivvis Decl, # (8) Exhibit 7 to Chivvis Decl, # (9) Exhibit 8 to Chivvis Decl, # (10) Exhibit 9 to Chivvis Decl, # (11) Exhibit 10 to Chivvis Decl, # (12) Exhibit 11 to Chivvis Decl, # (13) Exhibit 12 to Chivvis Decl, # (14) Exhibit 13 to Chivvis Decl, # (15) Exhibit 14 to Chivvis Decl, # (16) Exhibit 15 to Chivvis Decl, # (17) Exhibit 16 to Chivvis Decl, # (18) Exhibit 17 to Chivvis Decl, # (19) Exhibit 18 to Chivvis Decl, # (20) Exhibit 19 to Chivvis Decl, # (21) Exhibit 20 to Chivvis Decl, # (22) Exhibit 21 to Chivvis Decl, # (23) Exhibit 22 to Chivvis Decl, # (24) Exhibit 23 to Chivvis Decl, # (25) Exhibit 24 to Chivvis Decl, # (26) Exhibit 25 to Chivvis Decl, # (27) Exhibit 26 to Chivvis Decl, # (28) Exhibit 27 to Chivvis Decl, # (29) Exhibit 28 to Chivvis Decl, # (30) Exhibit 29 to Chivvis Decl, # (31) Exhibit 30 to Chivvis Decl, # (32) Exhibit 31 to Chivvis Decl, # (33) Exhibit 32 to Chivvis Decl, # (34) Exhibit 33 to Chivvis Decl, # (35) Exhibit 34 to Chivvis Decl, # (36) Exhibit 35 to Chivvis Decl, # (37) Exhibit 36 to Chivvis Decl)(Chivvis, Matthew)
Sep 15, 2022 252 response in opposition to motion (Exhibit 1 to Chivvis Decl) (1)
Docket Text: RESPONSE by Evolve BioSystems, Inc., Regents of the University of Californiain Opposition to MOTION by Defendant Abbott Laboratories for protective order [248] (Public/Redacted Versions) (Attachments: # (1) Declaration of M. Chivvis, # (2) Exhibit 1 to Chivvis Decl, # (3) Exhibit 2 to Chivvis Decl, # (4) Exhibit 3 to Chivvis Decl, # (5) Exhibit 4 to Chivvis Decl, # (6) Exhibit 5 to Chivvis Decl, # (7) Exhibit 6 to Chivvis Decl, # (8) Exhibit 7 to Chivvis Decl, # (9) Exhibit 8 to Chivvis Decl, # (10) Exhibit 9 to Chivvis Decl, # (11) Exhibit 10 to Chivvis Decl, # (12) Exhibit 11 to Chivvis Decl, # (13) Exhibit 12 to Chivvis Decl, # (14) Exhibit 13 to Chivvis Decl, # (15) Exhibit 14 to Chivvis Decl, # (16) Exhibit 15 to Chivvis Decl, # (17) Exhibit 16 to Chivvis Decl, # (18) Exhibit 17 to Chivvis Decl, # (19) Exhibit 18 to Chivvis Decl, # (20) Exhibit 19 to Chivvis Decl, # (21) Exhibit 20 to Chivvis Decl, # (22) Exhibit 21 to Chivvis Decl, # (23) Exhibit 22 to Chivvis Decl, # (24) Exhibit 23 to Chivvis Decl, # (25) Exhibit 24 to Chivvis Decl, # (26) Exhibit 25 to Chivvis Decl, # (27) Exhibit 26 to Chivvis Decl, # (28) Exhibit 27 to Chivvis Decl, # (29) Exhibit 28 to Chivvis Decl, # (30) Exhibit 29 to Chivvis Decl, # (31) Exhibit 30 to Chivvis Decl, # (32) Exhibit 31 to Chivvis Decl, # (33) Exhibit 32 to Chivvis Decl, # (34) Exhibit 33 to Chivvis Decl, # (35) Exhibit 34 to Chivvis Decl, # (36) Exhibit 35 to Chivvis Decl, # (37) Exhibit 36 to Chivvis Decl)(Chivvis, Matthew)
Sep 15, 2022 252 response in opposition to motion (Exhibit 2 to Chivvis Decl) (1)
Docket Text: RESPONSE by Evolve BioSystems, Inc., Regents of the University of Californiain Opposition to MOTION by Defendant Abbott Laboratories for protective order [248] (Public/Redacted Versions) (Attachments: # (1) Declaration of M. Chivvis, # (2) Exhibit 1 to Chivvis Decl, # (3) Exhibit 2 to Chivvis Decl, # (4) Exhibit 3 to Chivvis Decl, # (5) Exhibit 4 to Chivvis Decl, # (6) Exhibit 5 to Chivvis Decl, # (7) Exhibit 6 to Chivvis Decl, # (8) Exhibit 7 to Chivvis Decl, # (9) Exhibit 8 to Chivvis Decl, # (10) Exhibit 9 to Chivvis Decl, # (11) Exhibit 10 to Chivvis Decl, # (12) Exhibit 11 to Chivvis Decl, # (13) Exhibit 12 to Chivvis Decl, # (14) Exhibit 13 to Chivvis Decl, # (15) Exhibit 14 to Chivvis Decl, # (16) Exhibit 15 to Chivvis Decl, # (17) Exhibit 16 to Chivvis Decl, # (18) Exhibit 17 to Chivvis Decl, # (19) Exhibit 18 to Chivvis Decl, # (20) Exhibit 19 to Chivvis Decl, # (21) Exhibit 20 to Chivvis Decl, # (22) Exhibit 21 to Chivvis Decl, # (23) Exhibit 22 to Chivvis Decl, # (24) Exhibit 23 to Chivvis Decl, # (25) Exhibit 24 to Chivvis Decl, # (26) Exhibit 25 to Chivvis Decl, # (27) Exhibit 26 to Chivvis Decl, # (28) Exhibit 27 to Chivvis Decl, # (29) Exhibit 28 to Chivvis Decl, # (30) Exhibit 29 to Chivvis Decl, # (31) Exhibit 30 to Chivvis Decl, # (32) Exhibit 31 to Chivvis Decl, # (33) Exhibit 32 to Chivvis Decl, # (34) Exhibit 33 to Chivvis Decl, # (35) Exhibit 34 to Chivvis Decl, # (36) Exhibit 35 to Chivvis Decl, # (37) Exhibit 36 to Chivvis Decl)(Chivvis, Matthew)
Sep 15, 2022 252 response in opposition to motion (Exhibit 3 to Chivvis Decl) (1)
Docket Text: RESPONSE by Evolve BioSystems, Inc., Regents of the University of Californiain Opposition to MOTION by Defendant Abbott Laboratories for protective order [248] (Public/Redacted Versions) (Attachments: # (1) Declaration of M. Chivvis, # (2) Exhibit 1 to Chivvis Decl, # (3) Exhibit 2 to Chivvis Decl, # (4) Exhibit 3 to Chivvis Decl, # (5) Exhibit 4 to Chivvis Decl, # (6) Exhibit 5 to Chivvis Decl, # (7) Exhibit 6 to Chivvis Decl, # (8) Exhibit 7 to Chivvis Decl, # (9) Exhibit 8 to Chivvis Decl, # (10) Exhibit 9 to Chivvis Decl, # (11) Exhibit 10 to Chivvis Decl, # (12) Exhibit 11 to Chivvis Decl, # (13) Exhibit 12 to Chivvis Decl, # (14) Exhibit 13 to Chivvis Decl, # (15) Exhibit 14 to Chivvis Decl, # (16) Exhibit 15 to Chivvis Decl, # (17) Exhibit 16 to Chivvis Decl, # (18) Exhibit 17 to Chivvis Decl, # (19) Exhibit 18 to Chivvis Decl, # (20) Exhibit 19 to Chivvis Decl, # (21) Exhibit 20 to Chivvis Decl, # (22) Exhibit 21 to Chivvis Decl, # (23) Exhibit 22 to Chivvis Decl, # (24) Exhibit 23 to Chivvis Decl, # (25) Exhibit 24 to Chivvis Decl, # (26) Exhibit 25 to Chivvis Decl, # (27) Exhibit 26 to Chivvis Decl, # (28) Exhibit 27 to Chivvis Decl, # (29) Exhibit 28 to Chivvis Decl, # (30) Exhibit 29 to Chivvis Decl, # (31) Exhibit 30 to Chivvis Decl, # (32) Exhibit 31 to Chivvis Decl, # (33) Exhibit 32 to Chivvis Decl, # (34) Exhibit 33 to Chivvis Decl, # (35) Exhibit 34 to Chivvis Decl, # (36) Exhibit 35 to Chivvis Decl, # (37) Exhibit 36 to Chivvis Decl)(Chivvis, Matthew)
Sep 15, 2022 252 response in opposition to motion (Exhibit 4 to Chivvis Decl) (1)
Docket Text: RESPONSE by Evolve BioSystems, Inc., Regents of the University of Californiain Opposition to MOTION by Defendant Abbott Laboratories for protective order [248] (Public/Redacted Versions) (Attachments: # (1) Declaration of M. Chivvis, # (2) Exhibit 1 to Chivvis Decl, # (3) Exhibit 2 to Chivvis Decl, # (4) Exhibit 3 to Chivvis Decl, # (5) Exhibit 4 to Chivvis Decl, # (6) Exhibit 5 to Chivvis Decl, # (7) Exhibit 6 to Chivvis Decl, # (8) Exhibit 7 to Chivvis Decl, # (9) Exhibit 8 to Chivvis Decl, # (10) Exhibit 9 to Chivvis Decl, # (11) Exhibit 10 to Chivvis Decl, # (12) Exhibit 11 to Chivvis Decl, # (13) Exhibit 12 to Chivvis Decl, # (14) Exhibit 13 to Chivvis Decl, # (15) Exhibit 14 to Chivvis Decl, # (16) Exhibit 15 to Chivvis Decl, # (17) Exhibit 16 to Chivvis Decl, # (18) Exhibit 17 to Chivvis Decl, # (19) Exhibit 18 to Chivvis Decl, # (20) Exhibit 19 to Chivvis Decl, # (21) Exhibit 20 to Chivvis Decl, # (22) Exhibit 21 to Chivvis Decl, # (23) Exhibit 22 to Chivvis Decl, # (24) Exhibit 23 to Chivvis Decl, # (25) Exhibit 24 to Chivvis Decl, # (26) Exhibit 25 to Chivvis Decl, # (27) Exhibit 26 to Chivvis Decl, # (28) Exhibit 27 to Chivvis Decl, # (29) Exhibit 28 to Chivvis Decl, # (30) Exhibit 29 to Chivvis Decl, # (31) Exhibit 30 to Chivvis Decl, # (32) Exhibit 31 to Chivvis Decl, # (33) Exhibit 32 to Chivvis Decl, # (34) Exhibit 33 to Chivvis Decl, # (35) Exhibit 34 to Chivvis Decl, # (36) Exhibit 35 to Chivvis Decl, # (37) Exhibit 36 to Chivvis Decl)(Chivvis, Matthew)
Sep 15, 2022 252 response in opposition to motion (Exhibit 5 to Chivvis Decl) (1)
Docket Text: RESPONSE by Evolve BioSystems, Inc., Regents of the University of Californiain Opposition to MOTION by Defendant Abbott Laboratories for protective order [248] (Public/Redacted Versions) (Attachments: # (1) Declaration of M. Chivvis, # (2) Exhibit 1 to Chivvis Decl, # (3) Exhibit 2 to Chivvis Decl, # (4) Exhibit 3 to Chivvis Decl, # (5) Exhibit 4 to Chivvis Decl, # (6) Exhibit 5 to Chivvis Decl, # (7) Exhibit 6 to Chivvis Decl, # (8) Exhibit 7 to Chivvis Decl, # (9) Exhibit 8 to Chivvis Decl, # (10) Exhibit 9 to Chivvis Decl, # (11) Exhibit 10 to Chivvis Decl, # (12) Exhibit 11 to Chivvis Decl, # (13) Exhibit 12 to Chivvis Decl, # (14) Exhibit 13 to Chivvis Decl, # (15) Exhibit 14 to Chivvis Decl, # (16) Exhibit 15 to Chivvis Decl, # (17) Exhibit 16 to Chivvis Decl, # (18) Exhibit 17 to Chivvis Decl, # (19) Exhibit 18 to Chivvis Decl, # (20) Exhibit 19 to Chivvis Decl, # (21) Exhibit 20 to Chivvis Decl, # (22) Exhibit 21 to Chivvis Decl, # (23) Exhibit 22 to Chivvis Decl, # (24) Exhibit 23 to Chivvis Decl, # (25) Exhibit 24 to Chivvis Decl, # (26) Exhibit 25 to Chivvis Decl, # (27) Exhibit 26 to Chivvis Decl, # (28) Exhibit 27 to Chivvis Decl, # (29) Exhibit 28 to Chivvis Decl, # (30) Exhibit 29 to Chivvis Decl, # (31) Exhibit 30 to Chivvis Decl, # (32) Exhibit 31 to Chivvis Decl, # (33) Exhibit 32 to Chivvis Decl, # (34) Exhibit 33 to Chivvis Decl, # (35) Exhibit 34 to Chivvis Decl, # (36) Exhibit 35 to Chivvis Decl, # (37) Exhibit 36 to Chivvis Decl)(Chivvis, Matthew)
Sep 15, 2022 252 response in opposition to motion (Exhibit 6 to Chivvis Decl) (1)
Docket Text: RESPONSE by Evolve BioSystems, Inc., Regents of the University of Californiain Opposition to MOTION by Defendant Abbott Laboratories for protective order [248] (Public/Redacted Versions) (Attachments: # (1) Declaration of M. Chivvis, # (2) Exhibit 1 to Chivvis Decl, # (3) Exhibit 2 to Chivvis Decl, # (4) Exhibit 3 to Chivvis Decl, # (5) Exhibit 4 to Chivvis Decl, # (6) Exhibit 5 to Chivvis Decl, # (7) Exhibit 6 to Chivvis Decl, # (8) Exhibit 7 to Chivvis Decl, # (9) Exhibit 8 to Chivvis Decl, # (10) Exhibit 9 to Chivvis Decl, # (11) Exhibit 10 to Chivvis Decl, # (12) Exhibit 11 to Chivvis Decl, # (13) Exhibit 12 to Chivvis Decl, # (14) Exhibit 13 to Chivvis Decl, # (15) Exhibit 14 to Chivvis Decl, # (16) Exhibit 15 to Chivvis Decl, # (17) Exhibit 16 to Chivvis Decl, # (18) Exhibit 17 to Chivvis Decl, # (19) Exhibit 18 to Chivvis Decl, # (20) Exhibit 19 to Chivvis Decl, # (21) Exhibit 20 to Chivvis Decl, # (22) Exhibit 21 to Chivvis Decl, # (23) Exhibit 22 to Chivvis Decl, # (24) Exhibit 23 to Chivvis Decl, # (25) Exhibit 24 to Chivvis Decl, # (26) Exhibit 25 to Chivvis Decl, # (27) Exhibit 26 to Chivvis Decl, # (28) Exhibit 27 to Chivvis Decl, # (29) Exhibit 28 to Chivvis Decl, # (30) Exhibit 29 to Chivvis Decl, # (31) Exhibit 30 to Chivvis Decl, # (32) Exhibit 31 to Chivvis Decl, # (33) Exhibit 32 to Chivvis Decl, # (34) Exhibit 33 to Chivvis Decl, # (35) Exhibit 34 to Chivvis Decl, # (36) Exhibit 35 to Chivvis Decl, # (37) Exhibit 36 to Chivvis Decl)(Chivvis, Matthew)
Sep 15, 2022 252 response in opposition to motion (Exhibit 7 to Chivvis Decl) (1)
Docket Text: RESPONSE by Evolve BioSystems, Inc., Regents of the University of Californiain Opposition to MOTION by Defendant Abbott Laboratories for protective order [248] (Public/Redacted Versions) (Attachments: # (1) Declaration of M. Chivvis, # (2) Exhibit 1 to Chivvis Decl, # (3) Exhibit 2 to Chivvis Decl, # (4) Exhibit 3 to Chivvis Decl, # (5) Exhibit 4 to Chivvis Decl, # (6) Exhibit 5 to Chivvis Decl, # (7) Exhibit 6 to Chivvis Decl, # (8) Exhibit 7 to Chivvis Decl, # (9) Exhibit 8 to Chivvis Decl, # (10) Exhibit 9 to Chivvis Decl, # (11) Exhibit 10 to Chivvis Decl, # (12) Exhibit 11 to Chivvis Decl, # (13) Exhibit 12 to Chivvis Decl, # (14) Exhibit 13 to Chivvis Decl, # (15) Exhibit 14 to Chivvis Decl, # (16) Exhibit 15 to Chivvis Decl, # (17) Exhibit 16 to Chivvis Decl, # (18) Exhibit 17 to Chivvis Decl, # (19) Exhibit 18 to Chivvis Decl, # (20) Exhibit 19 to Chivvis Decl, # (21) Exhibit 20 to Chivvis Decl, # (22) Exhibit 21 to Chivvis Decl, # (23) Exhibit 22 to Chivvis Decl, # (24) Exhibit 23 to Chivvis Decl, # (25) Exhibit 24 to Chivvis Decl, # (26) Exhibit 25 to Chivvis Decl, # (27) Exhibit 26 to Chivvis Decl, # (28) Exhibit 27 to Chivvis Decl, # (29) Exhibit 28 to Chivvis Decl, # (30) Exhibit 29 to Chivvis Decl, # (31) Exhibit 30 to Chivvis Decl, # (32) Exhibit 31 to Chivvis Decl, # (33) Exhibit 32 to Chivvis Decl, # (34) Exhibit 33 to Chivvis Decl, # (35) Exhibit 34 to Chivvis Decl, # (36) Exhibit 35 to Chivvis Decl, # (37) Exhibit 36 to Chivvis Decl)(Chivvis, Matthew)
Sep 15, 2022 252 response in opposition to motion (Exhibit 8 to Chivvis Decl) (1)
Docket Text: RESPONSE by Evolve BioSystems, Inc., Regents of the University of Californiain Opposition to MOTION by Defendant Abbott Laboratories for protective order [248] (Public/Redacted Versions) (Attachments: # (1) Declaration of M. Chivvis, # (2) Exhibit 1 to Chivvis Decl, # (3) Exhibit 2 to Chivvis Decl, # (4) Exhibit 3 to Chivvis Decl, # (5) Exhibit 4 to Chivvis Decl, # (6) Exhibit 5 to Chivvis Decl, # (7) Exhibit 6 to Chivvis Decl, # (8) Exhibit 7 to Chivvis Decl, # (9) Exhibit 8 to Chivvis Decl, # (10) Exhibit 9 to Chivvis Decl, # (11) Exhibit 10 to Chivvis Decl, # (12) Exhibit 11 to Chivvis Decl, # (13) Exhibit 12 to Chivvis Decl, # (14) Exhibit 13 to Chivvis Decl, # (15) Exhibit 14 to Chivvis Decl, # (16) Exhibit 15 to Chivvis Decl, # (17) Exhibit 16 to Chivvis Decl, # (18) Exhibit 17 to Chivvis Decl, # (19) Exhibit 18 to Chivvis Decl, # (20) Exhibit 19 to Chivvis Decl, # (21) Exhibit 20 to Chivvis Decl, # (22) Exhibit 21 to Chivvis Decl, # (23) Exhibit 22 to Chivvis Decl, # (24) Exhibit 23 to Chivvis Decl, # (25) Exhibit 24 to Chivvis Decl, # (26) Exhibit 25 to Chivvis Decl, # (27) Exhibit 26 to Chivvis Decl, # (28) Exhibit 27 to Chivvis Decl, # (29) Exhibit 28 to Chivvis Decl, # (30) Exhibit 29 to Chivvis Decl, # (31) Exhibit 30 to Chivvis Decl, # (32) Exhibit 31 to Chivvis Decl, # (33) Exhibit 32 to Chivvis Decl, # (34) Exhibit 33 to Chivvis Decl, # (35) Exhibit 34 to Chivvis Decl, # (36) Exhibit 35 to Chivvis Decl, # (37) Exhibit 36 to Chivvis Decl)(Chivvis, Matthew)
Sep 15, 2022 252 response in opposition to motion (Exhibit 9 to Chivvis Decl) (1)
Docket Text: RESPONSE by Evolve BioSystems, Inc., Regents of the University of Californiain Opposition to MOTION by Defendant Abbott Laboratories for protective order [248] (Public/Redacted Versions) (Attachments: # (1) Declaration of M. Chivvis, # (2) Exhibit 1 to Chivvis Decl, # (3) Exhibit 2 to Chivvis Decl, # (4) Exhibit 3 to Chivvis Decl, # (5) Exhibit 4 to Chivvis Decl, # (6) Exhibit 5 to Chivvis Decl, # (7) Exhibit 6 to Chivvis Decl, # (8) Exhibit 7 to Chivvis Decl, # (9) Exhibit 8 to Chivvis Decl, # (10) Exhibit 9 to Chivvis Decl, # (11) Exhibit 10 to Chivvis Decl, # (12) Exhibit 11 to Chivvis Decl, # (13) Exhibit 12 to Chivvis Decl, # (14) Exhibit 13 to Chivvis Decl, # (15) Exhibit 14 to Chivvis Decl, # (16) Exhibit 15 to Chivvis Decl, # (17) Exhibit 16 to Chivvis Decl, # (18) Exhibit 17 to Chivvis Decl, # (19) Exhibit 18 to Chivvis Decl, # (20) Exhibit 19 to Chivvis Decl, # (21) Exhibit 20 to Chivvis Decl, # (22) Exhibit 21 to Chivvis Decl, # (23) Exhibit 22 to Chivvis Decl, # (24) Exhibit 23 to Chivvis Decl, # (25) Exhibit 24 to Chivvis Decl, # (26) Exhibit 25 to Chivvis Decl, # (27) Exhibit 26 to Chivvis Decl, # (28) Exhibit 27 to Chivvis Decl, # (29) Exhibit 28 to Chivvis Decl, # (30) Exhibit 29 to Chivvis Decl, # (31) Exhibit 30 to Chivvis Decl, # (32) Exhibit 31 to Chivvis Decl, # (33) Exhibit 32 to Chivvis Decl, # (34) Exhibit 33 to Chivvis Decl, # (35) Exhibit 34 to Chivvis Decl, # (36) Exhibit 35 to Chivvis Decl, # (37) Exhibit 36 to Chivvis Decl)(Chivvis, Matthew)
Sep 15, 2022 252 response in opposition to motion (Exhibit 10 to Chivvis Decl) (1)
Docket Text: RESPONSE by Evolve BioSystems, Inc., Regents of the University of Californiain Opposition to MOTION by Defendant Abbott Laboratories for protective order [248] (Public/Redacted Versions) (Attachments: # (1) Declaration of M. Chivvis, # (2) Exhibit 1 to Chivvis Decl, # (3) Exhibit 2 to Chivvis Decl, # (4) Exhibit 3 to Chivvis Decl, # (5) Exhibit 4 to Chivvis Decl, # (6) Exhibit 5 to Chivvis Decl, # (7) Exhibit 6 to Chivvis Decl, # (8) Exhibit 7 to Chivvis Decl, # (9) Exhibit 8 to Chivvis Decl, # (10) Exhibit 9 to Chivvis Decl, # (11) Exhibit 10 to Chivvis Decl, # (12) Exhibit 11 to Chivvis Decl, # (13) Exhibit 12 to Chivvis Decl, # (14) Exhibit 13 to Chivvis Decl, # (15) Exhibit 14 to Chivvis Decl, # (16) Exhibit 15 to Chivvis Decl, # (17) Exhibit 16 to Chivvis Decl, # (18) Exhibit 17 to Chivvis Decl, # (19) Exhibit 18 to Chivvis Decl, # (20) Exhibit 19 to Chivvis Decl, # (21) Exhibit 20 to Chivvis Decl, # (22) Exhibit 21 to Chivvis Decl, # (23) Exhibit 22 to Chivvis Decl, # (24) Exhibit 23 to Chivvis Decl, # (25) Exhibit 24 to Chivvis Decl, # (26) Exhibit 25 to Chivvis Decl, # (27) Exhibit 26 to Chivvis Decl, # (28) Exhibit 27 to Chivvis Decl, # (29) Exhibit 28 to Chivvis Decl, # (30) Exhibit 29 to Chivvis Decl, # (31) Exhibit 30 to Chivvis Decl, # (32) Exhibit 31 to Chivvis Decl, # (33) Exhibit 32 to Chivvis Decl, # (34) Exhibit 33 to Chivvis Decl, # (35) Exhibit 34 to Chivvis Decl, # (36) Exhibit 35 to Chivvis Decl, # (37) Exhibit 36 to Chivvis Decl)(Chivvis, Matthew)
Sep 15, 2022 252 response in opposition to motion (Exhibit 11 to Chivvis Decl) (1)
Docket Text: RESPONSE by Evolve BioSystems, Inc., Regents of the University of Californiain Opposition to MOTION by Defendant Abbott Laboratories for protective order [248] (Public/Redacted Versions) (Attachments: # (1) Declaration of M. Chivvis, # (2) Exhibit 1 to Chivvis Decl, # (3) Exhibit 2 to Chivvis Decl, # (4) Exhibit 3 to Chivvis Decl, # (5) Exhibit 4 to Chivvis Decl, # (6) Exhibit 5 to Chivvis Decl, # (7) Exhibit 6 to Chivvis Decl, # (8) Exhibit 7 to Chivvis Decl, # (9) Exhibit 8 to Chivvis Decl, # (10) Exhibit 9 to Chivvis Decl, # (11) Exhibit 10 to Chivvis Decl, # (12) Exhibit 11 to Chivvis Decl, # (13) Exhibit 12 to Chivvis Decl, # (14) Exhibit 13 to Chivvis Decl, # (15) Exhibit 14 to Chivvis Decl, # (16) Exhibit 15 to Chivvis Decl, # (17) Exhibit 16 to Chivvis Decl, # (18) Exhibit 17 to Chivvis Decl, # (19) Exhibit 18 to Chivvis Decl, # (20) Exhibit 19 to Chivvis Decl, # (21) Exhibit 20 to Chivvis Decl, # (22) Exhibit 21 to Chivvis Decl, # (23) Exhibit 22 to Chivvis Decl, # (24) Exhibit 23 to Chivvis Decl, # (25) Exhibit 24 to Chivvis Decl, # (26) Exhibit 25 to Chivvis Decl, # (27) Exhibit 26 to Chivvis Decl, # (28) Exhibit 27 to Chivvis Decl, # (29) Exhibit 28 to Chivvis Decl, # (30) Exhibit 29 to Chivvis Decl, # (31) Exhibit 30 to Chivvis Decl, # (32) Exhibit 31 to Chivvis Decl, # (33) Exhibit 32 to Chivvis Decl, # (34) Exhibit 33 to Chivvis Decl, # (35) Exhibit 34 to Chivvis Decl, # (36) Exhibit 35 to Chivvis Decl, # (37) Exhibit 36 to Chivvis Decl)(Chivvis, Matthew)
Sep 15, 2022 252 response in opposition to motion (Exhibit 12 to Chivvis Decl) (1)
Docket Text: RESPONSE by Evolve BioSystems, Inc., Regents of the University of Californiain Opposition to MOTION by Defendant Abbott Laboratories for protective order [248] (Public/Redacted Versions) (Attachments: # (1) Declaration of M. Chivvis, # (2) Exhibit 1 to Chivvis Decl, # (3) Exhibit 2 to Chivvis Decl, # (4) Exhibit 3 to Chivvis Decl, # (5) Exhibit 4 to Chivvis Decl, # (6) Exhibit 5 to Chivvis Decl, # (7) Exhibit 6 to Chivvis Decl, # (8) Exhibit 7 to Chivvis Decl, # (9) Exhibit 8 to Chivvis Decl, # (10) Exhibit 9 to Chivvis Decl, # (11) Exhibit 10 to Chivvis Decl, # (12) Exhibit 11 to Chivvis Decl, # (13) Exhibit 12 to Chivvis Decl, # (14) Exhibit 13 to Chivvis Decl, # (15) Exhibit 14 to Chivvis Decl, # (16) Exhibit 15 to Chivvis Decl, # (17) Exhibit 16 to Chivvis Decl, # (18) Exhibit 17 to Chivvis Decl, # (19) Exhibit 18 to Chivvis Decl, # (20) Exhibit 19 to Chivvis Decl, # (21) Exhibit 20 to Chivvis Decl, # (22) Exhibit 21 to Chivvis Decl, # (23) Exhibit 22 to Chivvis Decl, # (24) Exhibit 23 to Chivvis Decl, # (25) Exhibit 24 to Chivvis Decl, # (26) Exhibit 25 to Chivvis Decl, # (27) Exhibit 26 to Chivvis Decl, # (28) Exhibit 27 to Chivvis Decl, # (29) Exhibit 28 to Chivvis Decl, # (30) Exhibit 29 to Chivvis Decl, # (31) Exhibit 30 to Chivvis Decl, # (32) Exhibit 31 to Chivvis Decl, # (33) Exhibit 32 to Chivvis Decl, # (34) Exhibit 33 to Chivvis Decl, # (35) Exhibit 34 to Chivvis Decl, # (36) Exhibit 35 to Chivvis Decl, # (37) Exhibit 36 to Chivvis Decl)(Chivvis, Matthew)
Sep 15, 2022 252 response in opposition to motion (Exhibit 13 to Chivvis Decl) (1)
Docket Text: RESPONSE by Evolve BioSystems, Inc., Regents of the University of Californiain Opposition to MOTION by Defendant Abbott Laboratories for protective order [248] (Public/Redacted Versions) (Attachments: # (1) Declaration of M. Chivvis, # (2) Exhibit 1 to Chivvis Decl, # (3) Exhibit 2 to Chivvis Decl, # (4) Exhibit 3 to Chivvis Decl, # (5) Exhibit 4 to Chivvis Decl, # (6) Exhibit 5 to Chivvis Decl, # (7) Exhibit 6 to Chivvis Decl, # (8) Exhibit 7 to Chivvis Decl, # (9) Exhibit 8 to Chivvis Decl, # (10) Exhibit 9 to Chivvis Decl, # (11) Exhibit 10 to Chivvis Decl, # (12) Exhibit 11 to Chivvis Decl, # (13) Exhibit 12 to Chivvis Decl, # (14) Exhibit 13 to Chivvis Decl, # (15) Exhibit 14 to Chivvis Decl, # (16) Exhibit 15 to Chivvis Decl, # (17) Exhibit 16 to Chivvis Decl, # (18) Exhibit 17 to Chivvis Decl, # (19) Exhibit 18 to Chivvis Decl, # (20) Exhibit 19 to Chivvis Decl, # (21) Exhibit 20 to Chivvis Decl, # (22) Exhibit 21 to Chivvis Decl, # (23) Exhibit 22 to Chivvis Decl, # (24) Exhibit 23 to Chivvis Decl, # (25) Exhibit 24 to Chivvis Decl, # (26) Exhibit 25 to Chivvis Decl, # (27) Exhibit 26 to Chivvis Decl, # (28) Exhibit 27 to Chivvis Decl, # (29) Exhibit 28 to Chivvis Decl, # (30) Exhibit 29 to Chivvis Decl, # (31) Exhibit 30 to Chivvis Decl, # (32) Exhibit 31 to Chivvis Decl, # (33) Exhibit 32 to Chivvis Decl, # (34) Exhibit 33 to Chivvis Decl, # (35) Exhibit 34 to Chivvis Decl, # (36) Exhibit 35 to Chivvis Decl, # (37) Exhibit 36 to Chivvis Decl)(Chivvis, Matthew)
Sep 15, 2022 252 response in opposition to motion (Exhibit 14 to Chivvis Decl) (1)
Docket Text: RESPONSE by Evolve BioSystems, Inc., Regents of the University of Californiain Opposition to MOTION by Defendant Abbott Laboratories for protective order [248] (Public/Redacted Versions) (Attachments: # (1) Declaration of M. Chivvis, # (2) Exhibit 1 to Chivvis Decl, # (3) Exhibit 2 to Chivvis Decl, # (4) Exhibit 3 to Chivvis Decl, # (5) Exhibit 4 to Chivvis Decl, # (6) Exhibit 5 to Chivvis Decl, # (7) Exhibit 6 to Chivvis Decl, # (8) Exhibit 7 to Chivvis Decl, # (9) Exhibit 8 to Chivvis Decl, # (10) Exhibit 9 to Chivvis Decl, # (11) Exhibit 10 to Chivvis Decl, # (12) Exhibit 11 to Chivvis Decl, # (13) Exhibit 12 to Chivvis Decl, # (14) Exhibit 13 to Chivvis Decl, # (15) Exhibit 14 to Chivvis Decl, # (16) Exhibit 15 to Chivvis Decl, # (17) Exhibit 16 to Chivvis Decl, # (18) Exhibit 17 to Chivvis Decl, # (19) Exhibit 18 to Chivvis Decl, # (20) Exhibit 19 to Chivvis Decl, # (21) Exhibit 20 to Chivvis Decl, # (22) Exhibit 21 to Chivvis Decl, # (23) Exhibit 22 to Chivvis Decl, # (24) Exhibit 23 to Chivvis Decl, # (25) Exhibit 24 to Chivvis Decl, # (26) Exhibit 25 to Chivvis Decl, # (27) Exhibit 26 to Chivvis Decl, # (28) Exhibit 27 to Chivvis Decl, # (29) Exhibit 28 to Chivvis Decl, # (30) Exhibit 29 to Chivvis Decl, # (31) Exhibit 30 to Chivvis Decl, # (32) Exhibit 31 to Chivvis Decl, # (33) Exhibit 32 to Chivvis Decl, # (34) Exhibit 33 to Chivvis Decl, # (35) Exhibit 34 to Chivvis Decl, # (36) Exhibit 35 to Chivvis Decl, # (37) Exhibit 36 to Chivvis Decl)(Chivvis, Matthew)
Sep 15, 2022 252 response in opposition to motion (Exhibit 15 to Chivvis Decl) (1)
Docket Text: RESPONSE by Evolve BioSystems, Inc., Regents of the University of Californiain Opposition to MOTION by Defendant Abbott Laboratories for protective order [248] (Public/Redacted Versions) (Attachments: # (1) Declaration of M. Chivvis, # (2) Exhibit 1 to Chivvis Decl, # (3) Exhibit 2 to Chivvis Decl, # (4) Exhibit 3 to Chivvis Decl, # (5) Exhibit 4 to Chivvis Decl, # (6) Exhibit 5 to Chivvis Decl, # (7) Exhibit 6 to Chivvis Decl, # (8) Exhibit 7 to Chivvis Decl, # (9) Exhibit 8 to Chivvis Decl, # (10) Exhibit 9 to Chivvis Decl, # (11) Exhibit 10 to Chivvis Decl, # (12) Exhibit 11 to Chivvis Decl, # (13) Exhibit 12 to Chivvis Decl, # (14) Exhibit 13 to Chivvis Decl, # (15) Exhibit 14 to Chivvis Decl, # (16) Exhibit 15 to Chivvis Decl, # (17) Exhibit 16 to Chivvis Decl, # (18) Exhibit 17 to Chivvis Decl, # (19) Exhibit 18 to Chivvis Decl, # (20) Exhibit 19 to Chivvis Decl, # (21) Exhibit 20 to Chivvis Decl, # (22) Exhibit 21 to Chivvis Decl, # (23) Exhibit 22 to Chivvis Decl, # (24) Exhibit 23 to Chivvis Decl, # (25) Exhibit 24 to Chivvis Decl, # (26) Exhibit 25 to Chivvis Decl, # (27) Exhibit 26 to Chivvis Decl, # (28) Exhibit 27 to Chivvis Decl, # (29) Exhibit 28 to Chivvis Decl, # (30) Exhibit 29 to Chivvis Decl, # (31) Exhibit 30 to Chivvis Decl, # (32) Exhibit 31 to Chivvis Decl, # (33) Exhibit 32 to Chivvis Decl, # (34) Exhibit 33 to Chivvis Decl, # (35) Exhibit 34 to Chivvis Decl, # (36) Exhibit 35 to Chivvis Decl, # (37) Exhibit 36 to Chivvis Decl)(Chivvis, Matthew)
Sep 15, 2022 252 response in opposition to motion (Exhibit 16 to Chivvis Decl) (1)
Docket Text: RESPONSE by Evolve BioSystems, Inc., Regents of the University of Californiain Opposition to MOTION by Defendant Abbott Laboratories for protective order [248] (Public/Redacted Versions) (Attachments: # (1) Declaration of M. Chivvis, # (2) Exhibit 1 to Chivvis Decl, # (3) Exhibit 2 to Chivvis Decl, # (4) Exhibit 3 to Chivvis Decl, # (5) Exhibit 4 to Chivvis Decl, # (6) Exhibit 5 to Chivvis Decl, # (7) Exhibit 6 to Chivvis Decl, # (8) Exhibit 7 to Chivvis Decl, # (9) Exhibit 8 to Chivvis Decl, # (10) Exhibit 9 to Chivvis Decl, # (11) Exhibit 10 to Chivvis Decl, # (12) Exhibit 11 to Chivvis Decl, # (13) Exhibit 12 to Chivvis Decl, # (14) Exhibit 13 to Chivvis Decl, # (15) Exhibit 14 to Chivvis Decl, # (16) Exhibit 15 to Chivvis Decl, # (17) Exhibit 16 to Chivvis Decl, # (18) Exhibit 17 to Chivvis Decl, # (19) Exhibit 18 to Chivvis Decl, # (20) Exhibit 19 to Chivvis Decl, # (21) Exhibit 20 to Chivvis Decl, # (22) Exhibit 21 to Chivvis Decl, # (23) Exhibit 22 to Chivvis Decl, # (24) Exhibit 23 to Chivvis Decl, # (25) Exhibit 24 to Chivvis Decl, # (26) Exhibit 25 to Chivvis Decl, # (27) Exhibit 26 to Chivvis Decl, # (28) Exhibit 27 to Chivvis Decl, # (29) Exhibit 28 to Chivvis Decl, # (30) Exhibit 29 to Chivvis Decl, # (31) Exhibit 30 to Chivvis Decl, # (32) Exhibit 31 to Chivvis Decl, # (33) Exhibit 32 to Chivvis Decl, # (34) Exhibit 33 to Chivvis Decl, # (35) Exhibit 34 to Chivvis Decl, # (36) Exhibit 35 to Chivvis Decl, # (37) Exhibit 36 to Chivvis Decl)(Chivvis, Matthew)
Sep 15, 2022 252 response in opposition to motion (Exhibit 17 to Chivvis Decl) (1)
Docket Text: RESPONSE by Evolve BioSystems, Inc., Regents of the University of Californiain Opposition to MOTION by Defendant Abbott Laboratories for protective order [248] (Public/Redacted Versions) (Attachments: # (1) Declaration of M. Chivvis, # (2) Exhibit 1 to Chivvis Decl, # (3) Exhibit 2 to Chivvis Decl, # (4) Exhibit 3 to Chivvis Decl, # (5) Exhibit 4 to Chivvis Decl, # (6) Exhibit 5 to Chivvis Decl, # (7) Exhibit 6 to Chivvis Decl, # (8) Exhibit 7 to Chivvis Decl, # (9) Exhibit 8 to Chivvis Decl, # (10) Exhibit 9 to Chivvis Decl, # (11) Exhibit 10 to Chivvis Decl, # (12) Exhibit 11 to Chivvis Decl, # (13) Exhibit 12 to Chivvis Decl, # (14) Exhibit 13 to Chivvis Decl, # (15) Exhibit 14 to Chivvis Decl, # (16) Exhibit 15 to Chivvis Decl, # (17) Exhibit 16 to Chivvis Decl, # (18) Exhibit 17 to Chivvis Decl, # (19) Exhibit 18 to Chivvis Decl, # (20) Exhibit 19 to Chivvis Decl, # (21) Exhibit 20 to Chivvis Decl, # (22) Exhibit 21 to Chivvis Decl, # (23) Exhibit 22 to Chivvis Decl, # (24) Exhibit 23 to Chivvis Decl, # (25) Exhibit 24 to Chivvis Decl, # (26) Exhibit 25 to Chivvis Decl, # (27) Exhibit 26 to Chivvis Decl, # (28) Exhibit 27 to Chivvis Decl, # (29) Exhibit 28 to Chivvis Decl, # (30) Exhibit 29 to Chivvis Decl, # (31) Exhibit 30 to Chivvis Decl, # (32) Exhibit 31 to Chivvis Decl, # (33) Exhibit 32 to Chivvis Decl, # (34) Exhibit 33 to Chivvis Decl, # (35) Exhibit 34 to Chivvis Decl, # (36) Exhibit 35 to Chivvis Decl, # (37) Exhibit 36 to Chivvis Decl)(Chivvis, Matthew)
Sep 15, 2022 252 response in opposition to motion (Exhibit 18 to Chivvis Decl) (1)
Docket Text: RESPONSE by Evolve BioSystems, Inc., Regents of the University of Californiain Opposition to MOTION by Defendant Abbott Laboratories for protective order [248] (Public/Redacted Versions) (Attachments: # (1) Declaration of M. Chivvis, # (2) Exhibit 1 to Chivvis Decl, # (3) Exhibit 2 to Chivvis Decl, # (4) Exhibit 3 to Chivvis Decl, # (5) Exhibit 4 to Chivvis Decl, # (6) Exhibit 5 to Chivvis Decl, # (7) Exhibit 6 to Chivvis Decl, # (8) Exhibit 7 to Chivvis Decl, # (9) Exhibit 8 to Chivvis Decl, # (10) Exhibit 9 to Chivvis Decl, # (11) Exhibit 10 to Chivvis Decl, # (12) Exhibit 11 to Chivvis Decl, # (13) Exhibit 12 to Chivvis Decl, # (14) Exhibit 13 to Chivvis Decl, # (15) Exhibit 14 to Chivvis Decl, # (16) Exhibit 15 to Chivvis Decl, # (17) Exhibit 16 to Chivvis Decl, # (18) Exhibit 17 to Chivvis Decl, # (19) Exhibit 18 to Chivvis Decl, # (20) Exhibit 19 to Chivvis Decl, # (21) Exhibit 20 to Chivvis Decl, # (22) Exhibit 21 to Chivvis Decl, # (23) Exhibit 22 to Chivvis Decl, # (24) Exhibit 23 to Chivvis Decl, # (25) Exhibit 24 to Chivvis Decl, # (26) Exhibit 25 to Chivvis Decl, # (27) Exhibit 26 to Chivvis Decl, # (28) Exhibit 27 to Chivvis Decl, # (29) Exhibit 28 to Chivvis Decl, # (30) Exhibit 29 to Chivvis Decl, # (31) Exhibit 30 to Chivvis Decl, # (32) Exhibit 31 to Chivvis Decl, # (33) Exhibit 32 to Chivvis Decl, # (34) Exhibit 33 to Chivvis Decl, # (35) Exhibit 34 to Chivvis Decl, # (36) Exhibit 35 to Chivvis Decl, # (37) Exhibit 36 to Chivvis Decl)(Chivvis, Matthew)
Sep 15, 2022 252 response in opposition to motion (Exhibit 19 to Chivvis Decl) (1)
Docket Text: RESPONSE by Evolve BioSystems, Inc., Regents of the University of Californiain Opposition to MOTION by Defendant Abbott Laboratories for protective order [248] (Public/Redacted Versions) (Attachments: # (1) Declaration of M. Chivvis, # (2) Exhibit 1 to Chivvis Decl, # (3) Exhibit 2 to Chivvis Decl, # (4) Exhibit 3 to Chivvis Decl, # (5) Exhibit 4 to Chivvis Decl, # (6) Exhibit 5 to Chivvis Decl, # (7) Exhibit 6 to Chivvis Decl, # (8) Exhibit 7 to Chivvis Decl, # (9) Exhibit 8 to Chivvis Decl, # (10) Exhibit 9 to Chivvis Decl, # (11) Exhibit 10 to Chivvis Decl, # (12) Exhibit 11 to Chivvis Decl, # (13) Exhibit 12 to Chivvis Decl, # (14) Exhibit 13 to Chivvis Decl, # (15) Exhibit 14 to Chivvis Decl, # (16) Exhibit 15 to Chivvis Decl, # (17) Exhibit 16 to Chivvis Decl, # (18) Exhibit 17 to Chivvis Decl, # (19) Exhibit 18 to Chivvis Decl, # (20) Exhibit 19 to Chivvis Decl, # (21) Exhibit 20 to Chivvis Decl, # (22) Exhibit 21 to Chivvis Decl, # (23) Exhibit 22 to Chivvis Decl, # (24) Exhibit 23 to Chivvis Decl, # (25) Exhibit 24 to Chivvis Decl, # (26) Exhibit 25 to Chivvis Decl, # (27) Exhibit 26 to Chivvis Decl, # (28) Exhibit 27 to Chivvis Decl, # (29) Exhibit 28 to Chivvis Decl, # (30) Exhibit 29 to Chivvis Decl, # (31) Exhibit 30 to Chivvis Decl, # (32) Exhibit 31 to Chivvis Decl, # (33) Exhibit 32 to Chivvis Decl, # (34) Exhibit 33 to Chivvis Decl, # (35) Exhibit 34 to Chivvis Decl, # (36) Exhibit 35 to Chivvis Decl, # (37) Exhibit 36 to Chivvis Decl)(Chivvis, Matthew)
Sep 15, 2022 252 response in opposition to motion (Exhibit 20 to Chivvis Decl) (1)
Docket Text: RESPONSE by Evolve BioSystems, Inc., Regents of the University of Californiain Opposition to MOTION by Defendant Abbott Laboratories for protective order [248] (Public/Redacted Versions) (Attachments: # (1) Declaration of M. Chivvis, # (2) Exhibit 1 to Chivvis Decl, # (3) Exhibit 2 to Chivvis Decl, # (4) Exhibit 3 to Chivvis Decl, # (5) Exhibit 4 to Chivvis Decl, # (6) Exhibit 5 to Chivvis Decl, # (7) Exhibit 6 to Chivvis Decl, # (8) Exhibit 7 to Chivvis Decl, # (9) Exhibit 8 to Chivvis Decl, # (10) Exhibit 9 to Chivvis Decl, # (11) Exhibit 10 to Chivvis Decl, # (12) Exhibit 11 to Chivvis Decl, # (13) Exhibit 12 to Chivvis Decl, # (14) Exhibit 13 to Chivvis Decl, # (15) Exhibit 14 to Chivvis Decl, # (16) Exhibit 15 to Chivvis Decl, # (17) Exhibit 16 to Chivvis Decl, # (18) Exhibit 17 to Chivvis Decl, # (19) Exhibit 18 to Chivvis Decl, # (20) Exhibit 19 to Chivvis Decl, # (21) Exhibit 20 to Chivvis Decl, # (22) Exhibit 21 to Chivvis Decl, # (23) Exhibit 22 to Chivvis Decl, # (24) Exhibit 23 to Chivvis Decl, # (25) Exhibit 24 to Chivvis Decl, # (26) Exhibit 25 to Chivvis Decl, # (27) Exhibit 26 to Chivvis Decl, # (28) Exhibit 27 to Chivvis Decl, # (29) Exhibit 28 to Chivvis Decl, # (30) Exhibit 29 to Chivvis Decl, # (31) Exhibit 30 to Chivvis Decl, # (32) Exhibit 31 to Chivvis Decl, # (33) Exhibit 32 to Chivvis Decl, # (34) Exhibit 33 to Chivvis Decl, # (35) Exhibit 34 to Chivvis Decl, # (36) Exhibit 35 to Chivvis Decl, # (37) Exhibit 36 to Chivvis Decl)(Chivvis, Matthew)
Sep 15, 2022 252 response in opposition to motion (Exhibit 21 to Chivvis Decl) (1)
Docket Text: RESPONSE by Evolve BioSystems, Inc., Regents of the University of Californiain Opposition to MOTION by Defendant Abbott Laboratories for protective order [248] (Public/Redacted Versions) (Attachments: # (1) Declaration of M. Chivvis, # (2) Exhibit 1 to Chivvis Decl, # (3) Exhibit 2 to Chivvis Decl, # (4) Exhibit 3 to Chivvis Decl, # (5) Exhibit 4 to Chivvis Decl, # (6) Exhibit 5 to Chivvis Decl, # (7) Exhibit 6 to Chivvis Decl, # (8) Exhibit 7 to Chivvis Decl, # (9) Exhibit 8 to Chivvis Decl, # (10) Exhibit 9 to Chivvis Decl, # (11) Exhibit 10 to Chivvis Decl, # (12) Exhibit 11 to Chivvis Decl, # (13) Exhibit 12 to Chivvis Decl, # (14) Exhibit 13 to Chivvis Decl, # (15) Exhibit 14 to Chivvis Decl, # (16) Exhibit 15 to Chivvis Decl, # (17) Exhibit 16 to Chivvis Decl, # (18) Exhibit 17 to Chivvis Decl, # (19) Exhibit 18 to Chivvis Decl, # (20) Exhibit 19 to Chivvis Decl, # (21) Exhibit 20 to Chivvis Decl, # (22) Exhibit 21 to Chivvis Decl, # (23) Exhibit 22 to Chivvis Decl, # (24) Exhibit 23 to Chivvis Decl, # (25) Exhibit 24 to Chivvis Decl, # (26) Exhibit 25 to Chivvis Decl, # (27) Exhibit 26 to Chivvis Decl, # (28) Exhibit 27 to Chivvis Decl, # (29) Exhibit 28 to Chivvis Decl, # (30) Exhibit 29 to Chivvis Decl, # (31) Exhibit 30 to Chivvis Decl, # (32) Exhibit 31 to Chivvis Decl, # (33) Exhibit 32 to Chivvis Decl, # (34) Exhibit 33 to Chivvis Decl, # (35) Exhibit 34 to Chivvis Decl, # (36) Exhibit 35 to Chivvis Decl, # (37) Exhibit 36 to Chivvis Decl)(Chivvis, Matthew)
Sep 15, 2022 252 response in opposition to motion (Exhibit 22 to Chivvis Decl) (1)
Docket Text: RESPONSE by Evolve BioSystems, Inc., Regents of the University of Californiain Opposition to MOTION by Defendant Abbott Laboratories for protective order [248] (Public/Redacted Versions) (Attachments: # (1) Declaration of M. Chivvis, # (2) Exhibit 1 to Chivvis Decl, # (3) Exhibit 2 to Chivvis Decl, # (4) Exhibit 3 to Chivvis Decl, # (5) Exhibit 4 to Chivvis Decl, # (6) Exhibit 5 to Chivvis Decl, # (7) Exhibit 6 to Chivvis Decl, # (8) Exhibit 7 to Chivvis Decl, # (9) Exhibit 8 to Chivvis Decl, # (10) Exhibit 9 to Chivvis Decl, # (11) Exhibit 10 to Chivvis Decl, # (12) Exhibit 11 to Chivvis Decl, # (13) Exhibit 12 to Chivvis Decl, # (14) Exhibit 13 to Chivvis Decl, # (15) Exhibit 14 to Chivvis Decl, # (16) Exhibit 15 to Chivvis Decl, # (17) Exhibit 16 to Chivvis Decl, # (18) Exhibit 17 to Chivvis Decl, # (19) Exhibit 18 to Chivvis Decl, # (20) Exhibit 19 to Chivvis Decl, # (21) Exhibit 20 to Chivvis Decl, # (22) Exhibit 21 to Chivvis Decl, # (23) Exhibit 22 to Chivvis Decl, # (24) Exhibit 23 to Chivvis Decl, # (25) Exhibit 24 to Chivvis Decl, # (26) Exhibit 25 to Chivvis Decl, # (27) Exhibit 26 to Chivvis Decl, # (28) Exhibit 27 to Chivvis Decl, # (29) Exhibit 28 to Chivvis Decl, # (30) Exhibit 29 to Chivvis Decl, # (31) Exhibit 30 to Chivvis Decl, # (32) Exhibit 31 to Chivvis Decl, # (33) Exhibit 32 to Chivvis Decl, # (34) Exhibit 33 to Chivvis Decl, # (35) Exhibit 34 to Chivvis Decl, # (36) Exhibit 35 to Chivvis Decl, # (37) Exhibit 36 to Chivvis Decl)(Chivvis, Matthew)
Sep 15, 2022 252 response in opposition to motion (Exhibit 23 to Chivvis Decl) (1)
Docket Text: RESPONSE by Evolve BioSystems, Inc., Regents of the University of Californiain Opposition to MOTION by Defendant Abbott Laboratories for protective order [248] (Public/Redacted Versions) (Attachments: # (1) Declaration of M. Chivvis, # (2) Exhibit 1 to Chivvis Decl, # (3) Exhibit 2 to Chivvis Decl, # (4) Exhibit 3 to Chivvis Decl, # (5) Exhibit 4 to Chivvis Decl, # (6) Exhibit 5 to Chivvis Decl, # (7) Exhibit 6 to Chivvis Decl, # (8) Exhibit 7 to Chivvis Decl, # (9) Exhibit 8 to Chivvis Decl, # (10) Exhibit 9 to Chivvis Decl, # (11) Exhibit 10 to Chivvis Decl, # (12) Exhibit 11 to Chivvis Decl, # (13) Exhibit 12 to Chivvis Decl, # (14) Exhibit 13 to Chivvis Decl, # (15) Exhibit 14 to Chivvis Decl, # (16) Exhibit 15 to Chivvis Decl, # (17) Exhibit 16 to Chivvis Decl, # (18) Exhibit 17 to Chivvis Decl, # (19) Exhibit 18 to Chivvis Decl, # (20) Exhibit 19 to Chivvis Decl, # (21) Exhibit 20 to Chivvis Decl, # (22) Exhibit 21 to Chivvis Decl, # (23) Exhibit 22 to Chivvis Decl, # (24) Exhibit 23 to Chivvis Decl, # (25) Exhibit 24 to Chivvis Decl, # (26) Exhibit 25 to Chivvis Decl, # (27) Exhibit 26 to Chivvis Decl, # (28) Exhibit 27 to Chivvis Decl, # (29) Exhibit 28 to Chivvis Decl, # (30) Exhibit 29 to Chivvis Decl, # (31) Exhibit 30 to Chivvis Decl, # (32) Exhibit 31 to Chivvis Decl, # (33) Exhibit 32 to Chivvis Decl, # (34) Exhibit 33 to Chivvis Decl, # (35) Exhibit 34 to Chivvis Decl, # (36) Exhibit 35 to Chivvis Decl, # (37) Exhibit 36 to Chivvis Decl)(Chivvis, Matthew)
Sep 15, 2022 252 response in opposition to motion (Exhibit 24 to Chivvis Decl) (1)
Docket Text: RESPONSE by Evolve BioSystems, Inc., Regents of the University of Californiain Opposition to MOTION by Defendant Abbott Laboratories for protective order [248] (Public/Redacted Versions) (Attachments: # (1) Declaration of M. Chivvis, # (2) Exhibit 1 to Chivvis Decl, # (3) Exhibit 2 to Chivvis Decl, # (4) Exhibit 3 to Chivvis Decl, # (5) Exhibit 4 to Chivvis Decl, # (6) Exhibit 5 to Chivvis Decl, # (7) Exhibit 6 to Chivvis Decl, # (8) Exhibit 7 to Chivvis Decl, # (9) Exhibit 8 to Chivvis Decl, # (10) Exhibit 9 to Chivvis Decl, # (11) Exhibit 10 to Chivvis Decl, # (12) Exhibit 11 to Chivvis Decl, # (13) Exhibit 12 to Chivvis Decl, # (14) Exhibit 13 to Chivvis Decl, # (15) Exhibit 14 to Chivvis Decl, # (16) Exhibit 15 to Chivvis Decl, # (17) Exhibit 16 to Chivvis Decl, # (18) Exhibit 17 to Chivvis Decl, # (19) Exhibit 18 to Chivvis Decl, # (20) Exhibit 19 to Chivvis Decl, # (21) Exhibit 20 to Chivvis Decl, # (22) Exhibit 21 to Chivvis Decl, # (23) Exhibit 22 to Chivvis Decl, # (24) Exhibit 23 to Chivvis Decl, # (25) Exhibit 24 to Chivvis Decl, # (26) Exhibit 25 to Chivvis Decl, # (27) Exhibit 26 to Chivvis Decl, # (28) Exhibit 27 to Chivvis Decl, # (29) Exhibit 28 to Chivvis Decl, # (30) Exhibit 29 to Chivvis Decl, # (31) Exhibit 30 to Chivvis Decl, # (32) Exhibit 31 to Chivvis Decl, # (33) Exhibit 32 to Chivvis Decl, # (34) Exhibit 33 to Chivvis Decl, # (35) Exhibit 34 to Chivvis Decl, # (36) Exhibit 35 to Chivvis Decl, # (37) Exhibit 36 to Chivvis Decl)(Chivvis, Matthew)
Sep 15, 2022 252 response in opposition to motion (Exhibit 25 to Chivvis Decl) (1)
Docket Text: RESPONSE by Evolve BioSystems, Inc., Regents of the University of Californiain Opposition to MOTION by Defendant Abbott Laboratories for protective order [248] (Public/Redacted Versions) (Attachments: # (1) Declaration of M. Chivvis, # (2) Exhibit 1 to Chivvis Decl, # (3) Exhibit 2 to Chivvis Decl, # (4) Exhibit 3 to Chivvis Decl, # (5) Exhibit 4 to Chivvis Decl, # (6) Exhibit 5 to Chivvis Decl, # (7) Exhibit 6 to Chivvis Decl, # (8) Exhibit 7 to Chivvis Decl, # (9) Exhibit 8 to Chivvis Decl, # (10) Exhibit 9 to Chivvis Decl, # (11) Exhibit 10 to Chivvis Decl, # (12) Exhibit 11 to Chivvis Decl, # (13) Exhibit 12 to Chivvis Decl, # (14) Exhibit 13 to Chivvis Decl, # (15) Exhibit 14 to Chivvis Decl, # (16) Exhibit 15 to Chivvis Decl, # (17) Exhibit 16 to Chivvis Decl, # (18) Exhibit 17 to Chivvis Decl, # (19) Exhibit 18 to Chivvis Decl, # (20) Exhibit 19 to Chivvis Decl, # (21) Exhibit 20 to Chivvis Decl, # (22) Exhibit 21 to Chivvis Decl, # (23) Exhibit 22 to Chivvis Decl, # (24) Exhibit 23 to Chivvis Decl, # (25) Exhibit 24 to Chivvis Decl, # (26) Exhibit 25 to Chivvis Decl, # (27) Exhibit 26 to Chivvis Decl, # (28) Exhibit 27 to Chivvis Decl, # (29) Exhibit 28 to Chivvis Decl, # (30) Exhibit 29 to Chivvis Decl, # (31) Exhibit 30 to Chivvis Decl, # (32) Exhibit 31 to Chivvis Decl, # (33) Exhibit 32 to Chivvis Decl, # (34) Exhibit 33 to Chivvis Decl, # (35) Exhibit 34 to Chivvis Decl, # (36) Exhibit 35 to Chivvis Decl, # (37) Exhibit 36 to Chivvis Decl)(Chivvis, Matthew)
Sep 15, 2022 252 response in opposition to motion (Exhibit 26 to Chivvis Decl) (1)
Docket Text: RESPONSE by Evolve BioSystems, Inc., Regents of the University of Californiain Opposition to MOTION by Defendant Abbott Laboratories for protective order [248] (Public/Redacted Versions) (Attachments: # (1) Declaration of M. Chivvis, # (2) Exhibit 1 to Chivvis Decl, # (3) Exhibit 2 to Chivvis Decl, # (4) Exhibit 3 to Chivvis Decl, # (5) Exhibit 4 to Chivvis Decl, # (6) Exhibit 5 to Chivvis Decl, # (7) Exhibit 6 to Chivvis Decl, # (8) Exhibit 7 to Chivvis Decl, # (9) Exhibit 8 to Chivvis Decl, # (10) Exhibit 9 to Chivvis Decl, # (11) Exhibit 10 to Chivvis Decl, # (12) Exhibit 11 to Chivvis Decl, # (13) Exhibit 12 to Chivvis Decl, # (14) Exhibit 13 to Chivvis Decl, # (15) Exhibit 14 to Chivvis Decl, # (16) Exhibit 15 to Chivvis Decl, # (17) Exhibit 16 to Chivvis Decl, # (18) Exhibit 17 to Chivvis Decl, # (19) Exhibit 18 to Chivvis Decl, # (20) Exhibit 19 to Chivvis Decl, # (21) Exhibit 20 to Chivvis Decl, # (22) Exhibit 21 to Chivvis Decl, # (23) Exhibit 22 to Chivvis Decl, # (24) Exhibit 23 to Chivvis Decl, # (25) Exhibit 24 to Chivvis Decl, # (26) Exhibit 25 to Chivvis Decl, # (27) Exhibit 26 to Chivvis Decl, # (28) Exhibit 27 to Chivvis Decl, # (29) Exhibit 28 to Chivvis Decl, # (30) Exhibit 29 to Chivvis Decl, # (31) Exhibit 30 to Chivvis Decl, # (32) Exhibit 31 to Chivvis Decl, # (33) Exhibit 32 to Chivvis Decl, # (34) Exhibit 33 to Chivvis Decl, # (35) Exhibit 34 to Chivvis Decl, # (36) Exhibit 35 to Chivvis Decl, # (37) Exhibit 36 to Chivvis Decl)(Chivvis, Matthew)
Sep 15, 2022 252 response in opposition to motion (Exhibit 27 to Chivvis Decl) (1)
Docket Text: RESPONSE by Evolve BioSystems, Inc., Regents of the University of Californiain Opposition to MOTION by Defendant Abbott Laboratories for protective order [248] (Public/Redacted Versions) (Attachments: # (1) Declaration of M. Chivvis, # (2) Exhibit 1 to Chivvis Decl, # (3) Exhibit 2 to Chivvis Decl, # (4) Exhibit 3 to Chivvis Decl, # (5) Exhibit 4 to Chivvis Decl, # (6) Exhibit 5 to Chivvis Decl, # (7) Exhibit 6 to Chivvis Decl, # (8) Exhibit 7 to Chivvis Decl, # (9) Exhibit 8 to Chivvis Decl, # (10) Exhibit 9 to Chivvis Decl, # (11) Exhibit 10 to Chivvis Decl, # (12) Exhibit 11 to Chivvis Decl, # (13) Exhibit 12 to Chivvis Decl, # (14) Exhibit 13 to Chivvis Decl, # (15) Exhibit 14 to Chivvis Decl, # (16) Exhibit 15 to Chivvis Decl, # (17) Exhibit 16 to Chivvis Decl, # (18) Exhibit 17 to Chivvis Decl, # (19) Exhibit 18 to Chivvis Decl, # (20) Exhibit 19 to Chivvis Decl, # (21) Exhibit 20 to Chivvis Decl, # (22) Exhibit 21 to Chivvis Decl, # (23) Exhibit 22 to Chivvis Decl, # (24) Exhibit 23 to Chivvis Decl, # (25) Exhibit 24 to Chivvis Decl, # (26) Exhibit 25 to Chivvis Decl, # (27) Exhibit 26 to Chivvis Decl, # (28) Exhibit 27 to Chivvis Decl, # (29) Exhibit 28 to Chivvis Decl, # (30) Exhibit 29 to Chivvis Decl, # (31) Exhibit 30 to Chivvis Decl, # (32) Exhibit 31 to Chivvis Decl, # (33) Exhibit 32 to Chivvis Decl, # (34) Exhibit 33 to Chivvis Decl, # (35) Exhibit 34 to Chivvis Decl, # (36) Exhibit 35 to Chivvis Decl, # (37) Exhibit 36 to Chivvis Decl)(Chivvis, Matthew)
Sep 15, 2022 252 response in opposition to motion (Exhibit 28 to Chivvis Decl) (1)
Docket Text: RESPONSE by Evolve BioSystems, Inc., Regents of the University of Californiain Opposition to MOTION by Defendant Abbott Laboratories for protective order [248] (Public/Redacted Versions) (Attachments: # (1) Declaration of M. Chivvis, # (2) Exhibit 1 to Chivvis Decl, # (3) Exhibit 2 to Chivvis Decl, # (4) Exhibit 3 to Chivvis Decl, # (5) Exhibit 4 to Chivvis Decl, # (6) Exhibit 5 to Chivvis Decl, # (7) Exhibit 6 to Chivvis Decl, # (8) Exhibit 7 to Chivvis Decl, # (9) Exhibit 8 to Chivvis Decl, # (10) Exhibit 9 to Chivvis Decl, # (11) Exhibit 10 to Chivvis Decl, # (12) Exhibit 11 to Chivvis Decl, # (13) Exhibit 12 to Chivvis Decl, # (14) Exhibit 13 to Chivvis Decl, # (15) Exhibit 14 to Chivvis Decl, # (16) Exhibit 15 to Chivvis Decl, # (17) Exhibit 16 to Chivvis Decl, # (18) Exhibit 17 to Chivvis Decl, # (19) Exhibit 18 to Chivvis Decl, # (20) Exhibit 19 to Chivvis Decl, # (21) Exhibit 20 to Chivvis Decl, # (22) Exhibit 21 to Chivvis Decl, # (23) Exhibit 22 to Chivvis Decl, # (24) Exhibit 23 to Chivvis Decl, # (25) Exhibit 24 to Chivvis Decl, # (26) Exhibit 25 to Chivvis Decl, # (27) Exhibit 26 to Chivvis Decl, # (28) Exhibit 27 to Chivvis Decl, # (29) Exhibit 28 to Chivvis Decl, # (30) Exhibit 29 to Chivvis Decl, # (31) Exhibit 30 to Chivvis Decl, # (32) Exhibit 31 to Chivvis Decl, # (33) Exhibit 32 to Chivvis Decl, # (34) Exhibit 33 to Chivvis Decl, # (35) Exhibit 34 to Chivvis Decl, # (36) Exhibit 35 to Chivvis Decl, # (37) Exhibit 36 to Chivvis Decl)(Chivvis, Matthew)
Sep 15, 2022 252 response in opposition to motion (Exhibit 29 to Chivvis Decl) (1)
Docket Text: RESPONSE by Evolve BioSystems, Inc., Regents of the University of Californiain Opposition to MOTION by Defendant Abbott Laboratories for protective order [248] (Public/Redacted Versions) (Attachments: # (1) Declaration of M. Chivvis, # (2) Exhibit 1 to Chivvis Decl, # (3) Exhibit 2 to Chivvis Decl, # (4) Exhibit 3 to Chivvis Decl, # (5) Exhibit 4 to Chivvis Decl, # (6) Exhibit 5 to Chivvis Decl, # (7) Exhibit 6 to Chivvis Decl, # (8) Exhibit 7 to Chivvis Decl, # (9) Exhibit 8 to Chivvis Decl, # (10) Exhibit 9 to Chivvis Decl, # (11) Exhibit 10 to Chivvis Decl, # (12) Exhibit 11 to Chivvis Decl, # (13) Exhibit 12 to Chivvis Decl, # (14) Exhibit 13 to Chivvis Decl, # (15) Exhibit 14 to Chivvis Decl, # (16) Exhibit 15 to Chivvis Decl, # (17) Exhibit 16 to Chivvis Decl, # (18) Exhibit 17 to Chivvis Decl, # (19) Exhibit 18 to Chivvis Decl, # (20) Exhibit 19 to Chivvis Decl, # (21) Exhibit 20 to Chivvis Decl, # (22) Exhibit 21 to Chivvis Decl, # (23) Exhibit 22 to Chivvis Decl, # (24) Exhibit 23 to Chivvis Decl, # (25) Exhibit 24 to Chivvis Decl, # (26) Exhibit 25 to Chivvis Decl, # (27) Exhibit 26 to Chivvis Decl, # (28) Exhibit 27 to Chivvis Decl, # (29) Exhibit 28 to Chivvis Decl, # (30) Exhibit 29 to Chivvis Decl, # (31) Exhibit 30 to Chivvis Decl, # (32) Exhibit 31 to Chivvis Decl, # (33) Exhibit 32 to Chivvis Decl, # (34) Exhibit 33 to Chivvis Decl, # (35) Exhibit 34 to Chivvis Decl, # (36) Exhibit 35 to Chivvis Decl, # (37) Exhibit 36 to Chivvis Decl)(Chivvis, Matthew)
Sep 15, 2022 252 response in opposition to motion (Exhibit 30 to Chivvis Decl) (1)
Docket Text: RESPONSE by Evolve BioSystems, Inc., Regents of the University of Californiain Opposition to MOTION by Defendant Abbott Laboratories for protective order [248] (Public/Redacted Versions) (Attachments: # (1) Declaration of M. Chivvis, # (2) Exhibit 1 to Chivvis Decl, # (3) Exhibit 2 to Chivvis Decl, # (4) Exhibit 3 to Chivvis Decl, # (5) Exhibit 4 to Chivvis Decl, # (6) Exhibit 5 to Chivvis Decl, # (7) Exhibit 6 to Chivvis Decl, # (8) Exhibit 7 to Chivvis Decl, # (9) Exhibit 8 to Chivvis Decl, # (10) Exhibit 9 to Chivvis Decl, # (11) Exhibit 10 to Chivvis Decl, # (12) Exhibit 11 to Chivvis Decl, # (13) Exhibit 12 to Chivvis Decl, # (14) Exhibit 13 to Chivvis Decl, # (15) Exhibit 14 to Chivvis Decl, # (16) Exhibit 15 to Chivvis Decl, # (17) Exhibit 16 to Chivvis Decl, # (18) Exhibit 17 to Chivvis Decl, # (19) Exhibit 18 to Chivvis Decl, # (20) Exhibit 19 to Chivvis Decl, # (21) Exhibit 20 to Chivvis Decl, # (22) Exhibit 21 to Chivvis Decl, # (23) Exhibit 22 to Chivvis Decl, # (24) Exhibit 23 to Chivvis Decl, # (25) Exhibit 24 to Chivvis Decl, # (26) Exhibit 25 to Chivvis Decl, # (27) Exhibit 26 to Chivvis Decl, # (28) Exhibit 27 to Chivvis Decl, # (29) Exhibit 28 to Chivvis Decl, # (30) Exhibit 29 to Chivvis Decl, # (31) Exhibit 30 to Chivvis Decl, # (32) Exhibit 31 to Chivvis Decl, # (33) Exhibit 32 to Chivvis Decl, # (34) Exhibit 33 to Chivvis Decl, # (35) Exhibit 34 to Chivvis Decl, # (36) Exhibit 35 to Chivvis Decl, # (37) Exhibit 36 to Chivvis Decl)(Chivvis, Matthew)
Sep 15, 2022 252 response in opposition to motion (Exhibit 31 to Chivvis Decl) (1)
Docket Text: RESPONSE by Evolve BioSystems, Inc., Regents of the University of Californiain Opposition to MOTION by Defendant Abbott Laboratories for protective order [248] (Public/Redacted Versions) (Attachments: # (1) Declaration of M. Chivvis, # (2) Exhibit 1 to Chivvis Decl, # (3) Exhibit 2 to Chivvis Decl, # (4) Exhibit 3 to Chivvis Decl, # (5) Exhibit 4 to Chivvis Decl, # (6) Exhibit 5 to Chivvis Decl, # (7) Exhibit 6 to Chivvis Decl, # (8) Exhibit 7 to Chivvis Decl, # (9) Exhibit 8 to Chivvis Decl, # (10) Exhibit 9 to Chivvis Decl, # (11) Exhibit 10 to Chivvis Decl, # (12) Exhibit 11 to Chivvis Decl, # (13) Exhibit 12 to Chivvis Decl, # (14) Exhibit 13 to Chivvis Decl, # (15) Exhibit 14 to Chivvis Decl, # (16) Exhibit 15 to Chivvis Decl, # (17) Exhibit 16 to Chivvis Decl, # (18) Exhibit 17 to Chivvis Decl, # (19) Exhibit 18 to Chivvis Decl, # (20) Exhibit 19 to Chivvis Decl, # (21) Exhibit 20 to Chivvis Decl, # (22) Exhibit 21 to Chivvis Decl, # (23) Exhibit 22 to Chivvis Decl, # (24) Exhibit 23 to Chivvis Decl, # (25) Exhibit 24 to Chivvis Decl, # (26) Exhibit 25 to Chivvis Decl, # (27) Exhibit 26 to Chivvis Decl, # (28) Exhibit 27 to Chivvis Decl, # (29) Exhibit 28 to Chivvis Decl, # (30) Exhibit 29 to Chivvis Decl, # (31) Exhibit 30 to Chivvis Decl, # (32) Exhibit 31 to Chivvis Decl, # (33) Exhibit 32 to Chivvis Decl, # (34) Exhibit 33 to Chivvis Decl, # (35) Exhibit 34 to Chivvis Decl, # (36) Exhibit 35 to Chivvis Decl, # (37) Exhibit 36 to Chivvis Decl)(Chivvis, Matthew)
Sep 15, 2022 252 response in opposition to motion (Exhibit 32 to Chivvis Decl) (10)
Docket Text: RESPONSE by Evolve BioSystems, Inc., Regents of the University of Californiain Opposition to MOTION by Defendant Abbott Laboratories for protective order [248] (Public/Redacted Versions) (Attachments: # (1) Declaration of M. Chivvis, # (2) Exhibit 1 to Chivvis Decl, # (3) Exhibit 2 to Chivvis Decl, # (4) Exhibit 3 to Chivvis Decl, # (5) Exhibit 4 to Chivvis Decl, # (6) Exhibit 5 to Chivvis Decl, # (7) Exhibit 6 to Chivvis Decl, # (8) Exhibit 7 to Chivvis Decl, # (9) Exhibit 8 to Chivvis Decl, # (10) Exhibit 9 to Chivvis Decl, # (11) Exhibit 10 to Chivvis Decl, # (12) Exhibit 11 to Chivvis Decl, # (13) Exhibit 12 to Chivvis Decl, # (14) Exhibit 13 to Chivvis Decl, # (15) Exhibit 14 to Chivvis Decl, # (16) Exhibit 15 to Chivvis Decl, # (17) Exhibit 16 to Chivvis Decl, # (18) Exhibit 17 to Chivvis Decl, # (19) Exhibit 18 to Chivvis Decl, # (20) Exhibit 19 to Chivvis Decl, # (21) Exhibit 20 to Chivvis Decl, # (22) Exhibit 21 to Chivvis Decl, # (23) Exhibit 22 to Chivvis Decl, # (24) Exhibit 23 to Chivvis Decl, # (25) Exhibit 24 to Chivvis Decl, # (26) Exhibit 25 to Chivvis Decl, # (27) Exhibit 26 to Chivvis Decl, # (28) Exhibit 27 to Chivvis Decl, # (29) Exhibit 28 to Chivvis Decl, # (30) Exhibit 29 to Chivvis Decl, # (31) Exhibit 30 to Chivvis Decl, # (32) Exhibit 31 to Chivvis Decl, # (33) Exhibit 32 to Chivvis Decl, # (34) Exhibit 33 to Chivvis Decl, # (35) Exhibit 34 to Chivvis Decl, # (36) Exhibit 35 to Chivvis Decl, # (37) Exhibit 36 to Chivvis Decl)(Chivvis, Matthew)
Sep 15, 2022 252 response in opposition to motion (Exhibit 33 to Chivvis Decl) (4)
Docket Text: RESPONSE by Evolve BioSystems, Inc., Regents of the University of Californiain Opposition to MOTION by Defendant Abbott Laboratories for protective order [248] (Public/Redacted Versions) (Attachments: # (1) Declaration of M. Chivvis, # (2) Exhibit 1 to Chivvis Decl, # (3) Exhibit 2 to Chivvis Decl, # (4) Exhibit 3 to Chivvis Decl, # (5) Exhibit 4 to Chivvis Decl, # (6) Exhibit 5 to Chivvis Decl, # (7) Exhibit 6 to Chivvis Decl, # (8) Exhibit 7 to Chivvis Decl, # (9) Exhibit 8 to Chivvis Decl, # (10) Exhibit 9 to Chivvis Decl, # (11) Exhibit 10 to Chivvis Decl, # (12) Exhibit 11 to Chivvis Decl, # (13) Exhibit 12 to Chivvis Decl, # (14) Exhibit 13 to Chivvis Decl, # (15) Exhibit 14 to Chivvis Decl, # (16) Exhibit 15 to Chivvis Decl, # (17) Exhibit 16 to Chivvis Decl, # (18) Exhibit 17 to Chivvis Decl, # (19) Exhibit 18 to Chivvis Decl, # (20) Exhibit 19 to Chivvis Decl, # (21) Exhibit 20 to Chivvis Decl, # (22) Exhibit 21 to Chivvis Decl, # (23) Exhibit 22 to Chivvis Decl, # (24) Exhibit 23 to Chivvis Decl, # (25) Exhibit 24 to Chivvis Decl, # (26) Exhibit 25 to Chivvis Decl, # (27) Exhibit 26 to Chivvis Decl, # (28) Exhibit 27 to Chivvis Decl, # (29) Exhibit 28 to Chivvis Decl, # (30) Exhibit 29 to Chivvis Decl, # (31) Exhibit 30 to Chivvis Decl, # (32) Exhibit 31 to Chivvis Decl, # (33) Exhibit 32 to Chivvis Decl, # (34) Exhibit 33 to Chivvis Decl, # (35) Exhibit 34 to Chivvis Decl, # (36) Exhibit 35 to Chivvis Decl, # (37) Exhibit 36 to Chivvis Decl)(Chivvis, Matthew)
Sep 15, 2022 252 response in opposition to motion (Exhibit 34 to Chivvis Decl) (7)
Docket Text: RESPONSE by Evolve BioSystems, Inc., Regents of the University of Californiain Opposition to MOTION by Defendant Abbott Laboratories for protective order [248] (Public/Redacted Versions) (Attachments: # (1) Declaration of M. Chivvis, # (2) Exhibit 1 to Chivvis Decl, # (3) Exhibit 2 to Chivvis Decl, # (4) Exhibit 3 to Chivvis Decl, # (5) Exhibit 4 to Chivvis Decl, # (6) Exhibit 5 to Chivvis Decl, # (7) Exhibit 6 to Chivvis Decl, # (8) Exhibit 7 to Chivvis Decl, # (9) Exhibit 8 to Chivvis Decl, # (10) Exhibit 9 to Chivvis Decl, # (11) Exhibit 10 to Chivvis Decl, # (12) Exhibit 11 to Chivvis Decl, # (13) Exhibit 12 to Chivvis Decl, # (14) Exhibit 13 to Chivvis Decl, # (15) Exhibit 14 to Chivvis Decl, # (16) Exhibit 15 to Chivvis Decl, # (17) Exhibit 16 to Chivvis Decl, # (18) Exhibit 17 to Chivvis Decl, # (19) Exhibit 18 to Chivvis Decl, # (20) Exhibit 19 to Chivvis Decl, # (21) Exhibit 20 to Chivvis Decl, # (22) Exhibit 21 to Chivvis Decl, # (23) Exhibit 22 to Chivvis Decl, # (24) Exhibit 23 to Chivvis Decl, # (25) Exhibit 24 to Chivvis Decl, # (26) Exhibit 25 to Chivvis Decl, # (27) Exhibit 26 to Chivvis Decl, # (28) Exhibit 27 to Chivvis Decl, # (29) Exhibit 28 to Chivvis Decl, # (30) Exhibit 29 to Chivvis Decl, # (31) Exhibit 30 to Chivvis Decl, # (32) Exhibit 31 to Chivvis Decl, # (33) Exhibit 32 to Chivvis Decl, # (34) Exhibit 33 to Chivvis Decl, # (35) Exhibit 34 to Chivvis Decl, # (36) Exhibit 35 to Chivvis Decl, # (37) Exhibit 36 to Chivvis Decl)(Chivvis, Matthew)
Sep 15, 2022 252 response in opposition to motion (Exhibit 35 to Chivvis Decl) (1)
Docket Text: RESPONSE by Evolve BioSystems, Inc., Regents of the University of Californiain Opposition to MOTION by Defendant Abbott Laboratories for protective order [248] (Public/Redacted Versions) (Attachments: # (1) Declaration of M. Chivvis, # (2) Exhibit 1 to Chivvis Decl, # (3) Exhibit 2 to Chivvis Decl, # (4) Exhibit 3 to Chivvis Decl, # (5) Exhibit 4 to Chivvis Decl, # (6) Exhibit 5 to Chivvis Decl, # (7) Exhibit 6 to Chivvis Decl, # (8) Exhibit 7 to Chivvis Decl, # (9) Exhibit 8 to Chivvis Decl, # (10) Exhibit 9 to Chivvis Decl, # (11) Exhibit 10 to Chivvis Decl, # (12) Exhibit 11 to Chivvis Decl, # (13) Exhibit 12 to Chivvis Decl, # (14) Exhibit 13 to Chivvis Decl, # (15) Exhibit 14 to Chivvis Decl, # (16) Exhibit 15 to Chivvis Decl, # (17) Exhibit 16 to Chivvis Decl, # (18) Exhibit 17 to Chivvis Decl, # (19) Exhibit 18 to Chivvis Decl, # (20) Exhibit 19 to Chivvis Decl, # (21) Exhibit 20 to Chivvis Decl, # (22) Exhibit 21 to Chivvis Decl, # (23) Exhibit 22 to Chivvis Decl, # (24) Exhibit 23 to Chivvis Decl, # (25) Exhibit 24 to Chivvis Decl, # (26) Exhibit 25 to Chivvis Decl, # (27) Exhibit 26 to Chivvis Decl, # (28) Exhibit 27 to Chivvis Decl, # (29) Exhibit 28 to Chivvis Decl, # (30) Exhibit 29 to Chivvis Decl, # (31) Exhibit 30 to Chivvis Decl, # (32) Exhibit 31 to Chivvis Decl, # (33) Exhibit 32 to Chivvis Decl, # (34) Exhibit 33 to Chivvis Decl, # (35) Exhibit 34 to Chivvis Decl, # (36) Exhibit 35 to Chivvis Decl, # (37) Exhibit 36 to Chivvis Decl)(Chivvis, Matthew)
Sep 15, 2022 252 response in opposition to motion (Exhibit 36 to Chivvis Decl) (1)
Docket Text: RESPONSE by Evolve BioSystems, Inc., Regents of the University of Californiain Opposition to MOTION by Defendant Abbott Laboratories for protective order [248] (Public/Redacted Versions) (Attachments: # (1) Declaration of M. Chivvis, # (2) Exhibit 1 to Chivvis Decl, # (3) Exhibit 2 to Chivvis Decl, # (4) Exhibit 3 to Chivvis Decl, # (5) Exhibit 4 to Chivvis Decl, # (6) Exhibit 5 to Chivvis Decl, # (7) Exhibit 6 to Chivvis Decl, # (8) Exhibit 7 to Chivvis Decl, # (9) Exhibit 8 to Chivvis Decl, # (10) Exhibit 9 to Chivvis Decl, # (11) Exhibit 10 to Chivvis Decl, # (12) Exhibit 11 to Chivvis Decl, # (13) Exhibit 12 to Chivvis Decl, # (14) Exhibit 13 to Chivvis Decl, # (15) Exhibit 14 to Chivvis Decl, # (16) Exhibit 15 to Chivvis Decl, # (17) Exhibit 16 to Chivvis Decl, # (18) Exhibit 17 to Chivvis Decl, # (19) Exhibit 18 to Chivvis Decl, # (20) Exhibit 19 to Chivvis Decl, # (21) Exhibit 20 to Chivvis Decl, # (22) Exhibit 21 to Chivvis Decl, # (23) Exhibit 22 to Chivvis Decl, # (24) Exhibit 23 to Chivvis Decl, # (25) Exhibit 24 to Chivvis Decl, # (26) Exhibit 25 to Chivvis Decl, # (27) Exhibit 26 to Chivvis Decl, # (28) Exhibit 27 to Chivvis Decl, # (29) Exhibit 28 to Chivvis Decl, # (30) Exhibit 29 to Chivvis Decl, # (31) Exhibit 30 to Chivvis Decl, # (32) Exhibit 31 to Chivvis Decl, # (33) Exhibit 32 to Chivvis Decl, # (34) Exhibit 33 to Chivvis Decl, # (35) Exhibit 34 to Chivvis Decl, # (36) Exhibit 35 to Chivvis Decl, # (37) Exhibit 36 to Chivvis Decl)(Chivvis, Matthew)
Sep 15, 2022 254 motion to seal document (3)
Docket Text: MOTION by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California to seal document sealed response,,,,, [253] Unopposed Motion for Leave to File Under Seal Plaintiffs' Opposition to Defendant's Motion for Protective Order and Supporting Exhibits to the Declaration of Matthew A. Chivvis (Chivvis, Matthew)
Sep 8, 2022 251 assigning/reassigning Case (10)
Docket Text: EXECUTIVE COMMITTEE ORDER: The Honorable John Z. Lee having been confirmed for a seat on the Court of Appeals for the Seventh Circuit, It is hereby ordered that the cases on the attached list are to be reassigned to the other judges of this Court as indicated, pursuant to Local Rule 40.1(f). Signed by Executive Committee on 9/8/2022. (kl, )
Sep 2, 2022 250 order on motion for leave to file (1)
Docket Text: MINUTE entry before the Honorable Heather K. McShain: The Court is in receipt of Defendant Abbot Laboratories' unopposed motion for leave to file under seal [246] and its motion for protective order to prevent the deposition of Mr. Christopher Calamari [248]. Given that the motion for leave to file under seal is unopposed, and that Defendant's memorandum in support of its motion for a protective order includes confidential information, the Court finds good cause to grant Defendant's request to file portions of its memorandum under seal. Defendant's motion for leave to file under seal [246] is therefore granted, and the Court notes that sealed and redacted versions of the memorandum have already been filed on 09/01/2022 [247], [249]. Plaintiffs shall have until 09/15/2022 to file their response to Defendant's motion for a protective order. No reply to be filed unless further ordered by the Court. After the Court reviews the parties' briefing, it will determine whether it can rule on the papers, or whether a motion hearing is necessary. Mailed notice. (pk, )
Sep 1, 2022 246 motion for leave to file (4)
Docket Text: MOTION by Defendant Abbott Laboratories for leave to file Under Seal Portions of Defendant Abbott Laboratories' Motion for Protective Order (UNOPPOSED) (Wickramasekera, Nimalka)
Sep 1, 2022 248 motion for protective order (Main Document) (3)
Docket Text: MOTION by Defendant Abbott Laboratories for protective order (Attachments: # (1) Text of Proposed Order)(Wickramasekera, Nimalka)
Sep 1, 2022 248 motion for protective order (Text of Proposed Order) (1)
Docket Text: MOTION by Defendant Abbott Laboratories for protective order (Attachments: # (1) Text of Proposed Order)(Wickramasekera, Nimalka)
Sep 1, 2022 249 memorandum in support of motion (Main Document) (18)
Docket Text: MEMORANDUM by Abbott Laboratories in support of motion for protective order[248] (REDACTED) (Attachments: # (1) Declaration of Donald Carey Walker, # (2) Declaration of Kevin J. Boyle, # (3) Declaration of Robyn Spilker)(Wickramasekera, Nimalka)
Sep 1, 2022 249 memorandum in support of motion (Declaration of Donald Carey Walker) (0)
Docket Text: MEMORANDUM by Abbott Laboratories in support of motion for protective order[248] (REDACTED) (Attachments: # (1) Declaration of Donald Carey Walker, # (2) Declaration of Kevin J. Boyle, # (3) Declaration of Robyn Spilker)(Wickramasekera, Nimalka)
Sep 1, 2022 249 memorandum in support of motion (Declaration of Kevin J. Boyle) (0)
Docket Text: MEMORANDUM by Abbott Laboratories in support of motion for protective order[248] (REDACTED) (Attachments: # (1) Declaration of Donald Carey Walker, # (2) Declaration of Kevin J. Boyle, # (3) Declaration of Robyn Spilker)(Wickramasekera, Nimalka)
Sep 1, 2022 249 memorandum in support of motion (Declaration of Robyn Spilker) (0)
Docket Text: MEMORANDUM by Abbott Laboratories in support of motion for protective order[248] (REDACTED) (Attachments: # (1) Declaration of Donald Carey Walker, # (2) Declaration of Kevin J. Boyle, # (3) Declaration of Robyn Spilker)(Wickramasekera, Nimalka)
Aug 30, 2022 245 set deadlines (1)
Docket Text: MINUTE entry before the Honorable Heather K. McShain: This case has been referred to Magistrate Judge McShain for general discovery supervision [244]. On review of Judge Lee's 08/23/2022 minute order [243], a joint status report is due 09/16/2022 to update the Court on: (a) the progress of supplemental discovery; (b) the state of settlement discussions, if any; and (c) any other matters the parties wish to raise with the Court. The parties may contact chambers at any time (by email to Chambers_McShain@ilnd.uscourts.gov) if they would like the Court's assistance with settlement. Mailed notice. (pk, )
Aug 23, 2022 243 status hearing (1)
Docket Text: MINUTE entry before the Honorable John Z. Lee:Status hearing held on 8/23/22. For the reasons stated, the Court sets the following deadlines. The deadline for supplemental fact discovery as to the patent claims is 11/11/22. As part of supplemental discovery, each party may serve two additional interrogatories and ten requests for the production of documents. As to Defendant's unfair competition, false advertisement, and related counterclaims, the parties must exchange Rule 26(a)(1) disclosures by 8/31/22. The deadline for fact discovery as to those claims also is 11/11/22. This case is referred to Magistrate Judge McShain for general discovery supervision. The parties' joint status report regarding the status of discovery is due by 10/14/22. To the extent that Abbott would like leave to file amended contentions under the Local Patent Rules, it should file a motion for leave by 11/18/22. The motion should include the proposed amended contentions. Status hearing set for 11/22/22 at 1:30 p.m. by video. The parties will receive an invitation by email. At the status hearing, the Court will consider Abbott's motion for leave and set an expert discovery schedule. (ca, )
Aug 23, 2022 244 Expedited referral to magistrate judge (1)
Docket Text: Pursuant to Local Rule 72.1, this case is hereby referred to the calendar of Honorable Heather K. McShain for the purpose of holding proceedings related to: general discovery supervision.(ca, )
Aug 22, 2022 242 text entry (1)
Docket Text: MINUTE entry before the Honorable John Z. Lee: Pursuant to Plaintiffs' notice of voluntary dismissal, Count VI of Plaintiffs' counterclaims is dismissed without prejudice. (ca, )
Aug 18, 2022 241 notice of voluntary dismissal (2)
Docket Text: NOTICE of Voluntary Dismissal by Evolve BioSystems, Inc., Regents of the University of California Plaintiffs' Notice of Voluntary Dismissal Without Prejudice of Count VI of Plaintiffs' Counterclaims (Fed. R. Civ. P. 41) (Chivvis, Matthew)
Aug 12, 2022 240 statement (14)
Docket Text: JOINT STATEMENT by Evolve BioSystems, Inc., Regents of the University of California Joint Statement on Case Management Schedule (Chivvis, Matthew)
Jul 28, 2022 239 status hearing (1)
Docket Text: MINUTE entry before the Honorable John Z. Lee: Status hearing held on 7/28/22. The parties should meet and confer and file a proposed case management schedule by 8/12/22. A status hearing via video conference is set for 8/23/22 at 2:00 p.m. The parties will receive a Webex invitation by email. (ca, )
Jul 6, 2022 238 order (25)
Docket Text: ORDER : Plaintiffs Evolve Biosystems, Inc. and the Regents of the University of California (collectively, "Evolve") have sued Defendant Abbott Laboratories, ("Abbott") alleging infringement of United States Patents Nos. 8,197,872 ("the '872 patent") and 9,200,091 ("the '091 patent"). The parties seek construction of four terms that appear in the claims of these patents. For the reasons provided below, the Court construes the terms as stated in Appendix I. Signed by the Honorable John Z. Lee on 7/6/22. [For further details see order].(ca, )
Jun 29, 2022 237 terminate hearings (1)
Docket Text: MINUTE entry before the Honorable John Z. Lee:The status hearing set for 6/30/22 is reset for 7/28/22 9:30 a.m. The Court will issue its Markman order shortly. The call-in number is 888-273-3658 and the access code is 1637578. All persons granted remote access to proceedings are reminded of the general prohibition against photographing, recording, and rebroadcasting of court proceedings. Violation of these prohibitions may result in court-imposed sanctions, including removal of court issued media credentials, restricted entry to future hearings, denial of entry to future hearings, or any other sanctions deemed necessary by the Court. All participants should review the Court's standing order regarding telephone conferences that is on Judge Lee's website, which can be found at: https://www.ilnd.uscourts.gov/judge-info.aspx?4Qf5zc8loCI5U7rfMP9DHw==. (ca, )
Jun 10, 2022 236 order on motion to seal document (1)
Docket Text: MINUTE entry before the Honorable John Z. Lee:Defendant Abbott Laboratories' unopposed motion to seal document [233] is granted. (ca, )
Jun 9, 2022 233 motion to seal document (4)
Docket Text: MOTION by Defendant Abbott Laboratories to seal document sealed document[232] (Wickramasekera, Nimalka)
Jun 9, 2022 234 notice of motion (3)
Docket Text: NOTICE of Motion by Nimalka Ratnavali Wickramasekera for presentment of motion to seal document[233] before Honorable John Z. Lee on 6/14/2022 at 09:00 AM. (Wickramasekera, Nimalka)
Jun 9, 2022 235 answer to counterclaim (23)
Docket Text: ANSWER to counterclaim (Redacted) by Abbott Laboratories(Wickramasekera, Nimalka)
May 24, 2022 231 set/reset hearings (1)
Docket Text: MINUTE entry before the Honorable John Z. Lee:The status hearing set for 5/26/22 is reset for 6/30/22 at 9:30 a.m.The call-in number is 888-273-3658 and the access code is 1637578. All persons granted remote access to proceedings are reminded of the general prohibition against photographing, recording, and rebroadcasting of court proceedings. Violation of these prohibitions may result in court-imposed sanctions, including removal of court issued media credentials, restricted entry to future hearings, denial of entry to future hearings, or any other sanctions deemed necessary by the Court. All participants should review the Court's standing order regarding telephone conferences that is on Judge Lee's website, which can be found at: https://www.ilnd.uscourts.gov/judge-info.aspx?4Qf5zc8loCI5U7rfMP9DHw==. (ca, )
May 2, 2022 230 text entry (1)
Docket Text: MINUTE entry before the Honorable John Z. Lee:Pursuant to the parties stipulation [229], Defendant Abbott Laboratories answer to the counterclaims of Plaintiffs Evolve BioSystems, Inc. and the Regents of the University of California shall be filed on or before June 9, 2022.(ca, )
Apr 29, 2022 229 stipulation (2)
Docket Text: STIPULATION and (Proposed) Order to Extend Time (JOINT) (Wickramasekera, Nimalka)
Apr 20, 2022 228 terminate hearings (1)
Docket Text: MINUTE entry before the Honorable John Z. Lee:The status hearing set for 4/21/22 is reset for 5/26/22 at 9:00 a.m.The call-in number is 888-273-3658 and the access code is 1637578. All persons granted remote access to proceedings are reminded of the general prohibition against photographing, recording, and rebroadcasting of court proceedings. Violation of these prohibitions may result in court-imposed sanctions, including removal of court issued media credentials, restricted entry to future hearings, denial of entry to future hearings, or any other sanctions deemed necessary by the Court. All participants should review the Court's standing order regarding telephone conferences that is on Judge Lee's website, which can be found at: https://www.ilnd.uscourts.gov/judge-info.aspx?4Qf5zc8loCI5U7rfMP9DHw==. (ca, )
Apr 8, 2022 227 text entry (1)
Docket Text: MINUTE entry before the Honorable John Z. Lee:The request in the stipulation is granted. Abbot Laboratories answer is due by 5/5/22. (ca, )
Mar 31, 2022 226 stipulation (2)
Docket Text: STIPULATION and [Proposed] Order to Extend Time (JOINT) (Wickramasekera, Nimalka)
Mar 22, 2022 223 order on motion to dismiss (1)
Docket Text: MINUTE entry before the Honorable John Z. Lee: For the reasons provided in the memorandum opinion and order, the Court denies Defendant Abbott's motion to dismiss Evolve's Lanham Act false advertising counterclaim [207]. Because Evolve's Illinois and California state law unfair competition counterclaims rise and fall with Evolve's Lanham Act counterclaim, the Court also denies Abbott's motion to dismiss Evolve's Illinois and California unfair competition counterclaims. (ca, )
Mar 22, 2022 224 memorandum opinion and order (17)
Docket Text: MEMORANDUM Opinion and Order Signed by the Honorable John Z. Lee on 3/22/22.(ca, )
Mar 22, 2022 225 set/reset hearings (1)
Docket Text: MINUTE entry before the Honorable John Z. Lee:Status hearing set for 4/21/22 at 9:00 a.m. The call-in number is 888-273-3658 and the access code is 1637578. Counsel of record will receive a separate email at least 12 hours prior to the start of the telephonic hearing with instructions on how to join the call. All persons granted remote access to proceedings are reminded of the general prohibition against photographing, recording, and rebroadcasting of court proceedings. Violation of these prohibitions may result in court-imposed sanctions, including removal of court issued media credentials, restricted entry to future hearings, denial of entry to future hearings, or any other sanctions deemed necessary by the Court. All participants should review the Court's standing order regarding telephone conferences that is on Judge Lee's website, which can be found at: https://www.ilnd.uscourts.gov/judge-info.aspx?4Qf5zc8loCI5U7rfMP9DHw==. (ca, )
Jun 30, 2021 221 notice of change of address (1)
Docket Text: NOTICE by Todd H. Flaming of Change of Address (Flaming, Todd)
Jun 30, 2021 222 reply (21)
Docket Text: REPLY by Defendant Abbott Laboratories to motion to dismiss, [207] (Wickramasekera, Nimalka)
Jun 7, 2021 220 order on motion to seal document (1)
Docket Text: MINUTE entry before the Honorable John Z. Lee:Motion to file under seal [218] is granted. No appearance is required on the motion. (ca, )
Jun 4, 2021 216 memorandum in opposition to motion (Main Document) (20)
Docket Text: MEMORANDUM by Evolve BioSystems, Inc., Regents of the University of California in Opposition to motion to dismiss, [207] (Public/Redacted versions) (Attachments: # (1) Declaration of Matthew A. Chivvis, # (2) Exhibit A to the Chivvis Decl, # (3) Exhibit B to the Chivvis Decl, # (4) Exhibit C to the Chivvis Decl, # (5) Exhibit D to the Chivvis Decl, # (6) Exhibit E to the Chivvis Decl)(Chivvis, Matthew)
Jun 4, 2021 216 memorandum in opposition to motion (Declaration of Matthew A. Chivvis) (3)
Docket Text: MEMORANDUM by Evolve BioSystems, Inc., Regents of the University of California in Opposition to motion to dismiss, [207] (Public/Redacted versions) (Attachments: # (1) Declaration of Matthew A. Chivvis, # (2) Exhibit A to the Chivvis Decl, # (3) Exhibit B to the Chivvis Decl, # (4) Exhibit C to the Chivvis Decl, # (5) Exhibit D to the Chivvis Decl, # (6) Exhibit E to the Chivvis Decl)(Chivvis, Matthew)
Jun 4, 2021 216 memorandum in opposition to motion (Exhibit A to the Chivvis Decl) (1)
Docket Text: MEMORANDUM by Evolve BioSystems, Inc., Regents of the University of California in Opposition to motion to dismiss, [207] (Public/Redacted versions) (Attachments: # (1) Declaration of Matthew A. Chivvis, # (2) Exhibit A to the Chivvis Decl, # (3) Exhibit B to the Chivvis Decl, # (4) Exhibit C to the Chivvis Decl, # (5) Exhibit D to the Chivvis Decl, # (6) Exhibit E to the Chivvis Decl)(Chivvis, Matthew)
Jun 4, 2021 216 memorandum in opposition to motion (Exhibit B to the Chivvis Decl) (1)
Docket Text: MEMORANDUM by Evolve BioSystems, Inc., Regents of the University of California in Opposition to motion to dismiss, [207] (Public/Redacted versions) (Attachments: # (1) Declaration of Matthew A. Chivvis, # (2) Exhibit A to the Chivvis Decl, # (3) Exhibit B to the Chivvis Decl, # (4) Exhibit C to the Chivvis Decl, # (5) Exhibit D to the Chivvis Decl, # (6) Exhibit E to the Chivvis Decl)(Chivvis, Matthew)
Jun 4, 2021 216 memorandum in opposition to motion (Exhibit C to the Chivvis Decl) (1)
Docket Text: MEMORANDUM by Evolve BioSystems, Inc., Regents of the University of California in Opposition to motion to dismiss, [207] (Public/Redacted versions) (Attachments: # (1) Declaration of Matthew A. Chivvis, # (2) Exhibit A to the Chivvis Decl, # (3) Exhibit B to the Chivvis Decl, # (4) Exhibit C to the Chivvis Decl, # (5) Exhibit D to the Chivvis Decl, # (6) Exhibit E to the Chivvis Decl)(Chivvis, Matthew)
Jun 4, 2021 216 memorandum in opposition to motion (Exhibit D to the Chivvis Decl) (1)
Docket Text: MEMORANDUM by Evolve BioSystems, Inc., Regents of the University of California in Opposition to motion to dismiss, [207] (Public/Redacted versions) (Attachments: # (1) Declaration of Matthew A. Chivvis, # (2) Exhibit A to the Chivvis Decl, # (3) Exhibit B to the Chivvis Decl, # (4) Exhibit C to the Chivvis Decl, # (5) Exhibit D to the Chivvis Decl, # (6) Exhibit E to the Chivvis Decl)(Chivvis, Matthew)
Jun 4, 2021 216 memorandum in opposition to motion (Exhibit E to the Chivvis Decl) (1)
Docket Text: MEMORANDUM by Evolve BioSystems, Inc., Regents of the University of California in Opposition to motion to dismiss, [207] (Public/Redacted versions) (Attachments: # (1) Declaration of Matthew A. Chivvis, # (2) Exhibit A to the Chivvis Decl, # (3) Exhibit B to the Chivvis Decl, # (4) Exhibit C to the Chivvis Decl, # (5) Exhibit D to the Chivvis Decl, # (6) Exhibit E to the Chivvis Decl)(Chivvis, Matthew)
Jun 4, 2021 218 motion to seal document (3)
Docket Text: MOTION by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California to seal document sealed response, [217] (Unopposed Motion for Leave to File Under Seal Plaintiffs' Opposition to Abbott Laboratories' Motion to Dismiss Counts I-III of Plaintiffs' Counterclaims and Supporting Exhibits to the Declaration of Matthew A. Chivvis) (Chivvis, Matthew)
Jun 4, 2021 219 notice of motion (2)
Docket Text: (UNOPPOSED) NOTICE of Motion by Matthew Alan Chivvis for presentment of motion to seal document, [218] before Honorable John Z. Lee on 6/9/2021 at 09:00 AM. (Chivvis, Matthew)
May 5, 2021 212 order on motion to seal document (1)
Docket Text: MINUTE entry before the Honorable John Z. Lee: Evolve's response to Abbott's motion to dismiss Counts I-III of Evolve's counterclaims [207] is due May 18, 2021; Abbott's reply is due May 25, 2021. Abbott's motion to seal is granted [210]. No appearance on either motion is necessary. (ca, )
May 5, 2021 213 motion by filer to set a briefing schedule (3)
Docket Text: MOTION by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California to set a briefing schedule (UNOPPOSED MOTION TO MODIFY BRIEFING SCHEDULE FOR ABBOTT'S MOTION TO DISMISS COUNTS I-III OF PLAINTIFFS' COUNTERCLAIMS) (Chivvis, Matthew)
May 5, 2021 214 notice of motion (2)
Docket Text: (UNOPPOSED MOTION) NOTICE of Motion by Matthew Alan Chivvis for presentment of motion by filer to set a briefing schedule, [213] before Honorable John Z. Lee on 5/13/2021 at 09:00 AM. (Chivvis, Matthew)
May 5, 2021 215 order on motion to set a briefing schedule (1)
Docket Text: MINUTE entry before the Honorable John Z. Lee: Evolve's unopposed motion to alter the briefing schedule on Abbott's motion to dismiss Counts I-III of Evolve's Counterclaims [213] is granted. Evolve's response is due 6/4/21; Abbott's reply is due 6/30/21. No appearance on the motion is necessary. (ca, )
May 4, 2021 206 transcript (113)
Docket Text: TRANSCRIPT OF PROCEEDINGS held on 4/26/21 before the Honorable John Z. Lee. Order Number: 40601. Court Reporter Contact Information: Joseph Rickhoff, 312-435-5562, joseph_rickhoff@ilnd.uscourts.gov.

IMPORTANT: The transcript may be viewed at the court's public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through the Court Reporter/Transcriber or PACER. For further information on the redaction process, see the Court's web site at www.ilnd.uscourts.gov under Quick Links select Policy Regarding the Availability of Transcripts of Court Proceedings.

Redaction Request due 5/25/2021. Redacted Transcript Deadline set for 6/4/2021. Release of Transcript Restriction set for 8/2/2021. (Rickhoff, Joseph)
May 4, 2021 207 motion to dismiss (Main Document) (3)
Docket Text: MOTION by Defendant Abbott Laboratories to dismiss Counts I-III of Plaintiff's Counterclaims (Attachments: # (1) Memorandum in Support of Motion to Dismiss (Redacted), # (2) Declaration of Kevin J. Boyle in Support of Motion to Dismiss, # (3) Exhibit 1 to Boyle Decl, # (4) Exhibit 2 to Boyle Decl, # (5) Exhibit 3 to Boyle Decl)(Wickramasekera, Nimalka)
May 4, 2021 207 motion to dismiss (Memorandum in Support of Motion to Dismiss (Redacted)) (21)
Docket Text: MOTION by Defendant Abbott Laboratories to dismiss Counts I-III of Plaintiff's Counterclaims (Attachments: # (1) Memorandum in Support of Motion to Dismiss (Redacted), # (2) Declaration of Kevin J. Boyle in Support of Motion to Dismiss, # (3) Exhibit 1 to Boyle Decl, # (4) Exhibit 2 to Boyle Decl, # (5) Exhibit 3 to Boyle Decl)(Wickramasekera, Nimalka)
May 4, 2021 207 motion to dismiss (Declaration of Kevin J. Boyle in Support of Motion to Dismiss) (2)
Docket Text: MOTION by Defendant Abbott Laboratories to dismiss Counts I-III of Plaintiff's Counterclaims (Attachments: # (1) Memorandum in Support of Motion to Dismiss (Redacted), # (2) Declaration of Kevin J. Boyle in Support of Motion to Dismiss, # (3) Exhibit 1 to Boyle Decl, # (4) Exhibit 2 to Boyle Decl, # (5) Exhibit 3 to Boyle Decl)(Wickramasekera, Nimalka)
May 4, 2021 207 motion to dismiss (Exhibit 1 to Boyle Decl) (4)
Docket Text: MOTION by Defendant Abbott Laboratories to dismiss Counts I-III of Plaintiff's Counterclaims (Attachments: # (1) Memorandum in Support of Motion to Dismiss (Redacted), # (2) Declaration of Kevin J. Boyle in Support of Motion to Dismiss, # (3) Exhibit 1 to Boyle Decl, # (4) Exhibit 2 to Boyle Decl, # (5) Exhibit 3 to Boyle Decl)(Wickramasekera, Nimalka)
May 4, 2021 207 motion to dismiss (Exhibit 2 to Boyle Decl) (2)
Docket Text: MOTION by Defendant Abbott Laboratories to dismiss Counts I-III of Plaintiff's Counterclaims (Attachments: # (1) Memorandum in Support of Motion to Dismiss (Redacted), # (2) Declaration of Kevin J. Boyle in Support of Motion to Dismiss, # (3) Exhibit 1 to Boyle Decl, # (4) Exhibit 2 to Boyle Decl, # (5) Exhibit 3 to Boyle Decl)(Wickramasekera, Nimalka)
May 4, 2021 207 motion to dismiss (Exhibit 3 to Boyle Decl) (9)
Docket Text: MOTION by Defendant Abbott Laboratories to dismiss Counts I-III of Plaintiff's Counterclaims (Attachments: # (1) Memorandum in Support of Motion to Dismiss (Redacted), # (2) Declaration of Kevin J. Boyle in Support of Motion to Dismiss, # (3) Exhibit 1 to Boyle Decl, # (4) Exhibit 2 to Boyle Decl, # (5) Exhibit 3 to Boyle Decl)(Wickramasekera, Nimalka)
May 4, 2021 208 notice of motion (3)
Docket Text: NOTICE of Motion by Nimalka Ratnavali Wickramasekera for presentment of motion to dismiss, [207] before Honorable John Z. Lee on 5/11/2021 at 09:00 AM. (Wickramasekera, Nimalka)
May 4, 2021 210 motion to seal document (4)
Docket Text: MOTION by Defendant Abbott Laboratories to seal document sealed document[209] (Unopposed) (Wickramasekera, Nimalka)
May 4, 2021 211 notice of motion (3)
Docket Text: NOTICE of Motion by Nimalka Ratnavali Wickramasekera for presentment of motion to seal document[210] before Honorable John Z. Lee on 5/11/2021 at 09:00 AM. (Wickramasekera, Nimalka)
May 3, 2021 205 notice of filing (Main Document) (2)
Docket Text: NOTICE by All Plaintiffs (NOTICE OF FILING OF CLAIM CONSTRUCTION HEARING SLIDES) (Attachments: # (1) Declaration of Matthew A. Chivvis, # (2) Exhibit 1)(Chivvis, Matthew)
May 3, 2021 205 notice of filing (Declaration of Matthew A. Chivvis) (1)
Docket Text: NOTICE by All Plaintiffs (NOTICE OF FILING OF CLAIM CONSTRUCTION HEARING SLIDES) (Attachments: # (1) Declaration of Matthew A. Chivvis, # (2) Exhibit 1)(Chivvis, Matthew)
May 3, 2021 205 notice of filing (Exhibit 1) (18)
Docket Text: NOTICE by All Plaintiffs (NOTICE OF FILING OF CLAIM CONSTRUCTION HEARING SLIDES) (Attachments: # (1) Declaration of Matthew A. Chivvis, # (2) Exhibit 1)(Chivvis, Matthew)
Apr 28, 2021 204 notice of filing (Main Document) (3)
Docket Text: NOTICE by Abbott Laboratories of Markman Hearing Slides (Attachments: # (1) Declaration of Kevin Boyle, # (2) Exhibit 1)(Wickramasekera, Nimalka)
Apr 28, 2021 204 notice of filing (Declaration of Kevin Boyle) (1)
Docket Text: NOTICE by Abbott Laboratories of Markman Hearing Slides (Attachments: # (1) Declaration of Kevin Boyle, # (2) Exhibit 1)(Wickramasekera, Nimalka)
Apr 28, 2021 204 notice of filing (Exhibit 1) (30)
Docket Text: NOTICE by Abbott Laboratories of Markman Hearing Slides (Attachments: # (1) Declaration of Kevin Boyle, # (2) Exhibit 1)(Wickramasekera, Nimalka)
Apr 26, 2021 203 in court hearing (1)
Docket Text: MINUTE entry before the Honorable John Z. Lee: Claim construction hearing held on 4/26/21. Written opinion to follow. (ca, )
Apr 22, 2021 202 other (Main Document) (3)
Docket Text: Notice of Supplemental Authority by Abbott Laboratories (Attachments: # (1) Declaration of Kevin Boyle, # (2) Exhibit 1 to Boyle Decl)(Wickramasekera, Nimalka)
Apr 22, 2021 202 other (Declaration of Kevin Boyle) (1)
Docket Text: Notice of Supplemental Authority by Abbott Laboratories (Attachments: # (1) Declaration of Kevin Boyle, # (2) Exhibit 1 to Boyle Decl)(Wickramasekera, Nimalka)
Apr 22, 2021 202 other (Exhibit 1 to Boyle Decl) (7)
Docket Text: Notice of Supplemental Authority by Abbott Laboratories (Attachments: # (1) Declaration of Kevin Boyle, # (2) Exhibit 1 to Boyle Decl)(Wickramasekera, Nimalka)
Apr 8, 2021 201 order on motion for miscellaneous relief (1)
Docket Text: MINUTE entry before the Honorable John Z. Lee: In the joint status report dated 3/16/21, Evolve represents that it will assert the '653 Patent as part of its counterclaims, only if it receives an adverse ruling on the Markush issue raised in the '091 Patent. Based on this representation, the Court will grant Evolve's request that the Court proceed with construing the contested claims in the '872 and '091 Patents under the current schedule, before moving to the '653 Patent. Accordingly, the Court schedules a claim construction hearing regarding the '872 Patent and the '091 Patent for April 26, 2021, at 1:30 p.m. The hearing will take place via Microsoft Teams. A link will be provided to counsel of record. To the extent that the parties intend to present any materials during the hearing, they should provide copies via email to the courtroom deputy or mail a USB drive to chambers. If counsel is not available at that time, the parties should meet and confer and provide the courtroom deputy with three alternative dates and times. Abbott is ordered to file an answer or other responsive pleading to Evolve's counterclaims by 5/4/21; however, Abbott need not address any allegations that pertain solely to the '653 Patent, and all of its rights will be reserved as to those allegations. As for the '653 Patent, the Court will set a schedule after it issues its claim construction ruling, to the extent necessary. Plaintiffs' motion to set a set a schedule [197] is stricken without prejudice. Mailed notice (ags)
Apr 6, 2021 200 order on motion for miscellaneous relief (1)
Docket Text: MINUTE entry before the Honorable John Z. Lee: The Court takes Plaintiffs' motion to set a schedule [197] and Defendant's response under advisement and will issue a next week. The motion hearing set for 4/8/21 at 9:00 a.m. is stricken. Mailed notice (sxw)
Apr 5, 2021 197 motion for miscellaneous relief (4)
Docket Text: MOTION by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California (MOTION TO SET A SCHEDULE) (Chivvis, Matthew)
Apr 5, 2021 198 notice of motion (2)
Docket Text: NOTICE of Motion by Matthew Alan Chivvis for presentment of motion for miscellaneous relief[197] before Honorable John Z. Lee on 4/8/2021 at 09:00 AM. (Chivvis, Matthew)
Apr 5, 2021 199 response to motion (Main Document) (6)
Docket Text: RESPONSE by Abbott Laboratories to MOTION by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California (MOTION TO SET A SCHEDULE) [197] (Attachments: # (1) Declaration of Kevin Boyle, # (2) Exhibit 1 to Boyle Decl, # (3) Exhibit 2 to Boyle Decl)(Wickramasekera, Nimalka)
Apr 5, 2021 199 response to motion (Declaration of Kevin Boyle) (2)
Docket Text: RESPONSE by Abbott Laboratories to MOTION by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California (MOTION TO SET A SCHEDULE) [197] (Attachments: # (1) Declaration of Kevin Boyle, # (2) Exhibit 1 to Boyle Decl, # (3) Exhibit 2 to Boyle Decl)(Wickramasekera, Nimalka)
Apr 5, 2021 199 response to motion (Exhibit 1 to Boyle Decl) (7)
Docket Text: RESPONSE by Abbott Laboratories to MOTION by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California (MOTION TO SET A SCHEDULE) [197] (Attachments: # (1) Declaration of Kevin Boyle, # (2) Exhibit 1 to Boyle Decl, # (3) Exhibit 2 to Boyle Decl)(Wickramasekera, Nimalka)
Apr 5, 2021 199 response to motion (Exhibit 2 to Boyle Decl) (3)
Docket Text: RESPONSE by Abbott Laboratories to MOTION by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California (MOTION TO SET A SCHEDULE) [197] (Attachments: # (1) Declaration of Kevin Boyle, # (2) Exhibit 1 to Boyle Decl, # (3) Exhibit 2 to Boyle Decl)(Wickramasekera, Nimalka)
Mar 17, 2021 196 order on motion to seal document (1)
Docket Text: MINUTE entry before the Honorable John Z. Lee: The Court grants Plaintiffs' unopposed motion to seal document and to file a public redacted version [193]. Mailed notice (np, )
Mar 16, 2021 192 status report (Main Document) (11)
Docket Text: STATUS Report (JOINT STATUS REPORT) by Evolve BioSystems, Inc., Regents of the University of California (Attachments: # (1) Exhibit A, # (2) Exhibit B (slipsheet))(Chivvis, Matthew)
Mar 16, 2021 192 status report (Exhibit A) (4)
Docket Text: STATUS Report (JOINT STATUS REPORT) by Evolve BioSystems, Inc., Regents of the University of California (Attachments: # (1) Exhibit A, # (2) Exhibit B (slipsheet))(Chivvis, Matthew)
Mar 16, 2021 192 status report (Exhibit B (slipsheet)) (1)
Docket Text: STATUS Report (JOINT STATUS REPORT) by Evolve BioSystems, Inc., Regents of the University of California (Attachments: # (1) Exhibit A, # (2) Exhibit B (slipsheet))(Chivvis, Matthew)
Mar 16, 2021 194 motion to seal document (3)
Docket Text: MOTION by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California to seal document sealed document[193] (UNOPPOSED) (Chivvis, Matthew)
Mar 16, 2021 195 notice of motion (2)
Docket Text: (UNOPPOSED MOTION) NOTICE of Motion by Matthew Alan Chivvis for presentment of motion to seal document[194] before Honorable John Z. Lee on 3/23/2021 at 09:00 AM. (Chivvis, Matthew)
Mar 5, 2021 191 transcript (8)
Docket Text: TRANSCRIPT OF PROCEEDINGS held on 12/7/20 before the Honorable John Z. Lee. Order Number: 40208. Court Reporter Contact Information: Joseph Rickhoff, 312-435-5562, joseph_rickhoff@ilnd.uscourts.gov.

IMPORTANT: The transcript may be viewed at the court's public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through the Court Reporter/Transcriber or PACER. For further information on the redaction process, see the Court's web site at www.ilnd.uscourts.gov under Quick Links select Policy Regarding the Availability of Transcripts of Court Proceedings.

Redaction Request due 3/26/2021. Redacted Transcript Deadline set for 4/5/2021. Release of Transcript Restriction set for 6/3/2021. (Rickhoff, Joseph)
Mar 2, 2021 190 order on motion to continue (1)
Docket Text: MINUTE entry before the Honorable John Z. Lee:Joint motion to continue and consolidate the claim construction hearing [188] is granted. The claim construction hearing set for 3/10/21 is stricken. Abbott's response to Plaintiff's counterclaim is due by 5/4/21. The parties are directed to file a joint status report with a proposed schedule by 3/16/21. (ca, )
Mar 1, 2021 188 motion to continue (4)
Docket Text: MOTION by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California to continue (JOINT MOTION TO CONTINUE AND CONSOLIDATE CLAIM CONSTRUCTION HEARING) (Chivvis, Matthew)
Mar 1, 2021 189 notice of motion (4)
Docket Text: (JOINT MOTION) NOTICE of Motion by Matthew Alan Chivvis for presentment of motion to continue[188] before Honorable John Z. Lee on 3/4/2021 at 09:00 AM. (Chivvis, Matthew)
Feb 17, 2021 187 order on motion to seal document (1)
Docket Text: MINUTE entry before the Honorable John Z. Lee:Unopposed motion to file under seal counterclaims, answer and affirmative defenses [185] is granted. Mailed notice (ca, )
Feb 16, 2021 183 counterclaim (Main Document) (30)
Docket Text: (COUNTERCLAIMS, ANSWER, AND AFFIRMATIVE DEFENSES) COUNTERCLAIM filed by Evolve BioSystems, Inc., Regents of the University of California against Abbott Laboratories . (Attachments: # (1) Exhibit 1)(Chivvis, Matthew)
Feb 16, 2021 183 counterclaim (Exhibit 1) (20)
Docket Text: (COUNTERCLAIMS, ANSWER, AND AFFIRMATIVE DEFENSES) COUNTERCLAIM filed by Evolve BioSystems, Inc., Regents of the University of California against Abbott Laboratories . (Attachments: # (1) Exhibit 1)(Chivvis, Matthew)
Feb 16, 2021 185 motion to seal document (3)
Docket Text: MOTION by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California to seal document sealed document[184] (UNOPPOSED) (Chivvis, Matthew)
Feb 16, 2021 186 notice of motion (2)
Docket Text: (UNOPPOSED MOTION) NOTICE of Motion by Matthew Alan Chivvis for presentment of motion to seal document[185] before Honorable John Z. Lee on 2/23/2021 at 09:00 AM. (Chivvis, Matthew)
Feb 15, 2021 182 other (Main Document) (6)
Docket Text: Supplemental Reply Claim Construction Brief by Abbott Laboratories (Attachments: # (1) Declaration of Kevin J. Boyle, # (2) Exhibit 1, # (3) Exhibit 2)(Wickramasekera, Nimalka)
Feb 15, 2021 182 other (Declaration of Kevin J. Boyle) (2)
Docket Text: Supplemental Reply Claim Construction Brief by Abbott Laboratories (Attachments: # (1) Declaration of Kevin J. Boyle, # (2) Exhibit 1, # (3) Exhibit 2)(Wickramasekera, Nimalka)
Feb 15, 2021 182 other (Exhibit 1) (9)
Docket Text: Supplemental Reply Claim Construction Brief by Abbott Laboratories (Attachments: # (1) Declaration of Kevin J. Boyle, # (2) Exhibit 1, # (3) Exhibit 2)(Wickramasekera, Nimalka)
Feb 15, 2021 182 other (Exhibit 2) (6)
Docket Text: Supplemental Reply Claim Construction Brief by Abbott Laboratories (Attachments: # (1) Declaration of Kevin J. Boyle, # (2) Exhibit 1, # (3) Exhibit 2)(Wickramasekera, Nimalka)
Feb 8, 2021 181 other (Main Document) (8)
Docket Text: SUPPLEMENTAL RESPONSIVE CLAIM CONSTRUCTION BRIEF by Evolve BioSystems, Inc., Regents of the University of California (Attachments: # (1) Declaration of Matthew A. Chivvis in Support)(Chivvis, Matthew)
Feb 8, 2021 181 other (Declaration of Matthew A. Chivvis in Support) (14)
Docket Text: SUPPLEMENTAL RESPONSIVE CLAIM CONSTRUCTION BRIEF by Evolve BioSystems, Inc., Regents of the University of California (Attachments: # (1) Declaration of Matthew A. Chivvis in Support)(Chivvis, Matthew)
Jan 25, 2021 179 order on motion to withdraw as attorney (1)
Docket Text: MINUTE entry before the Honorable John Z. Lee: The Court grants the motion by attorney Dan H. Hoang to withdraw as attorney for Abbott Laboratories [178]. Mailed notice (ca, )
Jan 25, 2021 180 other (Main Document) (8)
Docket Text: Supplemental Opening Claim Construction Brief by Abbott Laboratories (Attachments: # (1) Declaration of Kevin J. Boyle, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3)(Wickramasekera, Nimalka)
Jan 25, 2021 180 other (Declaration of Kevin J. Boyle) (2)
Docket Text: Supplemental Opening Claim Construction Brief by Abbott Laboratories (Attachments: # (1) Declaration of Kevin J. Boyle, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3)(Wickramasekera, Nimalka)
Jan 25, 2021 180 other (Exhibit 1) (20)
Docket Text: Supplemental Opening Claim Construction Brief by Abbott Laboratories (Attachments: # (1) Declaration of Kevin J. Boyle, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3)(Wickramasekera, Nimalka)
Jan 25, 2021 180 other (Exhibit 2) (20)
Docket Text: Supplemental Opening Claim Construction Brief by Abbott Laboratories (Attachments: # (1) Declaration of Kevin J. Boyle, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3)(Wickramasekera, Nimalka)
Jan 25, 2021 180 other (Exhibit 3) (23)
Docket Text: Supplemental Opening Claim Construction Brief by Abbott Laboratories (Attachments: # (1) Declaration of Kevin J. Boyle, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3)(Wickramasekera, Nimalka)
Jan 22, 2021 178 motion to withdraw as attorney (4)
Docket Text: MOTION by Attorney Dan H. Hoang to withdraw as attorney for Abbott Laboratories. No party information provided (Wickramasekera, Nimalka)
Jan 21, 2021 177 other (5)
Docket Text: (SUPPLEMENTAL JOINT CLAIM CONSTRUCTION CHART AND STATUS REPORT) by Evolve BioSystems, Inc., Regents of the University of California (Chivvis, Matthew)
Jan 19, 2021 176 order on motion to appear pro hac vice (1)
Docket Text: MINUTE entry before the Honorable John Z. Lee:Motion to appear pro hac vice by Robert Kang [175] is granted.Mailed notice (ca, )
Jan 15, 2021 175 motion to appear pro hac vice (2)
Docket Text: MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-17831946. (Kang, Robert)
Jan 14, 2021 173 order on motion to supplement (1)
Docket Text: MINUTE entry before the Honorable John Z. Lee:The Court grants the parties' joint motion [170] to supplement the claim construction relating to a new claim construction dispute that has arisen since the parties completed claim construction briefing, and to strike and reschedule the claim construction hearing to allow for further briefing. Because resolution of this claim construction dispute may affect Abbott's pending Motion to Strike Final Infringement Contentions [117] and Evolve's Cross-Motion to Preclude Abbott from Exceeding Scope of Final Invalidity Contentions [164], the parties voluntarily withdraw both motions without prejudice. Accordingly, the motions are stricken [117] [164]. The parties shall submit a supplemental joint claim construction chart on January 21, 2021. Abbott's supplemental opening claim construction brief, up to six pages in length, is due on January 25, 2021. Evolve's supplemental opposition claim construction brief, up to six pages in length, is due on February 8, 2021. Abbott's supplemental reply claim construction brief, up to three pages in length, and Evolve's response to Abbott's counterclaims are due on February 15, 2021. The claim construction set for January 21, 2021, at 1:00 p.m. is stricken and reset to 3/10/21 at 10:30 a.m. via Microsoft Teams. Mailed notice (ca, )
Jan 14, 2021 174 attorney appearance (1)
Docket Text: ATTORNEY Appearance for Defendant Abbott Laboratories, Counter Claimant Abbott Laboratories by Kevin John Boyle (Boyle, Kevin)
Jan 13, 2021 170 motion to supplement (4)
Docket Text: MOTION by Counter Claimant Abbott Laboratories to supplement Claim Construction (Wickramasekera, Nimalka)
Jan 13, 2021 171 notice of motion (4)
Docket Text: Notice of Joint Motion NOTICE of Motion by Nimalka Ratnavali Wickramasekera for presentment of motion to supplement[170] before Honorable John Z. Lee on 1/19/2021 at 09:15 AM. (Wickramasekera, Nimalka)
Jan 13, 2021 172 memorandum in support of motion (6)
Docket Text: MEMORANDUM by Abbott Laboratories in support of motion to supplement[170] Parties Joint Motion to Submit Supplemental Claim Construction Briefing and Reschedule the Claim Construction Hearing (Wickramasekera, Nimalka)
Dec 22, 2020 169 order on motion to seal document (1)
Docket Text: MINUTE entry before the Honorable John Z. Lee:Plaintiff's unopposed motion to file exhibits to the declaration of Matthew Chivvis under seal [167] is granted. Mailed notice (ca, )
Dec 21, 2020 163 response in opposition to motion (18)
Docket Text: RESPONSE by Evolve BioSystems, Inc., Regents of the University of Californiain Opposition to MOTION by Defendant Abbott Laboratories to strike Final Infringement Contentions[117] (PLAINTIFF'S OPPOSITION TO ABBOTT'S MOTION TO STRIKE FINAL INFRINGEMENT CONTENTIONS) (Chivvis, Matthew)
Dec 21, 2020 164 motion for miscellaneous relief (16)
Docket Text: MOTION by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California (PLAINTIFFS' CROSS-MOTION TO PRECLUDE ABBOTT FROM EXCEEDING SCOPE OF FINAL INVALIDITY CONTENTIONS) (Chivvis, Matthew)
Dec 21, 2020 165 declaration (Main Document) (5)
Docket Text: DECLARATION of MATTHEW A. CHIVVIS IN SUPPORT OF (A) PLAINTIFFS' OPPOSITION TO ABBOTT'S MOTION TO STRIKE FINAL INFRINGEMENT CONTENTIONS AND (B) PLAINTIFFS' CROSS-MOTION TO PRECLUDE ABBOTT FROM EXCEEDING SCOPE OF FINAL INVALIDITY CONTENTIONS - PUBLIC (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3 (PLACEHOLDER), # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9 (PLACEHOLDER), # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25)(Chivvis, Matthew)
Dec 21, 2020 165 declaration (Exhibit 1) (30)
Docket Text: DECLARATION of MATTHEW A. CHIVVIS IN SUPPORT OF (A) PLAINTIFFS' OPPOSITION TO ABBOTT'S MOTION TO STRIKE FINAL INFRINGEMENT CONTENTIONS AND (B) PLAINTIFFS' CROSS-MOTION TO PRECLUDE ABBOTT FROM EXCEEDING SCOPE OF FINAL INVALIDITY CONTENTIONS - PUBLIC (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3 (PLACEHOLDER), # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9 (PLACEHOLDER), # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25)(Chivvis, Matthew)
Dec 21, 2020 165 declaration (Exhibit 2) (3)
Docket Text: DECLARATION of MATTHEW A. CHIVVIS IN SUPPORT OF (A) PLAINTIFFS' OPPOSITION TO ABBOTT'S MOTION TO STRIKE FINAL INFRINGEMENT CONTENTIONS AND (B) PLAINTIFFS' CROSS-MOTION TO PRECLUDE ABBOTT FROM EXCEEDING SCOPE OF FINAL INVALIDITY CONTENTIONS - PUBLIC (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3 (PLACEHOLDER), # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9 (PLACEHOLDER), # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25)(Chivvis, Matthew)
Dec 21, 2020 165 declaration (Exhibit 3 (PLACEHOLDER)) (1)
Docket Text: DECLARATION of MATTHEW A. CHIVVIS IN SUPPORT OF (A) PLAINTIFFS' OPPOSITION TO ABBOTT'S MOTION TO STRIKE FINAL INFRINGEMENT CONTENTIONS AND (B) PLAINTIFFS' CROSS-MOTION TO PRECLUDE ABBOTT FROM EXCEEDING SCOPE OF FINAL INVALIDITY CONTENTIONS - PUBLIC (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3 (PLACEHOLDER), # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9 (PLACEHOLDER), # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25)(Chivvis, Matthew)
Dec 21, 2020 165 declaration (Exhibit 4) (10)
Docket Text: DECLARATION of MATTHEW A. CHIVVIS IN SUPPORT OF (A) PLAINTIFFS' OPPOSITION TO ABBOTT'S MOTION TO STRIKE FINAL INFRINGEMENT CONTENTIONS AND (B) PLAINTIFFS' CROSS-MOTION TO PRECLUDE ABBOTT FROM EXCEEDING SCOPE OF FINAL INVALIDITY CONTENTIONS - PUBLIC (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3 (PLACEHOLDER), # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9 (PLACEHOLDER), # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25)(Chivvis, Matthew)
Dec 21, 2020 165 declaration (Exhibit 5) (2)
Docket Text: DECLARATION of MATTHEW A. CHIVVIS IN SUPPORT OF (A) PLAINTIFFS' OPPOSITION TO ABBOTT'S MOTION TO STRIKE FINAL INFRINGEMENT CONTENTIONS AND (B) PLAINTIFFS' CROSS-MOTION TO PRECLUDE ABBOTT FROM EXCEEDING SCOPE OF FINAL INVALIDITY CONTENTIONS - PUBLIC (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3 (PLACEHOLDER), # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9 (PLACEHOLDER), # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25)(Chivvis, Matthew)
Dec 21, 2020 165 declaration (Exhibit 6) (30)
Docket Text: DECLARATION of MATTHEW A. CHIVVIS IN SUPPORT OF (A) PLAINTIFFS' OPPOSITION TO ABBOTT'S MOTION TO STRIKE FINAL INFRINGEMENT CONTENTIONS AND (B) PLAINTIFFS' CROSS-MOTION TO PRECLUDE ABBOTT FROM EXCEEDING SCOPE OF FINAL INVALIDITY CONTENTIONS - PUBLIC (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3 (PLACEHOLDER), # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9 (PLACEHOLDER), # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25)(Chivvis, Matthew)
Dec 21, 2020 165 declaration (Exhibit 7) (8)
Docket Text: DECLARATION of MATTHEW A. CHIVVIS IN SUPPORT OF (A) PLAINTIFFS' OPPOSITION TO ABBOTT'S MOTION TO STRIKE FINAL INFRINGEMENT CONTENTIONS AND (B) PLAINTIFFS' CROSS-MOTION TO PRECLUDE ABBOTT FROM EXCEEDING SCOPE OF FINAL INVALIDITY CONTENTIONS - PUBLIC (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3 (PLACEHOLDER), # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9 (PLACEHOLDER), # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25)(Chivvis, Matthew)
Dec 21, 2020 165 declaration (Exhibit 8) (2)
Docket Text: DECLARATION of MATTHEW A. CHIVVIS IN SUPPORT OF (A) PLAINTIFFS' OPPOSITION TO ABBOTT'S MOTION TO STRIKE FINAL INFRINGEMENT CONTENTIONS AND (B) PLAINTIFFS' CROSS-MOTION TO PRECLUDE ABBOTT FROM EXCEEDING SCOPE OF FINAL INVALIDITY CONTENTIONS - PUBLIC (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3 (PLACEHOLDER), # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9 (PLACEHOLDER), # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25)(Chivvis, Matthew)
Dec 21, 2020 165 declaration (Exhibit 9 (PLACEHOLDER)) (1)
Docket Text: DECLARATION of MATTHEW A. CHIVVIS IN SUPPORT OF (A) PLAINTIFFS' OPPOSITION TO ABBOTT'S MOTION TO STRIKE FINAL INFRINGEMENT CONTENTIONS AND (B) PLAINTIFFS' CROSS-MOTION TO PRECLUDE ABBOTT FROM EXCEEDING SCOPE OF FINAL INVALIDITY CONTENTIONS - PUBLIC (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3 (PLACEHOLDER), # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9 (PLACEHOLDER), # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25)(Chivvis, Matthew)
Dec 21, 2020 165 declaration (Exhibit 10) (30)
Docket Text: DECLARATION of MATTHEW A. CHIVVIS IN SUPPORT OF (A) PLAINTIFFS' OPPOSITION TO ABBOTT'S MOTION TO STRIKE FINAL INFRINGEMENT CONTENTIONS AND (B) PLAINTIFFS' CROSS-MOTION TO PRECLUDE ABBOTT FROM EXCEEDING SCOPE OF FINAL INVALIDITY CONTENTIONS - PUBLIC (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3 (PLACEHOLDER), # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9 (PLACEHOLDER), # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25)(Chivvis, Matthew)
Dec 21, 2020 165 declaration (Exhibit 11) (5)
Docket Text: DECLARATION of MATTHEW A. CHIVVIS IN SUPPORT OF (A) PLAINTIFFS' OPPOSITION TO ABBOTT'S MOTION TO STRIKE FINAL INFRINGEMENT CONTENTIONS AND (B) PLAINTIFFS' CROSS-MOTION TO PRECLUDE ABBOTT FROM EXCEEDING SCOPE OF FINAL INVALIDITY CONTENTIONS - PUBLIC (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3 (PLACEHOLDER), # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9 (PLACEHOLDER), # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25)(Chivvis, Matthew)
Dec 21, 2020 165 declaration (Exhibit 12) (11)
Docket Text: DECLARATION of MATTHEW A. CHIVVIS IN SUPPORT OF (A) PLAINTIFFS' OPPOSITION TO ABBOTT'S MOTION TO STRIKE FINAL INFRINGEMENT CONTENTIONS AND (B) PLAINTIFFS' CROSS-MOTION TO PRECLUDE ABBOTT FROM EXCEEDING SCOPE OF FINAL INVALIDITY CONTENTIONS - PUBLIC (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3 (PLACEHOLDER), # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9 (PLACEHOLDER), # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25)(Chivvis, Matthew)
Dec 21, 2020 165 declaration (Exhibit 13) (3)
Docket Text: DECLARATION of MATTHEW A. CHIVVIS IN SUPPORT OF (A) PLAINTIFFS' OPPOSITION TO ABBOTT'S MOTION TO STRIKE FINAL INFRINGEMENT CONTENTIONS AND (B) PLAINTIFFS' CROSS-MOTION TO PRECLUDE ABBOTT FROM EXCEEDING SCOPE OF FINAL INVALIDITY CONTENTIONS - PUBLIC (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3 (PLACEHOLDER), # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9 (PLACEHOLDER), # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25)(Chivvis, Matthew)
Dec 21, 2020 165 declaration (Exhibit 14) (4)
Docket Text: DECLARATION of MATTHEW A. CHIVVIS IN SUPPORT OF (A) PLAINTIFFS' OPPOSITION TO ABBOTT'S MOTION TO STRIKE FINAL INFRINGEMENT CONTENTIONS AND (B) PLAINTIFFS' CROSS-MOTION TO PRECLUDE ABBOTT FROM EXCEEDING SCOPE OF FINAL INVALIDITY CONTENTIONS - PUBLIC (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3 (PLACEHOLDER), # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9 (PLACEHOLDER), # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25)(Chivvis, Matthew)
Dec 21, 2020 165 declaration (Exhibit 15) (7)
Docket Text: DECLARATION of MATTHEW A. CHIVVIS IN SUPPORT OF (A) PLAINTIFFS' OPPOSITION TO ABBOTT'S MOTION TO STRIKE FINAL INFRINGEMENT CONTENTIONS AND (B) PLAINTIFFS' CROSS-MOTION TO PRECLUDE ABBOTT FROM EXCEEDING SCOPE OF FINAL INVALIDITY CONTENTIONS - PUBLIC (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3 (PLACEHOLDER), # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9 (PLACEHOLDER), # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25)(Chivvis, Matthew)
Dec 21, 2020 165 declaration (Exhibit 16) (5)
Docket Text: DECLARATION of MATTHEW A. CHIVVIS IN SUPPORT OF (A) PLAINTIFFS' OPPOSITION TO ABBOTT'S MOTION TO STRIKE FINAL INFRINGEMENT CONTENTIONS AND (B) PLAINTIFFS' CROSS-MOTION TO PRECLUDE ABBOTT FROM EXCEEDING SCOPE OF FINAL INVALIDITY CONTENTIONS - PUBLIC (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3 (PLACEHOLDER), # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9 (PLACEHOLDER), # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25)(Chivvis, Matthew)
Dec 21, 2020 165 declaration (Exhibit 17) (10)
Docket Text: DECLARATION of MATTHEW A. CHIVVIS IN SUPPORT OF (A) PLAINTIFFS' OPPOSITION TO ABBOTT'S MOTION TO STRIKE FINAL INFRINGEMENT CONTENTIONS AND (B) PLAINTIFFS' CROSS-MOTION TO PRECLUDE ABBOTT FROM EXCEEDING SCOPE OF FINAL INVALIDITY CONTENTIONS - PUBLIC (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3 (PLACEHOLDER), # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9 (PLACEHOLDER), # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25)(Chivvis, Matthew)
Dec 21, 2020 165 declaration (Exhibit 18) (3)
Docket Text: DECLARATION of MATTHEW A. CHIVVIS IN SUPPORT OF (A) PLAINTIFFS' OPPOSITION TO ABBOTT'S MOTION TO STRIKE FINAL INFRINGEMENT CONTENTIONS AND (B) PLAINTIFFS' CROSS-MOTION TO PRECLUDE ABBOTT FROM EXCEEDING SCOPE OF FINAL INVALIDITY CONTENTIONS - PUBLIC (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3 (PLACEHOLDER), # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9 (PLACEHOLDER), # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25)(Chivvis, Matthew)
Dec 21, 2020 165 declaration (Exhibit 19) (19)
Docket Text: DECLARATION of MATTHEW A. CHIVVIS IN SUPPORT OF (A) PLAINTIFFS' OPPOSITION TO ABBOTT'S MOTION TO STRIKE FINAL INFRINGEMENT CONTENTIONS AND (B) PLAINTIFFS' CROSS-MOTION TO PRECLUDE ABBOTT FROM EXCEEDING SCOPE OF FINAL INVALIDITY CONTENTIONS - PUBLIC (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3 (PLACEHOLDER), # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9 (PLACEHOLDER), # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25)(Chivvis, Matthew)
Dec 21, 2020 165 declaration (Exhibit 20) (6)
Docket Text: DECLARATION of MATTHEW A. CHIVVIS IN SUPPORT OF (A) PLAINTIFFS' OPPOSITION TO ABBOTT'S MOTION TO STRIKE FINAL INFRINGEMENT CONTENTIONS AND (B) PLAINTIFFS' CROSS-MOTION TO PRECLUDE ABBOTT FROM EXCEEDING SCOPE OF FINAL INVALIDITY CONTENTIONS - PUBLIC (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3 (PLACEHOLDER), # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9 (PLACEHOLDER), # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25)(Chivvis, Matthew)
Dec 21, 2020 165 declaration (Exhibit 21) (2)
Docket Text: DECLARATION of MATTHEW A. CHIVVIS IN SUPPORT OF (A) PLAINTIFFS' OPPOSITION TO ABBOTT'S MOTION TO STRIKE FINAL INFRINGEMENT CONTENTIONS AND (B) PLAINTIFFS' CROSS-MOTION TO PRECLUDE ABBOTT FROM EXCEEDING SCOPE OF FINAL INVALIDITY CONTENTIONS - PUBLIC (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3 (PLACEHOLDER), # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9 (PLACEHOLDER), # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25)(Chivvis, Matthew)
Dec 21, 2020 165 declaration (Exhibit 22) (2)
Docket Text: DECLARATION of MATTHEW A. CHIVVIS IN SUPPORT OF (A) PLAINTIFFS' OPPOSITION TO ABBOTT'S MOTION TO STRIKE FINAL INFRINGEMENT CONTENTIONS AND (B) PLAINTIFFS' CROSS-MOTION TO PRECLUDE ABBOTT FROM EXCEEDING SCOPE OF FINAL INVALIDITY CONTENTIONS - PUBLIC (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3 (PLACEHOLDER), # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9 (PLACEHOLDER), # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25)(Chivvis, Matthew)
Dec 21, 2020 165 declaration (Exhibit 23) (3)
Docket Text: DECLARATION of MATTHEW A. CHIVVIS IN SUPPORT OF (A) PLAINTIFFS' OPPOSITION TO ABBOTT'S MOTION TO STRIKE FINAL INFRINGEMENT CONTENTIONS AND (B) PLAINTIFFS' CROSS-MOTION TO PRECLUDE ABBOTT FROM EXCEEDING SCOPE OF FINAL INVALIDITY CONTENTIONS - PUBLIC (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3 (PLACEHOLDER), # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9 (PLACEHOLDER), # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25)(Chivvis, Matthew)
Dec 21, 2020 165 declaration (Exhibit 24) (3)
Docket Text: DECLARATION of MATTHEW A. CHIVVIS IN SUPPORT OF (A) PLAINTIFFS' OPPOSITION TO ABBOTT'S MOTION TO STRIKE FINAL INFRINGEMENT CONTENTIONS AND (B) PLAINTIFFS' CROSS-MOTION TO PRECLUDE ABBOTT FROM EXCEEDING SCOPE OF FINAL INVALIDITY CONTENTIONS - PUBLIC (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3 (PLACEHOLDER), # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9 (PLACEHOLDER), # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25)(Chivvis, Matthew)
Dec 21, 2020 165 declaration (Exhibit 25) (7)
Docket Text: DECLARATION of MATTHEW A. CHIVVIS IN SUPPORT OF (A) PLAINTIFFS' OPPOSITION TO ABBOTT'S MOTION TO STRIKE FINAL INFRINGEMENT CONTENTIONS AND (B) PLAINTIFFS' CROSS-MOTION TO PRECLUDE ABBOTT FROM EXCEEDING SCOPE OF FINAL INVALIDITY CONTENTIONS - PUBLIC (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3 (PLACEHOLDER), # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9 (PLACEHOLDER), # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25)(Chivvis, Matthew)
Dec 21, 2020 167 motion to seal document (3)
Docket Text: MOTION by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California to seal document sealed document,,, [166] (PLAINTIFFS' UNOPPOSED MOTION FOR LEAVE TO FILE UNDER SEAL EXHIBITS TO THE DECLARATION OF MATTHEW A. CHIVVIS IN SUPPORT OF (A) PLAINTIFFS' OPPOSITION TO ABBOTT'S MOTION TO STRIKE FINAL INFRINGEMENT CONTENTIONS AND (B) PLAINTIFFS' CROSS-MOTION TO PRECLUDE ABBOTT FROM EXCEEDING SCOPE OF FINAL INVALIDITY CONTENTIONS) (Chivvis, Matthew)
Dec 21, 2020 168 notice of motion (2)
Docket Text: (UNOPPOSED MOTION) NOTICE of Motion by Matthew Alan Chivvis for presentment of motion to seal document, [167] before Honorable John Z. Lee on 12/29/2020 at 09:00 AM. (Chivvis, Matthew)
Dec 17, 2020 161 order on motion to compel (1)
Docket Text: MINUTE entry before the Honorable Heather K. McShain: Plaintiffs' motion to compel production of patent list [113] is granted in part and denied in part. Enter Memorandum Opinion and Order. Mailed notice. (pk, )
Dec 17, 2020 162 memorandum opinion and order (10)
Docket Text: MEMORANDUM Opinion and Order. Signed by the Honorable Heather K. McShain on 12/17/2020. Mailed notice. (pk, )
Dec 11, 2020 158 notice of filing (Main Document) (3)
Docket Text: NOTICE by Abbott Laboratories re MOTION by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California to compel (MOTION TO COMPEL PRODUCTION OF PATENT LIST)[113] (Supplemental Objections and Responses to Plaintiffs' Interrogatory No. 17 That is a Subject of Plaintiffs' Motion to Compel) (Attachments: # (1) Exhibit 1, # (2) Exhibit 2)(Wickramasekera, Nimalka)
Dec 11, 2020 158 notice of filing (Exhibit 1) (5)
Docket Text: NOTICE by Abbott Laboratories re MOTION by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California to compel (MOTION TO COMPEL PRODUCTION OF PATENT LIST)[113] (Supplemental Objections and Responses to Plaintiffs' Interrogatory No. 17 That is a Subject of Plaintiffs' Motion to Compel) (Attachments: # (1) Exhibit 1, # (2) Exhibit 2)(Wickramasekera, Nimalka)
Dec 11, 2020 158 notice of filing (Exhibit 2) (6)
Docket Text: NOTICE by Abbott Laboratories re MOTION by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California to compel (MOTION TO COMPEL PRODUCTION OF PATENT LIST)[113] (Supplemental Objections and Responses to Plaintiffs' Interrogatory No. 17 That is a Subject of Plaintiffs' Motion to Compel) (Attachments: # (1) Exhibit 1, # (2) Exhibit 2)(Wickramasekera, Nimalka)
Dec 11, 2020 159 Response (3)
Docket Text: RESPONSE by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California to notice of filing, [158] (RESPONSE TO NOTICE PROVIDED BY ABBOTT LABORATORIES) (Chivvis, Matthew)
Dec 11, 2020 160 reply (3)
Docket Text: REPLY by Defendant Abbott Laboratories to Response[159] re Notice of Supplemental Objections and Responses to Plaintiffs' Interrogatory No. 17 (Wickramasekera, Nimalka)
Dec 8, 2020 155 text entry (1)
Docket Text: MINUTE entry before the Honorable Heather K. McShain: On review of the parties' briefs concerning plaintiffs' motion to compel [113], the Court orders Abbott Laboratories to file under seal and ex parte an unredacted version of the Excel spreadsheet identified as Log No. 6 on Abbott Laboratories' Second Privilege Log (see [114-1] 6) on or before 12/10/2020. Mailed notice. (pk, )
Dec 7, 2020 156 status hearing (1)
Docket Text: MINUTE entry before the Honorable John Z. Lee: Status hearing held on 12/7/20. A claim construction hearing is set for 1/21/21 at 1:00 p.m. via Microsoft Teams. The dial in number is 872-703-5321, Passcode 356354203#. The attorneys must ensure that they and any witnesses log into the hearing using a robust internet connection. Any Powerpoint presentations should be emailed to the Courtroom Deputy by 1/19/21. Mailed notice (ca, )
Dec 6, 2020 154 order on motion for extension of time (1)
Docket Text: MINUTE entry before the Honorable John Z. Lee:Motion for extension of time to respond [152] is granted. Plaintiff shall respond to Defendant's answer and counterclaims by 1/18/21.Mailed notice (ca, )
Dec 4, 2020 151 other (4)
Docket Text: (JOINT CLAIM CONSTRUCTION CHART AND STATUS REPORT) by Evolve BioSystems, Inc., Regents of the University of California (Chivvis, Matthew)
Dec 4, 2020 152 extension of time (2)
Docket Text: MOTION by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California for extension of time (UNOPPOSED MOTION FOR EXTENSION OF TIME TO RESPOND TO DEFENDANT'S ANSWER AND COUNTERCLAIMS) (Chivvis, Matthew)
Dec 4, 2020 153 notice of motion (2)
Docket Text: (UNOPPOSED MOTION) NOTICE of Motion by Matthew Alan Chivvis for presentment of extension of time[152] before Honorable John Z. Lee on 12/10/2020 at 09:00 AM. (Chivvis, Matthew)
Dec 2, 2020 150 order on motion to withdraw as attorney (1)
Docket Text: MINUTE entry before the Honorable John Z. Lee:Motion to withdraw Stephanie Blij as attorney [147] is granted.Mailed notice (ca, )
Dec 1, 2020 146 order on motion to seal document (1)
Docket Text: MINUTE entry before the Honorable John Z. Lee:Motions to file under seal [142] [145] are granted.Mailed notice (ca, )
Dec 1, 2020 147 motion to withdraw as attorney (2)
Docket Text: MOTION by Attorney Stephanie J. Blij to withdraw as attorney for Evolve BioSystems, Inc., Regents of the University of California. No party information provided (Chivvis, Matthew)
Dec 1, 2020 148 notice of motion (2)
Docket Text: (UNOPPOSED MOTION) NOTICE of Motion by Matthew Alan Chivvis for presentment of motion to withdraw as attorney[147] before Honorable John Z. Lee on 12/8/2020 at 09:00 AM. (Chivvis, Matthew)
Dec 1, 2020 149 terminate hearings (1)
Docket Text: MINUTE entry before the Honorable John Z. Lee:The status hearing set for 12/2/20 is reset to 12/7/20 at 9:15 a.m., the dial in number remains the same.Mailed notice (ca, )
Nov 30, 2020 143 answer to complaint (30)
Docket Text: ANSWER to Complaint with Jury Demand , COUNTERCLAIM filed by Abbott Laboratories against Evolve BioSystems, Inc., Regents of the University of California (Redacted). by Abbott Laboratories(Wickramasekera, Nimalka)
Nov 30, 2020 145 motion to seal document (4)
Docket Text: MOTION by Defendant Abbott Laboratories to seal document sealed document[144] (Wickramasekera, Nimalka)
Nov 20, 2020 139 transcript (26)
Docket Text: TRANSCRIPT OF PROCEEDINGS held on 10/15/2020 before the Honorable Heather K. McShain. Order Number: 39425. Court Reporter Contact Information: TRACEY D. McCULLOUGH, 312-435-5570, tracey_mccullough@ilnd.uscourts.gov.

IMPORTANT: The transcript may be viewed at the court's public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through the Court Reporter/Transcriber or PACER. For further information on the redaction process, see the Court's web site at www.ilnd.uscourts.gov under Quick Links select Policy Regarding the Availability of Transcripts of Court Proceedings.

Redaction Request due 12/11/2020. Redacted Transcript Deadline set for 12/21/2020. Release of Transcript Restriction set for 2/18/2021. (Mccullough, Tracey)
Nov 20, 2020 140 reply (Main Document) (26)
Docket Text: REPLY by Defendant Abbott Laboratories Claim Construction Brief (Attachments: # (1) Declaration of Dan H. Hoang (with Exhibits 28 and 29))(Wickramasekera, Nimalka)
Nov 20, 2020 140 reply (Declaration of Dan H. Hoang (with Exhibits 28 and 29)) (4)
Docket Text: REPLY by Defendant Abbott Laboratories Claim Construction Brief (Attachments: # (1) Declaration of Dan H. Hoang (with Exhibits 28 and 29))(Wickramasekera, Nimalka)
Nov 20, 2020 142 motion to seal document (4)
Docket Text: MOTION by Defendant Abbott Laboratories to seal document sealed document[141] (Uncontested) (Wickramasekera, Nimalka)
Nov 17, 2020 138 reply (11)
Docket Text: REPLY by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California to motion to compel, [113] (REPLY IN SUPPORT OF MOTION TO COMPEL PRODUCTION OF PATENT LIST) (Chivvis, Matthew)
Nov 16, 2020 137 Order on Motion to Dismiss for Failure to State a Claim (17)
Docket Text: ORDER : Plaintiffs Evolve Biosystems, Inc. ("Evolve") and the Regents of the University of California ("the University") have sued Defendant Abbott Laboratories ("Abbott") under 35 U.S.C. §§ 271(a)(c) for inducement, contributory infringement, and direct infringement of U.S. Patent Nos. 8,197,872 ("'872 patent") and 9,200,091 ("'091 patent"). Abbott has moved to dismiss the complaint. For the reasons provided below, the motion [32] is denied. Signed by the Honorable John Z. Lee on 11/16/20. [For further details see order].Mailed notice(ca, )
Nov 13, 2020 135 order on motion for miscellaneous relief (1)
Docket Text: MINUTE entry before the Honorable John Z. Lee: The Court has reviewed the joint status report and Plaintiffs' motion for miscellaneous relief [132], and the motion is stricken as moot. The Court prefers that Defendant's motion to strike Plaintiffs' final infringement contentions be briefed separately from Plaintiffs' motion to strike Defendant's final invalidity contentions. The Court will issue rulings on both motions simultaneously. Plaintiffs' response to Defendant's motion to strike Plaintiffs' final infringement contentions [117] is due December 21, 2020. Defendant's reply is due January 25, 2021. Plaintiffs' motion to strike Defendant's final invalidity contentions is due December 21, 2020. No notice of motion shall be filed. Defendant's response to Plaintiffs' motion to strike Defendant's final invalidity contentions is due January 25, 2021. Plaintiffs' reply in support of their motion is due February 19, 2021. All briefs listed in these briefing schedules are limited to 13 pages. The parties are instructed to continue working together to reach stipulations regarding contentions, discovery, and briefing schedules whenever possible in order to avoid unnecessarily involving the limited judicial resources of the Court. If the parties envision that amended motions to strike will be filed after claim construction has concluded, then the parties should consider holding off on motion practice regarding final infringement contentions and final invalidity contentions until that time. Mailed notice (ca, )
Nov 13, 2020 136 order on motion to seal (1)
Docket Text: MINUTE entry before the Honorable John Z. Lee:Defendant's motion to seal exhibits [121] [130] are granted, and Defendant is reminded that all motions should indicate whether or not they are opposed.Mailed notice (ca, )
Nov 12, 2020 134 set/reset hearings (1)
Docket Text: MINUTE entry before the Honorable John Z. Lee:Status hearing set for 12/2/20 at 9:15 a.m., to set a claim construction hearing. In light of the COVID-19 pandemic and the related General Orders, the Court finds that it is necessary to conduct the status hearing via telephone conference. The call-in number is 888-273-3658 and the access code is 1637578. Counsel of record will receive a separate email at least 12 hours prior to the start of the telephonic hearing with instructions on how to join the call. All persons granted remote access to proceedings are reminded of the general prohibition against photographing, recording, and rebroadcasting of court proceedings. Violation of these prohibitions may result in court-imposed sanctions, including removal of court issued media credentials, restricted entry to future hearings, denial of entry to future hearings, or any other sanctions deemed necessary by the Court. All participants should review the Court's standing order regarding telephone conferences that is on Judge Lee's website, which can be found at: https://www.ilnd.uscourts.gov/judge-info.aspx?4Qf5zc8loCI5U7rfMP9DHw==. Mailed notice (ca, )
Nov 11, 2020 132 motion for miscellaneous relief (5)
Docket Text: MOTION by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California(MOTION TO SET BRIEFING SCHEDULE FOR ABBOTT'S MOTION TO STRIKE PLAINTIFFS' INFRINGEMENT CONTENTIONS AND FOR PLAINTIFFS' CROSS-MOTION ON ABBOTT'S INVALIDITY CONTENTIONS) (Chivvis, Matthew)
Nov 11, 2020 133 notice of motion (2)
Docket Text: NOTICE of Motion by Matthew Alan Chivvis for presentment of motion for miscellaneous relief, [132] before Honorable John Z. Lee on 11/16/2020 at 09:00 AM. (Chivvis, Matthew)
Nov 10, 2020 128 response in opposition to motion (Main Document) (21)
Docket Text: RESPONSE by Abbott Laboratoriesin Opposition to MOTION by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California to compel (MOTION TO COMPEL PRODUCTION OF PATENT LIST)[113] (Attachments: # (1) Declaration of Dan H. Hoang in Support of Abbott Laboratories' Opposition to Plaintiffs' Motion to Compel Production of Patent List)(Wickramasekera, Nimalka)
Nov 10, 2020 128 response in opposition to motion (Declaration of Dan H. Hoang in Support of Abbott Laboratories' Opposition) (30)
Docket Text: RESPONSE by Abbott Laboratoriesin Opposition to MOTION by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California to compel (MOTION TO COMPEL PRODUCTION OF PATENT LIST)[113] (Attachments: # (1) Declaration of Dan H. Hoang in Support of Abbott Laboratories' Opposition to Plaintiffs' Motion to Compel Production of Patent List)(Wickramasekera, Nimalka)
Nov 10, 2020 130 motion to seal document (4)
Docket Text: MOTION by Defendant Abbott Laboratories to seal document exhibit[129] (Wickramasekera, Nimalka)
Nov 10, 2020 131 status report (9)
Docket Text: STATUS Report (JOINT STATUS REPORT) by Evolve BioSystems, Inc., Regents of the University of California (Chivvis, Matthew)
Nov 8, 2020 127 order on motion to seal document (1)
Docket Text: MINUTE entry before the Honorable John Z. Lee:Motion for leave to file under seal brief and exhibits [125] is granted. Mailed notice (ca, )
Nov 6, 2020 123 Response (Main Document) (30)
Docket Text: RESPONSE by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California (RESPONSIVE CLAIM CONSTRUCTION BRIEF) (Attachments: # (1) Declaration (DECLARATION OF MATTHEW A. CHIVVIS IN SUPPORT), # (2) Exhibit A, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit N, # (12) Exhibit O)(Chivvis, Matthew)
Nov 6, 2020 123 Response (Declaration (DECLARATION OF MATTHEW A. CHIVVIS IN SUPPORT)) (5)
Docket Text: RESPONSE by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California (RESPONSIVE CLAIM CONSTRUCTION BRIEF) (Attachments: # (1) Declaration (DECLARATION OF MATTHEW A. CHIVVIS IN SUPPORT), # (2) Exhibit A, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit N, # (12) Exhibit O)(Chivvis, Matthew)
Nov 6, 2020 123 Response (Exhibit A) (6)
Docket Text: RESPONSE by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California (RESPONSIVE CLAIM CONSTRUCTION BRIEF) (Attachments: # (1) Declaration (DECLARATION OF MATTHEW A. CHIVVIS IN SUPPORT), # (2) Exhibit A, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit N, # (12) Exhibit O)(Chivvis, Matthew)
Nov 6, 2020 123 Response (Exhibit C) (7)
Docket Text: RESPONSE by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California (RESPONSIVE CLAIM CONSTRUCTION BRIEF) (Attachments: # (1) Declaration (DECLARATION OF MATTHEW A. CHIVVIS IN SUPPORT), # (2) Exhibit A, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit N, # (12) Exhibit O)(Chivvis, Matthew)
Nov 6, 2020 123 Response (Exhibit D) (7)
Docket Text: RESPONSE by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California (RESPONSIVE CLAIM CONSTRUCTION BRIEF) (Attachments: # (1) Declaration (DECLARATION OF MATTHEW A. CHIVVIS IN SUPPORT), # (2) Exhibit A, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit N, # (12) Exhibit O)(Chivvis, Matthew)
Nov 6, 2020 123 Response (Exhibit E) (9)
Docket Text: RESPONSE by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California (RESPONSIVE CLAIM CONSTRUCTION BRIEF) (Attachments: # (1) Declaration (DECLARATION OF MATTHEW A. CHIVVIS IN SUPPORT), # (2) Exhibit A, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit N, # (12) Exhibit O)(Chivvis, Matthew)
Nov 6, 2020 123 Response (Exhibit F) (11)
Docket Text: RESPONSE by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California (RESPONSIVE CLAIM CONSTRUCTION BRIEF) (Attachments: # (1) Declaration (DECLARATION OF MATTHEW A. CHIVVIS IN SUPPORT), # (2) Exhibit A, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit N, # (12) Exhibit O)(Chivvis, Matthew)
Nov 6, 2020 123 Response (Exhibit G) (5)
Docket Text: RESPONSE by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California (RESPONSIVE CLAIM CONSTRUCTION BRIEF) (Attachments: # (1) Declaration (DECLARATION OF MATTHEW A. CHIVVIS IN SUPPORT), # (2) Exhibit A, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit N, # (12) Exhibit O)(Chivvis, Matthew)
Nov 6, 2020 123 Response (Exhibit H) (10)
Docket Text: RESPONSE by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California (RESPONSIVE CLAIM CONSTRUCTION BRIEF) (Attachments: # (1) Declaration (DECLARATION OF MATTHEW A. CHIVVIS IN SUPPORT), # (2) Exhibit A, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit N, # (12) Exhibit O)(Chivvis, Matthew)
Nov 6, 2020 123 Response (Exhibit I) (5)
Docket Text: RESPONSE by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California (RESPONSIVE CLAIM CONSTRUCTION BRIEF) (Attachments: # (1) Declaration (DECLARATION OF MATTHEW A. CHIVVIS IN SUPPORT), # (2) Exhibit A, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit N, # (12) Exhibit O)(Chivvis, Matthew)
Nov 6, 2020 123 Response (Exhibit J) (6)
Docket Text: RESPONSE by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California (RESPONSIVE CLAIM CONSTRUCTION BRIEF) (Attachments: # (1) Declaration (DECLARATION OF MATTHEW A. CHIVVIS IN SUPPORT), # (2) Exhibit A, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit N, # (12) Exhibit O)(Chivvis, Matthew)
Nov 6, 2020 123 Response (Exhibit N) (5)
Docket Text: RESPONSE by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California (RESPONSIVE CLAIM CONSTRUCTION BRIEF) (Attachments: # (1) Declaration (DECLARATION OF MATTHEW A. CHIVVIS IN SUPPORT), # (2) Exhibit A, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit N, # (12) Exhibit O)(Chivvis, Matthew)
Nov 6, 2020 123 Response (Exhibit O) (27)
Docket Text: RESPONSE by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California (RESPONSIVE CLAIM CONSTRUCTION BRIEF) (Attachments: # (1) Declaration (DECLARATION OF MATTHEW A. CHIVVIS IN SUPPORT), # (2) Exhibit A, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit N, # (12) Exhibit O)(Chivvis, Matthew)
Nov 6, 2020 125 motion to seal document (4)
Docket Text: MOTION by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California to seal document sealed response,, [124] (MOTION FOR LEAVE TO FILE UNDER SEAL) (Chivvis, Matthew)
Nov 6, 2020 126 notice of motion (2)
Docket Text: NOTICE of Motion by Matthew Alan Chivvis for presentment of motion to seal document[125] before Honorable John Z. Lee on 11/12/2020 at 09:00 AM. (Chivvis, Matthew)
Oct 29, 2020 117 motion to strike (4)
Docket Text: MOTION by Defendant Abbott Laboratories to strike Final Infringement Contentions (Wickramasekera, Nimalka)
Oct 29, 2020 118 memorandum in support of motion (Main Document) (23)
Docket Text: MEMORANDUM by Abbott Laboratories in support of motion to strike[117] (Attachments: # (1) Declaration of Dan H. Hoang in Support of Abbott Laboratories' Motion to Strike Final Infringement Contentions)(Wickramasekera, Nimalka)
Oct 29, 2020 118 memorandum in support of motion (Declaration of Dan H. Hoang in Support of Abbott Laboratories' Motion to St) (30)
Docket Text: MEMORANDUM by Abbott Laboratories in support of motion to strike[117] (Attachments: # (1) Declaration of Dan H. Hoang in Support of Abbott Laboratories' Motion to Strike Final Infringement Contentions)(Wickramasekera, Nimalka)
Oct 29, 2020 120 notice of motion (3)
Docket Text: NOTICE of Motion by Nimalka Ratnavali Wickramasekera for presentment of motion to strike[117] before Honorable John Z. Lee on 11/16/2020 at 09:15 AM. (Wickramasekera, Nimalka)
Oct 29, 2020 121 motion to seal (5)
Docket Text: MOTION by Defendant Abbott Laboratories to seal Exhibits to Abbott Laboratories' Motion to Strike Final Infringement Contentions (Wickramasekera, Nimalka)
Oct 29, 2020 122 notice of motion (3)
Docket Text: NOTICE of Motion by Nimalka Ratnavali Wickramasekera for presentment of motion to seal[121] before Honorable John Z. Lee on 11/16/2020 at 09:15 AM. (Wickramasekera, Nimalka)
Oct 27, 2020 116 order on motion to seal document (1)
Docket Text: MINUTE entry before the Honorable Heather K. McShain: Plaintiffs' Motion for Leave to File Under Seal Evolve BioSystems, Inc. and the Regents of the University of California's Motion to Compel Production of Patent List [115] is granted. Plaintiffs' Motion to Compel [113] is entered and continued. Defendant's response due 11/10/2020. Plaintiffs' reply, if any, due 11/17/2020. Upon review of Plaintiffs' fully briefed motion, the Court will decide whether it can rule on the papers or will require a telephonic motion hearing to hear from the parties. Mailed notice. (pk, )
Oct 26, 2020 113 motion to compel (Main Document) (6)
Docket Text: MOTION by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California to compel (MOTION TO COMPEL PRODUCTION OF PATENT LIST) (Attachments: # (1) Declaration (DECLARATION OF MATTHEW A. CHIVVIS IN SUPPORT, INCLUDING EXHIBIT 4 and PLACEHOLDERS FOR EXHIBITS 1-3, 5))(Chivvis, Matthew)
Oct 26, 2020 113 motion to compel (Declaration (DECLARATION OF MATTHEW A. CHIVVIS IN SUPPORT, INCLUDING EXHIBIT 4) (22)
Docket Text: MOTION by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California to compel (MOTION TO COMPEL PRODUCTION OF PATENT LIST) (Attachments: # (1) Declaration (DECLARATION OF MATTHEW A. CHIVVIS IN SUPPORT, INCLUDING EXHIBIT 4 and PLACEHOLDERS FOR EXHIBITS 1-3, 5))(Chivvis, Matthew)
Oct 26, 2020 115 motion to seal document (4)
Docket Text: MOTION by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California to seal document sealed document, [114] (MOTION FOR LEAVE TO FILE UNDER SEAL) (Chivvis, Matthew)
Oct 23, 2020 111 order on motion to compel (1)
Docket Text: MINUTE entry before the Honorable Heather K. McShain: Plaintiffs' motion to compel production of two unredacted documents [80] is denied. Enter Order. Mailed notice. (pk, )
Oct 23, 2020 112 order (8)
Docket Text: ORDER. Signed by the Honorable Heather K. McShain on 10/23/2020. Mailed notice. (pk, )
Oct 13, 2020 107 set/reset hearings (1)
Docket Text: MINUTE entry before the Honorable Heather K. McShain: Motion hearing on plaintiff's motion to compel [80] is set for 10/15/2020 at 3pm. Mailed notice. (pk, )
Oct 13, 2020 108 text entry (1)
Docket Text: MINUTE entry before the Honorable Heather K. McShain: Minute entry [107] is amended to include call in information as follows, members of the public and media will be able to call in to listen to this hearing. To participate in the telephonic motion hearing, the dial-in number is 888-684-8852, followed by access code 8623687#. Persons granted remote access to proceedings are reminded of the general prohibition against photographing, recording, and rebroadcasting of court proceedings. Violation of these prohibitions may result in sanctions, including removal of court issued media credentials, restricted entry to future hearings, denial of entry to future hearings, or any other sanctions deemed necessary by the Court. Mailed notice. (pk, )
Oct 13, 2020 109 order on motion to seal document (1)
Docket Text: MINUTE entry before the Honorable John Z. Lee:Motion for leave to file exhibit 24 under seal [104] is granted. No appearance is required on the motion.Mailed notice (ca, )
Oct 13, 2020 110 order (2)
Docket Text: JOINT Stipulation and Order concerning agreed-upon claim term Signed by the Honorable John Z. Lee on 10/13/20. Mailed notice(ca, )
Oct 9, 2020 100 appendix (Main Document) (0)
Docket Text: APPENDIX (Joint Appendix Pursuant to Local Patent Rule 4.2(B)) (Attachments: # (1) Exhibit 1-3, # (2) Exhibit 4)(Wickramasekera, Nimalka)
Oct 9, 2020 100 appendix (Exhibit 1-3) (0)
Docket Text: APPENDIX (Joint Appendix Pursuant to Local Patent Rule 4.2(B)) (Attachments: # (1) Exhibit 1-3, # (2) Exhibit 4)(Wickramasekera, Nimalka)
Oct 9, 2020 100 appendix (Exhibit 4) (0)
Docket Text: APPENDIX (Joint Appendix Pursuant to Local Patent Rule 4.2(B)) (Attachments: # (1) Exhibit 1-3, # (2) Exhibit 4)(Wickramasekera, Nimalka)
Oct 9, 2020 101 stipulation (2)
Docket Text: STIPULATION (Joint Stipulation and Order Concerning Agreed-Upon Claim Term) (Wickramasekera, Nimalka)
Oct 9, 2020 102 other (Main Document) (30)
Docket Text: Opening Claim Construction Brief by Abbott Laboratories (Attachments: # (1) Declaration of Roger A. Clemens)(Wickramasekera, Nimalka)
Oct 9, 2020 104 motion to seal document (4)
Docket Text: MOTION by Defendant Abbott Laboratories to seal document sealed document[103] Exhibit 24 (Wickramasekera, Nimalka)
Oct 9, 2020 105 notice of motion (3)
Docket Text: Defendant's NOTICE of Motion by Nimalka Ratnavali Wickramasekera for presentment of motion to seal document[104] before Honorable John Z. Lee on 10/19/2020 at 09:15 AM. (Wickramasekera, Nimalka)
Oct 9, 2020 106 declaration (Main Document) (7)
Docket Text: DECLARATION of Dan Hoang regarding other[102] (Attachments: # (1) Exhibit 5-13, # (2) Exhibit 14, # (3) Exhibit 15, # (4) Exhibit 16-19, # (5) Exhibit 20-21, # (6) Exhibit 22-26, # (7) Exhibit 27)(Hoang, Dan)
Oct 9, 2020 106 declaration (Exhibit 5-13) (30)
Docket Text: DECLARATION of Dan Hoang regarding other[102] (Attachments: # (1) Exhibit 5-13, # (2) Exhibit 14, # (3) Exhibit 15, # (4) Exhibit 16-19, # (5) Exhibit 20-21, # (6) Exhibit 22-26, # (7) Exhibit 27)(Hoang, Dan)
Oct 9, 2020 106 declaration (Exhibit 14) (7)
Docket Text: DECLARATION of Dan Hoang regarding other[102] (Attachments: # (1) Exhibit 5-13, # (2) Exhibit 14, # (3) Exhibit 15, # (4) Exhibit 16-19, # (5) Exhibit 20-21, # (6) Exhibit 22-26, # (7) Exhibit 27)(Hoang, Dan)
Oct 9, 2020 106 declaration (Exhibit 15) (9)
Docket Text: DECLARATION of Dan Hoang regarding other[102] (Attachments: # (1) Exhibit 5-13, # (2) Exhibit 14, # (3) Exhibit 15, # (4) Exhibit 16-19, # (5) Exhibit 20-21, # (6) Exhibit 22-26, # (7) Exhibit 27)(Hoang, Dan)
Oct 9, 2020 106 declaration (Exhibit 16-19) (25)
Docket Text: DECLARATION of Dan Hoang regarding other[102] (Attachments: # (1) Exhibit 5-13, # (2) Exhibit 14, # (3) Exhibit 15, # (4) Exhibit 16-19, # (5) Exhibit 20-21, # (6) Exhibit 22-26, # (7) Exhibit 27)(Hoang, Dan)
Oct 9, 2020 106 declaration (Exhibit 20-21) (30)
Docket Text: DECLARATION of Dan Hoang regarding other[102] (Attachments: # (1) Exhibit 5-13, # (2) Exhibit 14, # (3) Exhibit 15, # (4) Exhibit 16-19, # (5) Exhibit 20-21, # (6) Exhibit 22-26, # (7) Exhibit 27)(Hoang, Dan)
Oct 9, 2020 106 declaration (Exhibit 22-26) (28)
Docket Text: DECLARATION of Dan Hoang regarding other[102] (Attachments: # (1) Exhibit 5-13, # (2) Exhibit 14, # (3) Exhibit 15, # (4) Exhibit 16-19, # (5) Exhibit 20-21, # (6) Exhibit 22-26, # (7) Exhibit 27)(Hoang, Dan)
Oct 9, 2020 106 declaration (Exhibit 27) (12)
Docket Text: DECLARATION of Dan Hoang regarding other[102] (Attachments: # (1) Exhibit 5-13, # (2) Exhibit 14, # (3) Exhibit 15, # (4) Exhibit 16-19, # (5) Exhibit 20-21, # (6) Exhibit 22-26, # (7) Exhibit 27)(Hoang, Dan)
Oct 9, 2020 102 other (Declaration of Roger A. Clemens) (30)
Docket Text: Opening Claim Construction Brief by Abbott Laboratories (Attachments: # (1) Declaration of Roger A. Clemens)(Wickramasekera, Nimalka)
Sep 29, 2020 98 text entry (1)
Docket Text: MINUTE entry before the Honorable Heather K. McShain: On review of the parties' briefs concerning the plaintiff's motion to compel [80], the Court orders Abbott Laboratories to file under seal and ex parte unredacted copies of the two documents at issue in the pending motion, ABT PROB-002069 and ABT PROB-001498, on or before 09/30/2020. Mailed notice. (pk, )
Sep 2, 2020 97 order on motion to seal document (1)
Docket Text: MINUTE entry before the Honorable Heather K. McShain: Plaintiffs' Motion for Leave To File Under Seal Plaintiffs' Reply In Support Of Its Motion To Compel Production Of Two Unredacted Documents [96] is granted. The Court notes that the sealed reply was filed on 09/01/2020 [95]. Mailed notice. (pk, )
Sep 1, 2020 94 reply (9)
Docket Text: REPLY by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California to motion to compel, [80] (REPLY IN SUPPORT OF MOTION TO COMPEL PRODUCTION OF TWO UNREDACTED DOCUMENTS) (Chivvis, Matthew)
Sep 1, 2020 96 motion to seal document (3)
Docket Text: MOTION by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California to seal document reply[95] (MOTION FOR LEAVE TO FILE UNDER SEAL) (Chivvis, Matthew)
Aug 19, 2020 92 text entry (1)
Docket Text: MINUTE entry before the Honorable John Z. Lee:The Court referred general discovery supervision to Magistrate Judge Schenkier, the previously assigned magistrate judge[52]. Accordingly, the Court notes that general discovery supervision remains referred to currently-assigned Magistrate Judge Heather K. McShain. Mailed notice (ca, )
Aug 19, 2020 93 order on motion for leave to file (1)
Docket Text: MINUTE entry before the Honorable Heather K. McShain: Defendant Abbott Laboratories' Motion for Leave to File Under Seal Defendant's Opposition to Motion to Compel Production of Two Unredacted Documents [89] is granted. The Court notes that the sealed memorandum and exhibits were filed on 08/18/2020 [91]. Mailed notice. (pk, )
Aug 18, 2020 89 motion for leave to file (5)
Docket Text: MOTION by Defendant Abbott Laboratories for leave to file Under Seal Defendant's Opposition to Motion to Compel Production of Two Unredacted Documents (Wickramasekera, Nimalka)
Aug 18, 2020 90 memorandum in opposition to motion (Main Document) (21)
Docket Text: MEMORANDUM by Abbott Laboratories in Opposition to motion to compel, [80] (Public Redacted Version) (Attachments: # (1) Declaration of Mark Engle, # (2) Declaration of Dan Hoang with Exhibits 1-2)(Wickramasekera, Nimalka)
Aug 18, 2020 90 memorandum in opposition to motion (Declaration of Mark Engle) (1)
Docket Text: MEMORANDUM by Abbott Laboratories in Opposition to motion to compel, [80] (Public Redacted Version) (Attachments: # (1) Declaration of Mark Engle, # (2) Declaration of Dan Hoang with Exhibits 1-2)(Wickramasekera, Nimalka)
Aug 18, 2020 90 memorandum in opposition to motion (Declaration of Dan Hoang with Exhibits 1-2) (5)
Docket Text: MEMORANDUM by Abbott Laboratories in Opposition to motion to compel, [80] (Public Redacted Version) (Attachments: # (1) Declaration of Mark Engle, # (2) Declaration of Dan Hoang with Exhibits 1-2)(Wickramasekera, Nimalka)
Aug 17, 2020 88 terminate hearings (1)
Docket Text: MINUTE entry before the Honorable John Z. Lee: Plaintiff's Responsive Claim Construction Brief 11/6/20; Defendant's Reply Claim Construction Brief 11/20/20; The Parties' Joint Claim Construction Chart 12/4/20.The claim construction hearing set for 9/15/20 is stricken.Mailed notice (ca, )
Aug 10, 2020 87 text entry (2)
Docket Text: MINUTE entry before the Honorable John Z. Lee: The Court enters the following schedule as proposed by the parties. Plaintiffs' List of Asserted Claims 6/23/20; Plaintiffs' Final Infringement Contentions 7/10/20; Defendant's Final Unenforceability and Invalidity Contentions 7/10/20; Defendant's Final Non Infringement Contentions 8/14/20; Plaintiffs' Final Enforceability and Validity Contentions 8/14/20; Parties Exchange Lists of Claim Terms and Proposed Constructions 09/4/20; NonDeposition Fact Discovery Closes 9/25/20; Defendant's Opening Claim Construction Brief 10/9/20. To the extent that Defendant disputes the sufficiency of Plaintiffs' Final Infringement Contentions, Defendant should file an appropriate motion with the Court. The Court orders the parties to file a joint written status report by 11/10/20. The report, which shall be as concise as possible, shall set forth: (1) the current deadlines imposed by the Court and whether the matter has been referred to the Magistrate Judge in any fashion (e.g., for discovery supervision; for resolution of a motion; for settlement; etc.); (2) the progress of discovery, if discovery is ongoing; (3) the status of briefing on unresolved motions, if any; (4) whether the parties have engaged or are engaging in settlement discussions and the status of those discussions; (5) for cases without any future court dates, an agreed proposed schedule; (6) for cases that have future court dates and if the parties believe there is good cause to extend the current deadlines, a proposed amended schedule and the basis for the request; (7) a request for any agreed action that the Court can take without a hearing; (8) and whether the parties believe a telephonic hearing or in-person hearing is necessary within the next 60 days, and, if so, the issue(s) that warrants discussion and the parties' respective positions. Mailed notice (ca, )
Aug 6, 2020 86 status report (8)
Docket Text: STATUS Report (JOINT STATUS REPORT ON DISCOVERY) by Evolve BioSystems, Inc., Regents of the University of California (Chivvis, Matthew)
Jul 22, 2020 85 order on motion to seal document (1)
Docket Text: MINUTE entry before the Honorable Heather K. McShain: The case has been referred [84] to this Court for ruling on plaintiffs' motion to seal [82] and motion to compel [80]. Plaintiffs' Motion for Leave to File Under Seal Memorandum in Support of Plaintiffs' Motion to Compel Two Unredacted Documents and Exhibits 1-9 To the Declaration of Matthew A. Chivvis, And References Thereto, In Support of Evolve Biosystems, Inc. and the Regents of The University of California's Motion to Compel [82] is granted. The Court notes that the sealed memorandum and exhibits were filed on 07/20/2020 [81]. Evolve Biosystems, Inc. and the Regents of The University of California's Motion to Compel Production of Two Unredacted Documents [80] is entered and continued. Defendant's response due 08/18/2020. Plaintiffs' reply, if any, due 09/01/2020. Upon review of plaintiffs' fully briefed motion, the Court will decide whether it can rule on the papers or will require a telephonic motion hearing to hear from the parties. Mailed notice. (pk, )
Jul 21, 2020 83 terminate hearings (1)
Docket Text: MINUTE entry before the Honorable John Z. Lee:Plaintiff's motion to compel [80] ad motion to file under seal [82] are referred to Magistrate Judge McShain. Mailed notice (ca, )
Jul 21, 2020 84 Expedited referral to magistrate judge (1)
Docket Text: Pursuant to Local Rule 72.1, this case is hereby referred to the calendar of Honorable Heather K. McShain for the purpose of holding proceedings related to: motion to seal document[82] and motion to compel [80].(ca, )Mailed notice.
Jul 20, 2020 80 motion to compel (Main Document) (3)
Docket Text: MOTION by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California to compel (MOTION TO COMPEL PRODUCTION OF TWO UNREDACTED DOCUMENTS) (Attachments: # (1) MEMORANDUM IN SUPPORT -- PUBLIC/REDACTED, # (2) DECLARATION OF MATTHEW A. CHIVVIS IN SUPPORT AND EXHIBITS 1-9 -- PUBLIC/REDACTED)(Chivvis, Matthew)
Jul 20, 2020 80 motion to compel (MEMORANDUM IN SUPPORT -- PUBLIC/REDACTED) (14)
Docket Text: MOTION by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California to compel (MOTION TO COMPEL PRODUCTION OF TWO UNREDACTED DOCUMENTS) (Attachments: # (1) MEMORANDUM IN SUPPORT -- PUBLIC/REDACTED, # (2) DECLARATION OF MATTHEW A. CHIVVIS IN SUPPORT AND EXHIBITS 1-9 -- PUBLIC/REDACTED)(Chivvis, Matthew)
Jul 20, 2020 80 motion to compel (DECLARATION OF MATTHEW A. CHIVVIS IN SUPPORT AND EXHIBITS 1-9 -- PUBLIC/REDACTE) (14)
Docket Text: MOTION by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California to compel (MOTION TO COMPEL PRODUCTION OF TWO UNREDACTED DOCUMENTS) (Attachments: # (1) MEMORANDUM IN SUPPORT -- PUBLIC/REDACTED, # (2) DECLARATION OF MATTHEW A. CHIVVIS IN SUPPORT AND EXHIBITS 1-9 -- PUBLIC/REDACTED)(Chivvis, Matthew)
Jul 20, 2020 82 motion to seal document (4)
Docket Text: MOTION by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California to seal document sealed document, [81] (Chivvis, Matthew)
Jul 10, 2020 79 order (8)
Docket Text: ORDER Fifth Amended General Order 20-0012 IN RE: CORONAVIRUS COVID-19 PUBLIC EMERGENCY Signed by the Chief Judge Rebecca R. Pallmeyer on July 10, 2020. This Order does not extend or modify any deadlines set in civil cases. No motions may be noticed for in-person presentment; the presiding judge will notify parties of the need, if any, for a hearing by electronic means or in-court proceeding. See attached Order. Signed by the Honorable Rebecca R. Pallmeyer on 7/10/2020: Mailed notice. (Clerk6, Docket)
May 28, 2020 78 text entry (1)
Docket Text: MINUTE entry before the Honorable John Z. Lee:The parties shall file a joint written report to Judge Lee on 8/6/20, addressing the status of discovery.Mailed notice (ca, )
May 26, 2020 77 order (8)
Docket Text: ORDER ORDER Fourth Amended General Order 20-0012 IN RE: CORONAVIRUS COVID-19 PUBLIC EMERGENCY Signed by the Chief Judge Rebecca R. Pallmeyer on May 26, 2020. This Order does not extend or modify any deadlines set in civil cases. For non-emergency motions, no motion may be noticed for presentment on a date earlier than July 15, 2020. See attached Order. Signed by the Honorable Rebecca R. Pallmeyer on 5/26/2020: Mailed notice. (docket7, )
May 18, 2020 75 status report (6)
Docket Text: STATUS Report (JOINT STATUS REPORT) by Evolve BioSystems, Inc., Regents of the University of California (Chivvis, Matthew)
Apr 29, 2020 76 order (5)
Docket Text: ORDER: (GENERAL ORDER 20-0018) It appearing that Heather K. McShain has entered on duty as a Magistrate Judge for the Northern District of Illinois, with a duty station in Chicago, Illinois, effective May 1, 2020; therefore It is hereby ordered pursuant to Local Rule 72.1 that Magistrate Judge McShain is to become the designated magistrate judge in any pending civil or criminal cases where Magistrate Judge Sidney I. Schenkier was the designated magistrate judge as of April 30, 2020; and It is further ordered pursuant to Internal Operating Procedure 17, the attached list of civil cases where the parties previously consented to proceed before Magistrate Judge Schenkier are hereby reassigned to Magistrate Judge McShain; and It is further ordered that the attached list of civil referral cases pending before Magistrate Judge Schenkier are hereby transferred to Magistrate Judge McShain; and It is further ordered that, unless otherwise ordered by Magistrate Judge McShain, all hearing dates, deadlines, and schedules set by Magistrate Judge Schenkier in the attached list of cases are to remain in effect. Signed by the Honorable Rebecca R. Pallmeyer on 4/29/2020. mailed notice(tg, )
Apr 24, 2020 74 order (11)
Docket Text: ORDER Third Amended General Order 20-0012 IN RE: CORONAVIRUS COVID-19 PUBLIC EMERGENCY Signed by the Chief Judge Rebecca R. Pallmeyer on April 24, 2020. All open cases are impacted by this Third Amended General Order. Parties are must carefully review all obligations under this Order, including the requirement listed in paragraph number 5 to file a joint written status report in most civil cases. See attached Order. Signed by the Honorable Rebecca R. Pallmeyer on 4/24/2020: Mailed notice. (docket6, )
Apr 7, 2020 73 terminate hearings (1)
Docket Text: MINUTE entry before the Honorable John Z. Lee:Pursuant to the Second Amended General Order 20-0012, In re: Coronovirus COVID-19 Public Emergency (dated Mar. 30, 2020), the status hearing set for 4/29/20 is hereby stricken. The Court will issue an order scheduling a status hearing at a future date. Mailed notice (ca, )
Mar 30, 2020 72 order (10)
Docket Text: ORDER Seconded Amended General Order 20-0012 IN RE: CORONAVIRUS COVID-19 PUBLIC EMERGENCY Signed by the Chief Judge Rebecca R. Pallmeyer on March 30, 2020. All open cases are impacted by this Second Amended General Order. Amended General Order 20-0012, entered on March 17, 2020, and General Order 20-0014, entered on March 20, 2020, are vacated and superseded by this Second Amended General. See attached Order for guidance.Signed by the Honorable Rebecca R. Pallmeyer on 3/30/2020: Mailed notice. (docket1, )
Mar 27, 2020 71 notice of change of address (2)
Docket Text: NOTICE by Charles Bennett Klein of Change of Address (Klein, Charles)
Mar 16, 2020 69 order (5)
Docket Text: ORDER Amended General Order 20-0012 IN RE: CORONAVIRUS COVID-19 PUBLIC EMERGENCY Signed by the Chief Judge Rebecca R. Pallmeyer on March 16, 2020. All open cases are impacted by this Amended General Order. See attached Order for guidance.Signed by the Honorable Rebecca R. Pallmeyer on 3/16/2020: Mailed notice. (ecw, )
Mar 16, 2020 70 order (5)
Docket Text: ORDER Amended General Order 20-0012 IN RE: CORONAVIRUS COVID-19 PUBLIC EMERGENCY Signed by the Chief Judge Rebecca R. Pallmeyer on March 16, 2020. All open cases are impacted by this Amended General Order. See attached Order for guidance.Signed by the Honorable Rebecca R. Pallmeyer on 3/16/2020: Mailed notice. (ecw, )
Mar 3, 2020 68 terminate hearings (1)
Docket Text: MINUTE entry before the Honorable John Z. Lee:In light of the proceedings before the Magistrate Judge, the status hearing set for 3/4/20 is reset to 4/29/20 at 9:00 a.m.Mailed notice (ca, )
Feb 24, 2020 66 status report (7)
Docket Text: STATUS Report (JOINT REPORT ON ESI PROTOCOL) by Evolve BioSystems, Inc., Regents of the University of California (Chivvis, Matthew)
Feb 24, 2020 67 terminate hearings (1)
Docket Text: MINUTE entry before the Honorable Sidney I. Schenkier: The Court has reviewed the parties' joint report on ESI protocol (doc. # [66]), which reflects substantial work and progress in moving forward on discovery of ESI. As a result, and at the request of the parties, we strike the status hearing set for 02/27/20 and RESET it to 03/31/20 at 9:00 a.m. Mailed notice. (dal, )
Feb 18, 2020 65 order on motion for miscellaneous relief (1)
Docket Text: MINUTE entry before the Honorable Sidney I. Schenkier: Parties' joint agreed motion for modification of the Court's order requiring in person meet and confer conferences (doc. # [63]) is granted; no appearance on the motion is required. In lieu of in person meet and confer conferences, the parties may conduct those conferences by videoconference in the presence of a court reporter. Mailed notice. (dal, )
Feb 14, 2020 63 motion for miscellaneous relief (3)
Docket Text: MOTION by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California (JOINT AGREED MOTION FOR MODIFICATION OF THE COURT'S ORDER REQUIRING IN-PERSON MEET AND CONFERS (DKT. 60) TO ALLOW FOR VIDEOCONFERENCING) (Chivvis, Matthew)
Feb 14, 2020 64 notice of motion (2)
Docket Text: NOTICE of Motion by Matthew Alan Chivvis for presentment of motion for miscellaneous relief, [63] before Honorable Sidney I. Schenkier on 2/25/2020 at 08:30 AM. (Chivvis, Matthew)
Feb 13, 2020 62 order on motion to compel (1)
Docket Text: MINUTE entry before the Honorable Sidney I. Schenkier: We have reviewed the parties' joint status report concerning plaintiffs' discovery requests (doc. # [61]). We applaud the parties on reaching agreements to resolve their disputes over those requests. Pursuant to the parties agreement as reflected in the report and as narrowed by the agreements reached, by 03/13/20 defendant shall produce documents in response to Requests for Production Nos. 3, 5, 12-14, 18, 20, 22, and 35-36 and responses to Interrogatories Nos. 1-2 and 4-9. Plaintiffs' motion to compel (doc. # [46]) is denied as moot and plaintiffs' motion to file under seal (doc. # [49]) is granted. We direct the parties to meet and confer about an ESI search protocol, and by 5:00 p.m. on 02/24/20, file a joint report setting forth their agreements, any areas of disagreement, and for each area of disagreement each side's respective position. The matter is set for a status hearing with the magistrate judge on 02/27/20 at 9:00 a.m. Mailed notice. (dal, )
Feb 12, 2020 59 text entry (1)
Docket Text: MINUTE entry before the Honorable Sidney I. Schenkier: ENTER ORDER. In view of the parties' 02/10/20 Joint Statement (doc. # [58]), we enter an order setting forth our determination of the Accused Products in the case and establishing a procedure for future meet and confer sessions that the parties conduct. Mailed notice. (dal, )
Feb 12, 2020 60 order (5)
Docket Text: ORDER signed by the Honorable Sidney I. Schenkier on 2/12/2020. Mailed notice. (dal, )
Feb 12, 2020 61 status report (14)
Docket Text: STATUS Report (JOINT STATUS REPORT REGARDING PLAINTIFFS' DISCOVERY REQUESTS) by Evolve BioSystems, Inc., Regents of the University of California (Chivvis, Matthew)
Feb 10, 2020 58 other (Main Document) (8)
Docket Text: Listing of Accused Products by Evolve BioSystems, Inc., Regents of the University of California (Attachments: # (1) Exhibit 1, # (2) Exhibit 2)(Chivvis, Matthew)
Feb 10, 2020 58 other (Exhibit 1) (30)
Docket Text: Listing of Accused Products by Evolve BioSystems, Inc., Regents of the University of California (Attachments: # (1) Exhibit 1, # (2) Exhibit 2)(Chivvis, Matthew)
Feb 10, 2020 58 other (Exhibit 2) (5)
Docket Text: Listing of Accused Products by Evolve BioSystems, Inc., Regents of the University of California (Attachments: # (1) Exhibit 1, # (2) Exhibit 2)(Chivvis, Matthew)
Feb 5, 2020 57 order on motion to compel (1)
Docket Text: MINUTE entry before the Honorable Sidney I. Schenkier: Status and motion hearings held. The Court enters and continues Plaintiffs' motion to compel production of documents and information (doc. #[46]). By 02/10/20, the parties will meet and confer regarding the accused products and submit to the Court in writing a list of the agreed products. In the case of any disagreements on accused products, the parties will identify each product and the basis for each side's position. By 02/12/20, the parties will meet and confer regarding specific discovery requests in the motion to compel, focusing on the technical/manufacturing information and inventor information discussed in open court, and shall file a joint status report listing any disputed requests which remain with each side's position on each disputed request. With respect to any information that the defense agrees to produce pursuant to the foregoing meet and confer sessions, the parties shall include in their submissions proposed deadlines for production. No further briefs on the motion to compel will be submitted. By 02/21/20, defendant will produce documents they already have agreed to produce pursuant to discovery requests. In its ruling on any disputes that arise from the meet and confer sessions, the Court will include a timeline for the parties to meet and confer to reach agreement on an ESI search protocol The Court will set a further status as necessary after reviewing the parties' submissions. Mailed notice. (dal, )
Feb 4, 2020 56 memorandum in support of motion (Main Document) (17)
Docket Text: MEMORANDUM (PUBLIC VERSION OF PREVIOUSLY SEALED MEMORANDUM IN SUPPORT OF MOTION TO COMPEL AND PREVIOUSLY SEALED EXHIBITS, ECF NO. 48) (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 5, # (5) Exhibit 6 (redacted), # (6) Exhibit 7, # (7) Exhibit 8, # (8) Exhibit 9, # (9) Exhibit 14)(Chivvis, Matthew)
Feb 4, 2020 56 memorandum in support of motion (Exhibit 1) (30)
Docket Text: MEMORANDUM (PUBLIC VERSION OF PREVIOUSLY SEALED MEMORANDUM IN SUPPORT OF MOTION TO COMPEL AND PREVIOUSLY SEALED EXHIBITS, ECF NO. 48) (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 5, # (5) Exhibit 6 (redacted), # (6) Exhibit 7, # (7) Exhibit 8, # (8) Exhibit 9, # (9) Exhibit 14)(Chivvis, Matthew)
Feb 4, 2020 56 memorandum in support of motion (Exhibit 2) (30)
Docket Text: MEMORANDUM (PUBLIC VERSION OF PREVIOUSLY SEALED MEMORANDUM IN SUPPORT OF MOTION TO COMPEL AND PREVIOUSLY SEALED EXHIBITS, ECF NO. 48) (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 5, # (5) Exhibit 6 (redacted), # (6) Exhibit 7, # (7) Exhibit 8, # (8) Exhibit 9, # (9) Exhibit 14)(Chivvis, Matthew)
Feb 4, 2020 56 memorandum in support of motion (Exhibit 3) (5)
Docket Text: MEMORANDUM (PUBLIC VERSION OF PREVIOUSLY SEALED MEMORANDUM IN SUPPORT OF MOTION TO COMPEL AND PREVIOUSLY SEALED EXHIBITS, ECF NO. 48) (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 5, # (5) Exhibit 6 (redacted), # (6) Exhibit 7, # (7) Exhibit 8, # (8) Exhibit 9, # (9) Exhibit 14)(Chivvis, Matthew)
Feb 4, 2020 56 memorandum in support of motion (Exhibit 5) (7)
Docket Text: MEMORANDUM (PUBLIC VERSION OF PREVIOUSLY SEALED MEMORANDUM IN SUPPORT OF MOTION TO COMPEL AND PREVIOUSLY SEALED EXHIBITS, ECF NO. 48) (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 5, # (5) Exhibit 6 (redacted), # (6) Exhibit 7, # (7) Exhibit 8, # (8) Exhibit 9, # (9) Exhibit 14)(Chivvis, Matthew)
Feb 4, 2020 56 memorandum in support of motion (Exhibit 6 (redacted)) (11)
Docket Text: MEMORANDUM (PUBLIC VERSION OF PREVIOUSLY SEALED MEMORANDUM IN SUPPORT OF MOTION TO COMPEL AND PREVIOUSLY SEALED EXHIBITS, ECF NO. 48) (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 5, # (5) Exhibit 6 (redacted), # (6) Exhibit 7, # (7) Exhibit 8, # (8) Exhibit 9, # (9) Exhibit 14)(Chivvis, Matthew)
Feb 4, 2020 56 memorandum in support of motion (Exhibit 7) (5)
Docket Text: MEMORANDUM (PUBLIC VERSION OF PREVIOUSLY SEALED MEMORANDUM IN SUPPORT OF MOTION TO COMPEL AND PREVIOUSLY SEALED EXHIBITS, ECF NO. 48) (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 5, # (5) Exhibit 6 (redacted), # (6) Exhibit 7, # (7) Exhibit 8, # (8) Exhibit 9, # (9) Exhibit 14)(Chivvis, Matthew)
Feb 4, 2020 56 memorandum in support of motion (Exhibit 8) (30)
Docket Text: MEMORANDUM (PUBLIC VERSION OF PREVIOUSLY SEALED MEMORANDUM IN SUPPORT OF MOTION TO COMPEL AND PREVIOUSLY SEALED EXHIBITS, ECF NO. 48) (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 5, # (5) Exhibit 6 (redacted), # (6) Exhibit 7, # (7) Exhibit 8, # (8) Exhibit 9, # (9) Exhibit 14)(Chivvis, Matthew)
Feb 4, 2020 56 memorandum in support of motion (Exhibit 9) (4)
Docket Text: MEMORANDUM (PUBLIC VERSION OF PREVIOUSLY SEALED MEMORANDUM IN SUPPORT OF MOTION TO COMPEL AND PREVIOUSLY SEALED EXHIBITS, ECF NO. 48) (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 5, # (5) Exhibit 6 (redacted), # (6) Exhibit 7, # (7) Exhibit 8, # (8) Exhibit 9, # (9) Exhibit 14)(Chivvis, Matthew)
Feb 4, 2020 56 memorandum in support of motion (Exhibit 14) (7)
Docket Text: MEMORANDUM (PUBLIC VERSION OF PREVIOUSLY SEALED MEMORANDUM IN SUPPORT OF MOTION TO COMPEL AND PREVIOUSLY SEALED EXHIBITS, ECF NO. 48) (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 5, # (5) Exhibit 6 (redacted), # (6) Exhibit 7, # (7) Exhibit 8, # (8) Exhibit 9, # (9) Exhibit 14)(Chivvis, Matthew)
Jan 29, 2020 51 terminate hearings (1)
Docket Text: MINUTE entry before the Honorable John Z. Lee:Plaintiff's motion to compel [46] and motion for leave to file under seal [49] are referred to Magistrate Judge Schenkier; including general discovery supervision. No appearance is required on the motions. Mailed notice (ca, )
Jan 29, 2020 52 Expedited referral to magistrate judge (1)
Docket Text: Pursuant to Local Rule 72.1, this case is hereby referred to the calendar of Honorable Sidney I. Schenkier for the purpose of holding proceedings related to: General discovery supervision and motion to seal document[49] motion to compel [46].(ca, ). Mailed notice.
Jan 29, 2020 53 notice of motion (3)
Docket Text: NOTICE of Motion by Matthew Alan Chivvis for presentment of motion to compel,, [46] before Honorable Sidney I. Schenkier on 2/4/2020 at 08:30 AM. (Chivvis, Matthew)
Jan 29, 2020 54 notice of motion (3)
Docket Text: NOTICE of Motion by Matthew Alan Chivvis for presentment of motion to seal document[49] before Honorable Sidney I. Schenkier on 2/4/2020 at 08:30 AM. (Chivvis, Matthew)
Jan 29, 2020 55 terminate hearings (1)
Docket Text: MINUTE entry before the Honorable Sidney I. Schenkier: The case has been referred to this Court (doc. #[52]). The motion hearings on plaintiffs' motion for leave to file under seal (doc. #[49]) and plaintiffs' motion to compel (doc. #[46]) noticed for 02/04/20 are stricken. The matter is set for a status hearing with the magistrate judge on 02/05/20 at 8:30 a.m. Mailed notice. (dal, )
Jan 27, 2020 46 motion to compel (Main Document) (3)
Docket Text: MOTION by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California to compel (MOTION TO COMPEL PRODUCTION OF DOCUMENTS AND INFORMATION) (Attachments: # (1) Memorandum in Support of Motion to Compel (public placeholder), # (2) Declaration of Matthew Chivvis in Support of Motion to Compel, # (3) Exhibit 4, # (4) Exhibit 10, # (5) Exhibit 11, # (6) Exhibit 12, # (7) Exhibit 13, # (8) Exhibit 15, # (9) Exhibit s 1-3, 5-9- 14 (public placeholders))(Chivvis, Matthew)
Jan 27, 2020 47 notice of motion (3)
Docket Text: NOTICE of Motion by Matthew Alan Chivvis for presentment of motion to compel,, [46] before Honorable John Z. Lee on 1/30/2020 at 09:00 AM. (Chivvis, Matthew)
Jan 27, 2020 49 motion to seal document (4)
Docket Text: MOTION by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California to seal document sealed document, [48] (Chivvis, Matthew)
Jan 27, 2020 50 notice of motion (3)
Docket Text: NOTICE of Motion by Matthew Alan Chivvis for presentment of motion to seal document[49] before Honorable John Z. Lee on 1/30/2020 at 09:00 AM. (Chivvis, Matthew)
Jan 27, 2020 46 motion to compel (Memorandum in Support of Motion to Compel (public placeholder)) (1)
Docket Text: MOTION by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California to compel (MOTION TO COMPEL PRODUCTION OF DOCUMENTS AND INFORMATION) (Attachments: # (1) Memorandum in Support of Motion to Compel (public placeholder), # (2) Declaration of Matthew Chivvis in Support of Motion to Compel, # (3) Exhibit 4, # (4) Exhibit 10, # (5) Exhibit 11, # (6) Exhibit 12, # (7) Exhibit 13, # (8) Exhibit 15, # (9) Exhibit s 1-3, 5-9- 14 (public placeholders))(Chivvis, Matthew)
Jan 27, 2020 46 motion to compel (Declaration of Matthew Chivvis in Support of Motion to Compel) (6)
Docket Text: MOTION by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California to compel (MOTION TO COMPEL PRODUCTION OF DOCUMENTS AND INFORMATION) (Attachments: # (1) Memorandum in Support of Motion to Compel (public placeholder), # (2) Declaration of Matthew Chivvis in Support of Motion to Compel, # (3) Exhibit 4, # (4) Exhibit 10, # (5) Exhibit 11, # (6) Exhibit 12, # (7) Exhibit 13, # (8) Exhibit 15, # (9) Exhibit s 1-3, 5-9- 14 (public placeholders))(Chivvis, Matthew)
Jan 27, 2020 46 motion to compel (Exhibit 4) (3)
Docket Text: MOTION by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California to compel (MOTION TO COMPEL PRODUCTION OF DOCUMENTS AND INFORMATION) (Attachments: # (1) Memorandum in Support of Motion to Compel (public placeholder), # (2) Declaration of Matthew Chivvis in Support of Motion to Compel, # (3) Exhibit 4, # (4) Exhibit 10, # (5) Exhibit 11, # (6) Exhibit 12, # (7) Exhibit 13, # (8) Exhibit 15, # (9) Exhibit s 1-3, 5-9- 14 (public placeholders))(Chivvis, Matthew)
Jan 27, 2020 46 motion to compel (Exhibit 10) (4)
Docket Text: MOTION by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California to compel (MOTION TO COMPEL PRODUCTION OF DOCUMENTS AND INFORMATION) (Attachments: # (1) Memorandum in Support of Motion to Compel (public placeholder), # (2) Declaration of Matthew Chivvis in Support of Motion to Compel, # (3) Exhibit 4, # (4) Exhibit 10, # (5) Exhibit 11, # (6) Exhibit 12, # (7) Exhibit 13, # (8) Exhibit 15, # (9) Exhibit s 1-3, 5-9- 14 (public placeholders))(Chivvis, Matthew)
Jan 27, 2020 46 motion to compel (Exhibit 11) (12)
Docket Text: MOTION by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California to compel (MOTION TO COMPEL PRODUCTION OF DOCUMENTS AND INFORMATION) (Attachments: # (1) Memorandum in Support of Motion to Compel (public placeholder), # (2) Declaration of Matthew Chivvis in Support of Motion to Compel, # (3) Exhibit 4, # (4) Exhibit 10, # (5) Exhibit 11, # (6) Exhibit 12, # (7) Exhibit 13, # (8) Exhibit 15, # (9) Exhibit s 1-3, 5-9- 14 (public placeholders))(Chivvis, Matthew)
Jan 27, 2020 46 motion to compel (Exhibit 12) (9)
Docket Text: MOTION by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California to compel (MOTION TO COMPEL PRODUCTION OF DOCUMENTS AND INFORMATION) (Attachments: # (1) Memorandum in Support of Motion to Compel (public placeholder), # (2) Declaration of Matthew Chivvis in Support of Motion to Compel, # (3) Exhibit 4, # (4) Exhibit 10, # (5) Exhibit 11, # (6) Exhibit 12, # (7) Exhibit 13, # (8) Exhibit 15, # (9) Exhibit s 1-3, 5-9- 14 (public placeholders))(Chivvis, Matthew)
Jan 27, 2020 46 motion to compel (Exhibit 13) (2)
Docket Text: MOTION by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California to compel (MOTION TO COMPEL PRODUCTION OF DOCUMENTS AND INFORMATION) (Attachments: # (1) Memorandum in Support of Motion to Compel (public placeholder), # (2) Declaration of Matthew Chivvis in Support of Motion to Compel, # (3) Exhibit 4, # (4) Exhibit 10, # (5) Exhibit 11, # (6) Exhibit 12, # (7) Exhibit 13, # (8) Exhibit 15, # (9) Exhibit s 1-3, 5-9- 14 (public placeholders))(Chivvis, Matthew)
Jan 27, 2020 46 motion to compel (Exhibit 15) (5)
Docket Text: MOTION by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California to compel (MOTION TO COMPEL PRODUCTION OF DOCUMENTS AND INFORMATION) (Attachments: # (1) Memorandum in Support of Motion to Compel (public placeholder), # (2) Declaration of Matthew Chivvis in Support of Motion to Compel, # (3) Exhibit 4, # (4) Exhibit 10, # (5) Exhibit 11, # (6) Exhibit 12, # (7) Exhibit 13, # (8) Exhibit 15, # (9) Exhibit s 1-3, 5-9- 14 (public placeholders))(Chivvis, Matthew)
Jan 27, 2020 46 motion to compel (Exhibit s 1-3, 5-9- 14 (public placeholders)) (1)
Docket Text: MOTION by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California to compel (MOTION TO COMPEL PRODUCTION OF DOCUMENTS AND INFORMATION) (Attachments: # (1) Memorandum in Support of Motion to Compel (public placeholder), # (2) Declaration of Matthew Chivvis in Support of Motion to Compel, # (3) Exhibit 4, # (4) Exhibit 10, # (5) Exhibit 11, # (6) Exhibit 12, # (7) Exhibit 13, # (8) Exhibit 15, # (9) Exhibit s 1-3, 5-9- 14 (public placeholders))(Chivvis, Matthew)
Jan 13, 2020 44 order on motion for protective order (1)
Docket Text: MINUTE entry before the Honorable John Z. Lee:Joint agreed motion for entry of a stipulated protective order [41] is granted. No appearance is required on the motion.Mailed notice (ca, )
Jan 13, 2020 45 protective order (23)
Docket Text: STIPULATED Protective Order Signed by the Honorable John Z. Lee on 1/13/20.Mailed notice(ca, )
Jan 10, 2020 43 reply to response to motion (21)
Docket Text: REPLY by Abbott Laboratories to MOTION TO DISMISS FOR FAILURE TO STATE A CLAIM by Defendant Abbott Laboratories [32] (Wickramasekera, Nimalka)
Jan 8, 2020 41 motion for protective order (Main Document) (4)
Docket Text: MOTION by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California for protective order (JOINT AGREED MOTION FOR ENTRY OF STIPULATED PROTECTIVE ORDER) (Attachments: # (1) Text of Proposed Order, # (2) Text of Proposed Order (redline comparing proposed order to Court's model order))(Chivvis, Matthew)
Jan 8, 2020 41 motion for protective order (Text of Proposed Order) (24)
Docket Text: MOTION by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California for protective order (JOINT AGREED MOTION FOR ENTRY OF STIPULATED PROTECTIVE ORDER) (Attachments: # (1) Text of Proposed Order, # (2) Text of Proposed Order (redline comparing proposed order to Court's model order))(Chivvis, Matthew)
Jan 8, 2020 41 motion for protective order (Text of Proposed Order (redline comparing proposed order to Court's model) (30)
Docket Text: MOTION by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California for protective order (JOINT AGREED MOTION FOR ENTRY OF STIPULATED PROTECTIVE ORDER) (Attachments: # (1) Text of Proposed Order, # (2) Text of Proposed Order (redline comparing proposed order to Court's model order))(Chivvis, Matthew)
Jan 8, 2020 42 notice of motion (2)
Docket Text: (JOINT AGREED MOTION) NOTICE of Motion by Matthew Alan Chivvis for presentment of motion for protective order, [41] before Honorable John Z. Lee on 1/15/2020 at 09:00 AM. (Chivvis, Matthew)
Dec 18, 2019 40 order on motion to seal document (1)
Docket Text: MINUTE entry before the Honorable John Z. Lee:The Court grants Plaintiffs' unopposed motion to seal certain exhibits attached to Plaintiffs' Opposition to Abbott Laboratories' Motion to Dismiss [38]. A redacted, public version shall be filed. Typically, under Local Rule 5.8, motions to file materials under seal must include a "statement indicating that the document is filed under seal in accordance with an order of the court and the date of that order." To date, however, neither party has moved for entry of a proposed protective (confidentiality) order. By January 8, 2020, the parties shall jointly move for entry of a proposed protective (confidentiality) order in compliance with Judge Lee's standing order.Mailed notice (ca, )
Dec 17, 2019 36 memorandum in opposition to motion (Main Document) (21)
Docket Text: MEMORANDUM by Evolve BioSystems, Inc., Regents of the University of California in Opposition to Motion to Dismiss for Failure to State a Claim[32] (Attachments: # (1) Declaration (Declaration of Matthew Chivvis in Support including Exhibits A-F))(Chivvis, Matthew)
Dec 17, 2019 36 memorandum in opposition to motion (Declaration (Declaration of Matthew Chivvis in Support including Exhibits A-F)) (26)
Docket Text: MEMORANDUM by Evolve BioSystems, Inc., Regents of the University of California in Opposition to Motion to Dismiss for Failure to State a Claim[32] (Attachments: # (1) Declaration (Declaration of Matthew Chivvis in Support including Exhibits A-F))(Chivvis, Matthew)
Dec 17, 2019 38 motion to seal document (3)
Docket Text: MOTION by Plaintiffs Evolve BioSystems, Inc., Regents of the University of California to seal document sealed document, [37] (UNOPPOSED Motion for Leave to File Under Seal Exhibits to the Declaration of Matthew A. Chivvis, and References Thereto, in Support of Plaintiffs' Opposition to Abbott Laboratories' Motion to Dismiss) (Chivvis, Matthew)
Dec 17, 2019 39 notice of motion (2)
Docket Text: (UNOPPOSED Motion) NOTICE of Motion by Matthew Alan Chivvis for presentment of motion to seal document, [38] before Honorable John Z. Lee on 1/7/2020 at 09:00 AM. (Chivvis, Matthew)
Nov 13, 2019 35 terminate hearings (1)
Docket Text: MINUTE entry before the Honorable John Z. Lee:Plaintiffs' response to Defendant's motion to dismiss is due 12/17/19; Defendant's reply is due 1/10/20 pursuant to the scheduling order entered by the Court. No appearance on the motion is necessary.Mailed notice (ca, )
Nov 12, 2019 32 Motion to Dismiss for Failure to State a Claim (3)
Docket Text: MOTION TO DISMISS FOR FAILURE TO STATE A CLAIM by Defendant Abbott Laboratories (Wickramasekera, Nimalka)
Nov 12, 2019 33 memorandum in support of motion (Main Document) (22)
Docket Text: MEMORANDUM by Abbott Laboratories in support of Motion to Dismiss for Failure to State a Claim[32] (Attachments: # (1) Declaration of Dan H. Hoang with Exhibits 1-3)(Wickramasekera, Nimalka)
Nov 12, 2019 33 memorandum in support of motion (Declaration of Dan H. Hoang with Exhibits 1-3) (30)
Docket Text: MEMORANDUM by Abbott Laboratories in support of Motion to Dismiss for Failure to State a Claim[32] (Attachments: # (1) Declaration of Dan H. Hoang with Exhibits 1-3)(Wickramasekera, Nimalka)
Nov 12, 2019 34 notice of motion (3)
Docket Text: NOTICE of Motion by Nimalka Ratnavali Wickramasekera for presentment of Motion to Dismiss for Failure to State a Claim[32] before Honorable John Z. Lee on 11/19/2019 at 09:00 AM. (Wickramasekera, Nimalka)
Oct 28, 2019 31 transcript (9)
Docket Text: TRANSCRIPT OF PROCEEDINGS held on 10/23/19 before the Honorable John Z. Lee. Court Reporter Contact Information: Joseph Rickhoff, 312-435-5562, joseph_rickhoff@ilnd.uscourts.gov.

IMPORTANT: The transcript may be viewed at the court's public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through the Court Reporter/Transcriber or PACER. For further information on the redaction process, see the Court's web site at www.ilnd.uscourts.gov under Quick Links select Policy Regarding the Availability of Transcripts of Court Proceedings.

Redaction Request due 11/18/2019. Redacted Transcript Deadline set for 11/29/2019. Release of Transcript Restriction set for 1/27/2020. (Rickhoff, Joseph)
Oct 24, 2019 28 text entry (1)
Docket Text: MINUTE entry before the Honorable John Z. Lee:The Court enters the following scheduling order: Defendant's anticipated Motion to Dismiss or Answer to the Amended Complaint is due by 11/12/19, the parties initial disclosures are due by 11/12/19; Plaintiffs' Initial Infringement Contentions are due by 11/26/19; Defendant's Initial Non-Infringement, Unenforceability, and Invalidity Contentions are due by 12/13/19; Plaintiffs' Response to Motion to Dismiss or Answer to Counterclaim is due by 12/17/19; Defendant's Reply in support of Motion to Dismiss is due by 1/10/20; Plaintiffs' Initial Response to Non-Infringement and Invalidity Contentions are due by 1/14/20; Plaintiffs' List of Asserted Claims is due by 4/7/20; Plaintiffs' Final Infringement Contentions are due by 4/21/20; Defendant's Final Unenforceability and Invalidity Contentions are due by 4/21/20; Defendant's Final Non-Infringement Contentions are due by 5/19/20; Plaintiffs' Final Enforceability and Validity Contentions are due by 5/19/20; Parties Exchange Lists of Claim Terms and Proposed Constructions by 6/2/20; Fact Discovery Closes; Defendant's Opening Claim Construction Brief is due by 7/7/20; Plaintiffs' Responsive Claim Construction Brief due by 8/4/20; Defendant's Reply Claim Construction Brief is due by 8/18/20; Parties' Joint Claim Construction Chart; Hearing on Claim Construction is set for 9/15/20 at 1:30 p.m. Mailed notice (ca, )
Oct 24, 2019 29 set/reset hearings (1)
Docket Text: MINUTE entry before the Honorable John Z. Lee:Claim construction hearing set for 9/15/20 at 1:30 p.m.Mailed notice (ca, )
Oct 24, 2019 30 order (2)
Docket Text: SCHEDULING ORDER Signed by the Honorable John Z. Lee on 10/24/19. Mailed notice(ca, )
Oct 23, 2019 27 status hearing (1)
Docket Text: MINUTE entry before the Honorable John Z. Lee:Status hearing held on 10/23/19. Defendant's motion to dismiss shall be due by 11/12/19; response due by 12/17/19; reply due by 1/10/20. The parties should submit a proposed scheduling order in Microsoft Word format to the proposed order mailbox and contact the courtroom deputy when they have done so. Out of town counsel may appear by telephone for the next status and should contact the courtroom deputy the day before with a call-in number. Status hearing set for 3/4/20 at 9:00 a.m.Mailed notice (ca, )
Oct 17, 2019 26 status report (9)
Docket Text: STATUS Report (JOINT INITIAL STATUS REPORT) by Evolve BioSystems, Inc., Regents of the University of California (Flaming, Todd)
Oct 10, 2019 24 motion to appear pro hac vice (Main Document) (2)
Docket Text: MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-16325729. (Attachments: # (1) Affidavits of Sponsors)(Klein, Charles)
Oct 10, 2019 24 motion to appear pro hac vice (Affidavits of Sponsors) (4)
Docket Text: MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-16325729. (Attachments: # (1) Affidavits of Sponsors)(Klein, Charles)
Oct 10, 2019 25 order on motion to appear pro hac vice (1)
Docket Text: MINUTE entry before the Honorable John Z. Lee:Motions for leave to appear pro hac vice by Parisa Jorjani [23] and Charles Klein [24] are granted.Mailed notice (ca, )
Oct 8, 2019 22 order on motion to appear pro hac vice (1)
Docket Text: MINUTE entry before the Honorable John Z. Lee:Motions to appear pro hac vice by James Hancock [19] and Stephanie Blij [21] are granted. Mailed notice (ca, )
Oct 8, 2019 23 motion to appear pro hac vice (3)
Docket Text: MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-16317097. (Parisa, Jorjani)
Oct 7, 2019 1 Amended Complaint* (1)
Oct 7, 2019 19 motion to appear pro hac vice (2)
Docket Text: MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-16311965. for James Hancock on behalf of Plaintiffs (Hancock, James)
Oct 7, 2019 20 amended complaint (Main Document) (18)
Docket Text: AMENDED complaint by Evolve BioSystems, Inc., Regents of the University of California against All Plaintiffs (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3)(Chivvis, Matthew)
Oct 7, 2019 20 amended complaint (Exhibit 1) (30)
Docket Text: AMENDED complaint by Evolve BioSystems, Inc., Regents of the University of California against All Plaintiffs (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3)(Chivvis, Matthew)
Oct 7, 2019 20 amended complaint (Exhibit 2) (19)
Docket Text: AMENDED complaint by Evolve BioSystems, Inc., Regents of the University of California against All Plaintiffs (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3)(Chivvis, Matthew)
Oct 7, 2019 20 amended complaint (Exhibit 3) (9)
Docket Text: AMENDED complaint by Evolve BioSystems, Inc., Regents of the University of California against All Plaintiffs (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3)(Chivvis, Matthew)
Oct 7, 2019 21 motion to appear pro hac vice (2)
Docket Text: MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-16313425. (Blij, Stephanie)
Sep 30, 2019 18 order on motion for extension of time to answer (1)
Docket Text: MINUTE entry before the Honorable John Z. Lee:Motion for extension of time until October 29, 2019 to answer [14] is granted. No appearance is required on the motion.Mailed notice (ca, )
Sep 26, 2019 13 attorney appearance (1)
Docket Text: ATTORNEY Appearance for Defendant Abbott Laboratories by Nimalka Ratnavali Wickramasekera (Wickramasekera, Nimalka)
Sep 26, 2019 14 motion for extension of time to file answer (4)
Docket Text: MOTION by Defendant Abbott Laboratories for extension of time to file answer regarding complaint[1] or Otherwise Respond to Plaintiffs' Complaint (AGREED) (Wickramasekera, Nimalka)
Sep 26, 2019 15 notice of motion (3)
Docket Text: NOTICE of Motion by Nimalka Ratnavali Wickramasekera for presentment of motion for extension of time to file answer[14] before Honorable John Z. Lee on 10/1/2019 at 09:00 AM. (Wickramasekera, Nimalka)
Sep 26, 2019 16 attorney appearance (1)
Docket Text: ATTORNEY Appearance for Defendant Abbott Laboratories by Dan Huy Hoang (Hoang, Dan)
Sep 26, 2019 17 attorney appearance (1)
Docket Text: ATTORNEY Appearance for Defendant Abbott Laboratories by Michael R. Rueckheim (Rueckheim, Michael)
Sep 24, 2019 12 summons returned executed (1)
Docket Text: SUMMONS Returned Executed by Evolve BioSystems, Inc., Regents of the University of California as to Abbott Laboratories on 9/17/2019, answer due 10/8/2019. (Flaming, Todd)
Sep 12, 2019 N/A summons issued (0)
Docket Text: SUMMONS Issued as to Defendant Abbott Laboratories (daj, )
Sep 6, 2019 11 set/reset hearings (1)
Docket Text: MINUTE entry before the Honorable John Z. Lee: Initial status hearing set for 10/23/19 at 9:00 a.m. The parties are directed to file a joint initial status report four business days prior to the initial status hearing. Mailed notice (ca, )
Sep 3, 2019 9 Patent/Trademark report (Main Document) (1)
Docket Text: MAILED patent report to Patent Trademark Office, Alexandria VA (Attachments: # (1) Exhibit)(mc, )
Sep 3, 2019 9 Patent/Trademark report (Exhibit) (30)
Docket Text: MAILED patent report to Patent Trademark Office, Alexandria VA (Attachments: # (1) Exhibit)(mc, )
Sep 3, 2019 10 order on motion to appear pro hac vice (1)
Docket Text: MINUTE entry before the Honorable John Z. Lee: Matthew A. Chivvis' motion for leave to appear pro hac vice for Plaintiffs [8] is granted. Mailed notice (mw, )
Aug 30, 2019 1 Complaint* (1)
Aug 30, 2019 N/A case assigned (0)
Docket Text: CASE ASSIGNED to the Honorable John Z. Lee. Designated as Magistrate Judge the Honorable Sidney I. Schenkier. Case assignment: Random assignment. (td, )
Aug 30, 2019 1 complaint (Main Document) (12)
Docket Text: COMPLAINT filed by Evolve BioSystems, Inc., Regents of the University of California; Jury Demand. Filing fee $ 400, receipt number 0752-16193024. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2)(Flaming, Todd)
Aug 30, 2019 1 complaint (Exhibit 1) (30)
Docket Text: COMPLAINT filed by Evolve BioSystems, Inc., Regents of the University of California; Jury Demand. Filing fee $ 400, receipt number 0752-16193024. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2)(Flaming, Todd)
Aug 30, 2019 1 complaint (Exhibit 2) (9)
Docket Text: COMPLAINT filed by Evolve BioSystems, Inc., Regents of the University of California; Jury Demand. Filing fee $ 400, receipt number 0752-16193024. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2)(Flaming, Todd)
Aug 30, 2019 2 civil cover sheet (2)
Docket Text: CIVIL Cover Sheet (Flaming, Todd)
Aug 30, 2019 3 attorney appearance (1)
Docket Text: ATTORNEY Appearance for Plaintiffs Evolve BioSystems, Inc., Regents of the University of California by Todd H. Flaming (Flaming, Todd)
Aug 30, 2019 4 other (2)
Docket Text: Local Rule 3.4 Notice of Claims Involving Patents by Evolve BioSystems, Inc., Regents of the University of California (Flaming, Todd)
Aug 30, 2019 5 notification of affiliates pursuant to local rule 3.2 (2)
Docket Text: NOTIFICATION of Affiliates pursuant to Local Rule 3.2 by All Plaintiffs (and FRCP 7.1) (Flaming, Todd)
Aug 30, 2019 6 other (2)
Docket Text: Local Rule 3.4 Notice of Claims Involving Patents (CORRECTED) by Evolve BioSystems, Inc., Regents of the University of California (Flaming, Todd)
Aug 30, 2019 7 notification of affiliates pursuant to local rule 3.2 (2)
Docket Text: NOTIFICATION of Affiliates pursuant to Local Rule 3.2 by All Plaintiffs (and FRCP 7.1) (CORRECTED) (Flaming, Todd)
Aug 30, 2019 8 motion to appear pro hac vice (2)
Docket Text: MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-16194073. (Chivvis, Matthew)
Menu